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GENERAL INTRODUCTION
Mrs. S.
Mrs. S., a 60-year old woman is married and has two daughters. Since four years, she suffers from a severe 
depressive episode. She feels down, is not interested anymore in activities she normally enjoys, has 
great trouble concentrating and only sleeps a couple of hours each night. She even experiences suicidal 
thoughts. In addition, she suffers from panic attacks. After a while, Mrs. S. stops working in her own 
business.
In terms of treatment, Mrs. S. first receives an antidepressant (SSRI) and anxiety-reducing medication 
(benzodiazepines) by her general practitioner. Unfortunately, the antidepressant has no effect and 
she is referred to a mental health care institution. There she receives cognitive-behavioral therapy and 
switches to other antidepressant (mirtazapine). After a while, an augmentation strategy is applied by 
adding quetiapine. The treatment has some minor effects. The suicidal thoughts disappear. However, 
Mrs. S. is still severely depressed. She barely sleeps 4-5 hours each night and ruminates a lot.
At a nearby mental health care institution, Mindfulness-Based Cognitive Therapy (MBCT) is available. 
Might MBCT be effective for Mrs. S.? And if so, how might MBCT work?
Major depressive disorder
Major depressive disorder (or depression) is a common psychiatric disorder, affecting 
about 30.3 million people each year in Europe (Wittchen et al., 2011). The two main 
symptoms of depression are sad mood and decreased interest or pleasure in normally 
enjoyable activities. To diagnose a major depressive disorder according to the Diagnostic 
statistical manual of Mental Disorder (4th ed., text rev.; DSM-IV-TR, American Psychiatric 
Association, 2000; 5th ed.; DSM-5, American Psychiatric Association, 2013), at least one of 
these two core symptoms has to be present. Other symptoms of a depressive episode 
are: insomnia or hypersomnia, feelings of excessive guilt or worthlessness, reduced 
or increased appetite or changes in weight, fatigue or loss of energy, psychomotor 
agitation or retardation, problems with concentration, and recurrent thoughts about 
death or suicide. To diagnose a major depressive disorder, in total at least five of these 
symptoms must be present for two weeks or longer, causing significant social or work-
related impairments (American Psychiatric Association, 2000, 2013). Approximately 
one out of five adults will suffer from one or more depressive episodes during their 
lifetime (Bijl, Ravelli, & Van Zessen, 1998; Kessler et al., 2003). Depression is one of the 
leading contributors to the worldwide disease burden according to the World Health 
Organization (Collins et al., 2011) and will be the most disabling disease in high income 
countries in 2030 (Mathers & Loncar, 2006). Depression is associated with a reduction in 
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general health (Moussavi et al., 2007) and an increased risk to attempt suicide (Kessler, 
Borges, & Walters, 1999). Depression is not only a very burdensome but also a highly 
recurrent disorder. About 75% of all patients experiences more than one depressive 
episode during their lifetime (Boland, Keller, Gotlib, & Hammen, 2002). 
Depression is not only prone to recurrence but also to chronicity. About 20% of all 
depressed patients develop a chronic course (Spijker et al., 2002), which is typically 
defined as fulfilling the criteria for a major depressive disorder during a period of 24 
months or longer (American Psychiatric Association, 2000). However, data of a large 
epidemiological study show that after a depressive episode of 12 months the chances of 
recovery decrease substantially (Spijker et al., 2002). Chronic depression not only has a 
tremendous influence on the personal life of a patient, his/her family, and work, but also 
causes high societal costs due to workplace losses and treatment costs (Pincus, 2001). 
Chronic depression is often associated with childhood adversity and a young age of 
onset at the first depressive episode (Hölzel, Härter, Reese, & Kriston, 2011). Furthermore, 
chronically depressed patients have higher chances of attempting suicide and it is 
very common that patients suffer of comorbid disorders such as anxiety disorders or 
personality disorder (Torpey & Klein, 2008). So far, only few studies have investigated 
whether chronically depressed patients show more dysfunctional cognitive information 
processing than non-chronic depressed patients. There are indications that compared 
with non-chronic depressed patients, chronically depressed patients show more 
dysfunctional attitudes, more cognitive reactivity, a higher external locus of control, and 
more neuroticism (Riso et al., 2003; Wiersma et al., 2011). This could partly explain why 
psychotherapy is less effective in chronically depressed patients compared with non-
chronic patients (Cuijpers, van Straten, Andersson, & van Oppen, 2008).
Treatment of depression
Several evidence-based treatments for depression are available. According to multi-
disciplinary treatment guidelines, mild to moderately depressed patients could 
be treated with psychological treatments such as behavioral activation, cognitive-
behavioral therapy (CBT), interpersonal therapy (IPT), short psychodynamic supportive 
therapy or antidepressant medication (NICE, 2009; Spijker et al., 2013) . For moderately 
to severely depressed patients, a combination of psychological treatment and 
pharmacotherapy is preferable. 
Although multiple evidence-based treatments are available, a substantial amount of 
patients do not respond sufficiently to treatment. About 50-60% does not respond 
to initial antidepressant medication or psychological treatment (DeRubeis, Hollon, 
Amsterdam, & et al., 2005; Fava, 2003). Even if several treatments are provided 
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successively, a substantial amount of patients fails to respond. Studies reported that 
up to 15%-33% of all depressed patients remain depressed despite of completion of 
several antidepressant treatments (Trevino, McClintock, Fischer, Vora, & Husain, 2014) 
or combined treatment with antidepressant medication and psychotherapy (Hollon et 
al., 2014; Peeters et al., 2016). Whereas chronic depression is commonly defined by the 
duration of depressive symptoms (American Psychiatric Association, 2000), there is no 
unified definition of treatment-resistance. Many clinical trials define treatment-resistance 
by the number of antidepressants that a patient received (Berlim & Turecki, 2007b), but 
also patients not responding to “standard treatment” (p.617, Kenny & Williams, 2007) 
are labeled as treatment-resistant in the literature. Importantly, chronic and treatment-
resistant depression are closely related. Chronic depression is associated with a lower 
response to treatment (Cuijpers et al., 2008) and patients not responding to several 
different treatments are likely to stay chronically depressed (Berlim & Turecki, 2007a). 
Recent papers acknowledge that only few studies are available on the effectiveness of 
treatments for chronic depression and that new treatment options are needed (Cuijpers, 
Huibers, & Furukawa, 2017; Mrazek, Hornberger, Altar, & Degtiar, 2014).
Mindfulness-Based Cognitive Therapy
Mindfulness-Based Cognitive Therapy (MBCT) is a relatively new psychological treatment, 
originally developed as a relapse prevention program for remitted depressed patients 
(Segal, Williams, & Teasdale, 2012). MBCT is an adaptation of Mindfulness-Based Stress 
Reduction (MBSR; Kabat-Zinn & Hanh, 2009), which was introduced in the late 1970s 
by Kabat-Zinn for patients with chronic pain or unexplained symptoms. A frequently 
used definition of ‘mindfulness’ is “paying attention in a particular way: on purpose, in 
the present moment, and non-judgmentally” (Kabat-Zinn, 1994; p.4). MBCT combines 
mindfulness meditation techniques with elements of CBT. 
MBCT is a group-based intervention consisting of eight 2.5 hour sessions and one ‘day 
of silence’ in the second half of the training (Segal et al., 2012). In addition, participants 
are encouraged to practice mindfulness techniques at home for approximately 30-
45 minutes each day. During MBCT, participants practice with formal and informal 
meditation techniques such as the ‘body scan’, sitting meditation, gentle movement 
practices based on hatha yoga, and the ‘three-minute breathing space’. A key element 
of all techniques is the instruction to notice any distracting thoughts with a non-
judgmental attitude, while bringing the attention back to the present moment. In 
contrast to CBT, MBCT focuses on the process of thinking rather than the content of 
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negative thoughts. During MBCT, participants learn to experience thoughts as activity 
in the mind and to decenter from the content of these thoughts, whereas during CBT 
patients learn to evaluate and substitute negative thoughts. 
During the last years, evidence for the effectiveness of MBCT has increased. As a result, 
MBCT has been included in multidisciplinary treatment guidelines as a strategy to 
prevent relapse in remitted depressed patients (NICE, 2009; Spijker et al., 2013). The 
most recent meta-analysis on the effectiveness of MBCT as relapse prevention program 
(Kuyken et al., 2016) re-analyzed individual patient data of 1258 participants and 
concluded that MBCT is effective in reducing chances of relapse, which was measured 
over a period of 60 weeks. Kuyken et al. (2016) also concluded that MBCT might even 
be slightly more effective than other active treatments to prevent relapse, such as 
antidepressant medication.
In addition, research has shown that MBCT not only decreases chances of relapse in 
remitted depressed patients but might also reduce depressive symptoms in currently 
depressed patients. Strauss et al. (2014) conducted a meta-analysis on available 
randomized controlled trials (RCT) that focused on patients who met DSM criteria of a 
current depressive or anxiety disorder. They concluded that MBCT significantly reduced 
depressive symptoms compared with inactive control conditions, and that MBCT might 
be as effective as other active treatments, including CBT. 
During the past years, researchers also started to investigate the effectiveness of MBCT 
for chronically or treatment-resistant depressed patients. Kenny and Williams (2007) 
found beneficial effects of MBCT for patients who experienced symptoms for more 
than 12 months despite previous treatment with antidepressant medication or CBT. 
However, this study did not include a control group. In line with the results by Kenny and 
Williams (2007), a randomized pilot study in chronically depressed patients (Barnhofer 
et al., 2009) found that participants receiving MBCT showed significantly less depressive 
symptoms compared to participants receiving treatment-as-usual (TAU). Based on 
these preliminary studies, an adequately powered RCT investigated the effectiveness 
of MBCT for pharmaco-resistant depressed patients comparing MBCT with a health-
enhancement program (Eisendrath et al., 2016). The authors concluded that MBCT let to a 
significant reduction in depressive symptoms, compared with the health-enhancement 
program, which was matched on treatment intensity to the MBCT. Similarly, an RCT 
comparing a brief mindfulness intervention with an active control condition consisting 
of psycho-education and resting in patients with chronic or lifetime history of recurrent 
depression found a reduction in depressive symptoms in the mindfulness group 
(Winnebeck, Fissler, Gärtner, Chadwick, & Barnhofer, 2017). In contrast, another RCT 
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comparing the effectiveness of MBCT with Cognitive Behavioural Analysis System of 
Psychotherapy (CBASP) and TAU (Michalak, Schultze, Heidenreich, & Schramm, 2015) 
in chronic depression found partly conflicting results. Results showed that MBCT was 
only superior to TAU at one of the two treatment sites, whereas CBASP was superior to 
TAU at both sites. There were no significant differences between the effects of MBCT 
and CBASP on depressive symptoms, however there was a trend favoring CBASP over 
MBCT. Adherence and competence of MBCT trainers were good, but MBCT groups had 
a maximum of six participants in contrast to the typical group size of 8-12 participants. 
This potentially hindered optimal exchange between the participants. Notably, there 
were also significant differences between the effectiveness of TAU between the 
treatment sites. The authors assume that this difference was caused by differences in 
patient populations. At one treatment site patients were recruited via advertisements, 
whereas at the other treatment site participants were referred by mental health care 
professionals. Possibly the mental health care professionals referred more patients who 
previously did not respond to treatment and therefore the participants at the second 
treatment site might have been more treatment-resistant. These differences between 
sites complicate conclusions and underpin the importance of describing participant 
characteristics more precisely. 
Taken together, there are indications that MBCT might decrease depressive symptoms in 
treatment-resistant and chronically depressed patients. However, not all studies showed 
significant results. Crucially, all controlled studies focusing on treatment-resistant 
patients investigated the effectiveness of MBCT for pharmaco-resistant depressed 
patients. However, if clinicians adhere to the recommendations of multidisciplinary 
treatment guidelines (NICE, 2009; Spijker et al., 2013), moderately to severely depressed 
patients should receive a combination of antidepressant medication and psychological 
treatment. Therefore, most moderately to severely depressed patients who seek 
professional advice, will not only receive pharmacotherapy but also psychological 
treatment. If patients do not respond to this combination of different treatments, only 
limited psychological treatments options remain (Cuijpers et al., 2017). Previous studies 
showed that MBCT might decrease depressive symptoms in chronically and treatment-
resistant depressed patients, however the effect of MBCT for chronically depressed 
patients who previously received a combination of antidepressant medication and 
psychological treatment is not known. 
Working mechanisms of MBCT 
Research about the exact mechanisms of change of mindfulness-based interventions 
is still in its infancy. Typically, studies investigating potential mechanisms of change 
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of MBCT base their choices for potential working mechanisms on the theoretical 
foundations of MBCT and MBSR. According to these theoretical underpinnings practice 
in mindfulness will lead to more awareness and non-judgmental acceptance of all kind 
of experiences, in combination with a more compassionate attitude towards the self 
and others (Segal et al., 2012). It is expected that these processes in turn will reduce 
psychological distress and will improve positive mental health. Based on systematic 
reviews and meta-analyses of the available literature, different authors (Alsubaie et 
al., 2017; Gu, Strauss, Bond, & Cavanagh, 2015; van der Velden et al., 2015) concluded, 
that there is evidence for several potential working mechanisms. However, they all 
highlighted that more rigorous study designs are needed. First indications whether 
a treatment indeed works via a hypothesized working mechanism can be gathered 
by correlation analyses or pre-post designs in which not only symptoms but also the 
potential working mechanism are assessed before and after treatment. More insight in 
the causal relationships between outcomes and potential working mechanisms can be 
obtained through applying mediation analyses. However, Kazdin (2007, 2009) points 
out that it is essential to investigate the temporal order of changes in the potential 
mediator and outcome before causal conclusions can be drawn.
In this section, the available evidence of four of the most prominent potential working 
mechanisms of MBCT will be discussed in more detail. These potential working 
mechanisms are on the one hand related to acquiring new skills and attitudes (i.e. 
increasing mindfulness skills and self-compassion) and on the other hand related to 
reducing dysfunctional cognitive processed (i.e. cognitive reactivity, rumination).
Mindfulness skills & self-compassion
Perhaps one of the most important questions about the working mechanisms of 
MBCT is whether improvements in depressive symptoms after MBCT are indeed due 
to increased mindfulness skills and self-compassion, as described in the theoretical 
underpinnings of MBCT (Segal et al., 2012). Mindfulness skills are typically measured 
with self-report measures such as the Five Facet Mindfulness Questionnaire (FFMQ; 
Baer et al., 2008; Bohlmeijer, ten Klooster, Fledderus, Veehof, & Baer, 2011). The FFMQ 
assesses mindfulness skills with five subscales: observing, describing, acting with 
awareness, non-judging of inner experience, and non-reactivity to inner experience. 
Self-compassion can be described as a combination of a) self-kindness; b) a sense of 
common humanity and c) mindfulness – holding painful thoughts and feelings in 
balanced awareness rather than identifying with them (Neff, 2003).
Based on a systematic review, van der Velden et al. (2015) conclude that increases in 
mindfulness skills might be linked to improvements in depressive symptoms and 
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lowered risk of relapse. They base this conclusion on several studies which found 
associations between increased mindfulness skills and reduced depressive symptoms 
(i.e. correlation analyses), and three studies that investigated whether mindfulness skills 
mediate the effect of MBCT on depressive symptoms. Therefore, it seems likely that the 
effect of MBCT in currently and remitted depressed patients is indeed due to an increase 
in mindfulness skills. In chronic or treatment-resistant depressed samples, the findings 
are more mixed. Most studies in these patient samples focused on symptom reduction 
and did not include measures of mindfulness skills (Barnhofer et al., 2009; Kenny & 
Williams, 2007; Michalak et al., 2015). In chronically depressed patients, Winnebeck et 
al. (2017) found increased mindfulness skills in the MBCT condition and no change in 
mindfulness skills in the active control condition. In contrast, Eisendrath et al. (2016) 
found no significant increase in mindfulness skills in the MBCT condition compared with 
a health-enhancement program in pharmaco-resistant depressed patients, although 
the MBCT condition significantly improved in depressive symptoms. It therefore remains 
unclear at present, whether MBCT improves mindfulness skills in chronic or treatment-
resistant depressed patients. 
To date, only a limited number of studies investigated whether self-compassion is a 
working mechanism of MBCT. Although research has shown that self-compassion is 
correlated with depressive symptoms (Krieger, Altenstein, Baettig, Doerig, & Holtforth, 
2013; Van Dam, Sheppard, Forsyth, & Earleywine, 2011) and might even predict 
depressive symptoms (Raes, 2011), findings on whether MBCT affects self-compassion 
in depressed patients are mixed. Kuyken et al. (2010) conclude that self-compassion 
mediated the effect of MBCT on depressive symptoms in recurrent depressed patients. In 
contrast, Eisendrath et al. (2016) found no effect of MBCT on self-compassion compared 
with a health-enhancement program in pharmaco-resistant depressed patients. This 
means that further studies are needed to investigate whether MBCT increases self-
compassion in currently and chronic or treatment-resistant depressed patients. 
Although the FFMQ is a widely used questionnaire, recent studies found indications that 
experience with meditation or mindfulness might influence how individuals interpret 
the exact meaning of some of the items (Gu et al., 2016; Van Dam, Earleywine, & Danoff-
Burg, 2009). This would be problematic in designs comparing mindfulness skills before 
and after mindfulness training, because an increase in mindfulness skills could then be 
the mere effect of a better understanding of the items. A recent review paper about the 
current evidence for mindfulness based interventions (Van Dam et al., 2018) therefore 
stresses the need for a uniform definition of mindfulness and reliable assessments 
of mindfulness skills. Recently, Bergomi et al. (Bergomi, Tschacher, & Kupper, 2014) 
developed a new questionnaire, called Comprehensive Inventory of Mindfulness 
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Experiences (CHIME) to address the limitations of existing questionnaires. The authors 
integrated subscales of different mindfulness questionnaires and reformulated items 
to make them intelligible for individuals with or without meditation experience. The 
CHIME has a stable factor structure (Krägeloh, Bergomi, Siegert, & Medvedev, 2017) but 
is currently only available in German. 
Cognitive reactivity & rumination
In addition to an increase in mindfulness skills and greater self-compassion, theoretical 
models of mindfulness (Segal et al., 2012) propose that mindfulness-based interventions 
influence dysfunctional cognitive processes.
According to Teasdale’s differential activation hypothesis (Teasdale, 1988) it is critical 
which cognitive processes and content are activated when an individual experiences 
a sad mood. If processed in a healthy way the negative mood state will be transient 
and mood will improve after a while. If a sad mood however activates dysfunctional 
attitudes, the negative mood state can persist and develop in a clinical depression. 
The ease with which a slight deterioration in mood activates depressive attitudes 
is described as cognitive reactivity (Van der Does & Williams, 2003). The hypothesis is 
based on the observation that dysfunctional attitudes are not merely a symptom of 
depression but can stay latently active once the depressive episode is in remission 
(Scher, Ingram, & Segal, 2005; Teasdale, 1988). Research findings support the hypothesis 
that cognitive reactivity is a vulnerability factor for the onset (Kruijt et al., 2013) and 
relapse of a depressive episode (Figueroa et al., 2015; Segal et al., 2006). If training in 
mindfulness would reduce cognitive reactivity in remitted depressed patients, this 
could decrease chances of relapse or recurrence. Studies have shown that mindfulness 
skills are negatively correlated with cognitive reactivity (Raes, Dewulf, Van Heeringen, 
& Williams, 2009) and that MBCT reduces cognitive reactivity in adults with low 
socioeconomic status (Van der Gucht, Takano, Van Broeck, & Raes, 2015). Furthermore, 
Michalak et al. (2011) found in an uncontrolled study in formerly depressed patients that 
after MBCT cognitive reactivity was reduced, which in turn predicted lower chances of 
relapse. Taken together, these studies imply that cognitive reactivity might be a working 
mechanism of MBCT. However further randomized-controlled studies are needed to test 
the hypothesis that MBCT affects cognitive reactivity in remitted depressed patients. 
Furthermore, it should be tested whether a decrease in depressive symptoms due to 
MBCT is mediated by a decrease in cognitive reactivity. 
Another dysfunctional cognitive process that is closely related to cognitive reactivity is 
depressive rumination. According to the response style theory (Nolen-Hoeksema, 1991) 
the duration and course of a depressive episode are influenced by how an individual 
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responds to depressive symptoms. Depressive rumination is defined as engaging in 
repetitive and passive thoughts about the symptoms and causes of negative mood 
states without engaging in problem solving (Nolen-Hoeksema, 2000). Although closely 
related, research has shown that cognitive reactivity and rumination explain unique 
variances in depressive symptoms (Moulds et al., 2008). Rumination is elicited by sad 
mood but also increases negative mood (Nolen-Hoeksema, Wisco, & Lyubomirsky, 
2008) and this way rumination and negative mood form a vicious circle. It is currently 
not entirely known which cognitive and neural processes influence this vicious circle. 
According to the ‘impaired disengagement model’ by Koster et al. (2011), depressed 
individuals have difficulty to disengage attention from negative thoughts, which 
emerge in reaction on negative mood (see Figure 1). By keeping attention focused 
on negative thoughts instead of redirecting attention away, rumination increases. In 
other words, the impaired disengagement model proposes that negative affect leads to 
negative thoughts, which will evolve to rumination if one’s attention is not redirected to 
other thoughts or activities. This hypothesis is supported by a study in college students 
which found that rumination is associated lower attentional control (Southworth, 
Grafton, MacLeod, & Watkins, 2017). One goal of MBCT is to enhance attentional control 
by teaching participants to redirect attention to the present moment once they become 
aware of dysfunctional negative thoughts. By increasing attentional control (i.e. the top 
arrows displayed in figure 1), MBCT might therefore break the vicious circle of negative 
thoughts and negative affect. 
Several RCT’s have indeed shown that participants report less depressive rumination 
after an MBCT or MBSR training (Geschwind, Peeters, Huibers, van Os, & Wichers, 2012; 
van Aalderen et al., 2011) and that rumination mediates the effects of MBCT or MBSR 
on clinical outcomes (Shahar, Britton, Sbarra, Figueredo, & Bootzin, 2010). However, van 
der Velden et al. (2015) point out that published (Batink, Peeters, Geschwind, van Os, & 
Wichers, 2013) and unpublished non-replications exist and it therefore might remain 
questionable whether rumination is a working mechanism of MBCT. 
Although rumination is present in chronic and non-chronic forms of depression (Riso et 
al., 2003), findings are mixed on whether MBCT has an effect on depressive rumination 
in chronic and treatment-resistant depressed patients. Eisendrath et al. (2016) found 
no effect of MBCT on rumination in pharmaco-resistant depressed patients. In contrast, 
Winnebeck et al. (2017) concluded that a brief training in mindfulness compared with 
an active control group resulted in decreased rumination in chronically or recurrently 
depressed patients. However, because the design of the study (Winnebeck et al., 
2017) included no measures during the MBCT, it remains unclear whether rumination 
mediated the effect on depressive symptoms and therefore can been seen as a working 
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mechanism. Almost all available studies used self-report measures of rumination, 
which limits the external validity. Van der Velden et al. (2015) therefore suggest to use 
additional experimental measures to assess the effects of MBCT on rumination. With 
regard to MBCT and rumination, further research is needed to investigate a) whether 
MBCT effects rumination in chronic and treatment-resistant forms of depression, b) 
whether this change in rumination is not limited to self-report but can also be observed 
in behavioral measures of rumination, and c) whether rumination mediates the effect of 
MBCT on depressive symptoms. 
FIGURE 1. A schematic outline of the impaired disengagement model of rumination. Reprinted 
from Koster, E. H., De Lissnyder, E., Derakshan, N., & De Raedt, R. (2011). Understanding depressive 
rumination from a cognitive science perspective: The impaired disengagement hypothesis. 
Clinical Psychology Review, 31(1), 138-145.
Overall, the results of the described studies indicate that mindfulness skills, self-
compassion, cognitive reactivity and rumination might be working mechanisms of 
MBCT. However, less is known about the working mechanisms of MBCT in chronically, 
treatment-resistant depressed patients. Furthermore, the methodological quality of 
most studies investigating working mechanisms of mindfulness based interventions 
has been criticized (Alsubaie et al., 2017). Therefore, future studies testing mediation 
effects should ideally use assessments of potential mediators during the MBCT training. 
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Further knowledge about the working mechanisms and moderators of MBCT would 
allow refining the MBCT training and would lead to better predictions for whom and 
when MBCT is most suited. 
Aims of this dissertation
The primary aim of this dissertation is to examine the effectiveness of MBCT for patients 
with chronic, treatment-resistant depression. Previous studies showed beneficial effects 
of MBCT for pharmaco-resistant depressed patients. However, the evidence of MBCT 
for chronic depression is mixed and it is unknown whether it is effective for depressed 
patients who not only received antidepressant medication but also psychological 
treatment. In a pragmatic RCT in chronically depressed patients who were treatment-
resistant to antidepressant medication and psychological treatment, the effectiveness 
of MBCT is compared to TAU. Furthermore, potential working mechanisms of MBCT 
are investigated. In remitted depressed patients, it is assessed whether MBCT reduces 
cognitive reactivity and whether this decrease in cognitive reactivity mediates the 
effect of MBCT on depressive symptoms. In chronically, treatment-resistant depressed 
patients, the effects of MBCT on a behavioral, on-line measure of rumination are 
assessed. In addition, psychometric properties of the Dutch translation of a new, 
comprehensive measure of mindfulness skills (CHIME) are presented. In summary, this 
dissertation addresses the following research questions:
Effectiveness of MBCT for patients with chronic, treatment-resistant 
depression
Primary research question
· What is the effect of MBCT compared to TAU on depressive symptoms in chronically, 
treatment-resistant depressed patients?
Secondary research questions
· What is the effect of MBCT compared to TAU on rumination, quality of life, mindfulness 
skills, and self-compassion in chronically, treatment-resistant depressed patients?
· Are there variables that moderate the effect of MBCT on depressive symptoms?
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Working mechanisms of MBCT
Cognitive reactivity
· What is the effect of MBCT compared to TAU on cognitive reactivity in remitted 
depressed patients? 
· Does change in cognitive reactivity mediate the effect of MBCT on residual 
depressive symptoms in remitted depressed patients?
Rumination
· What is the difference between never-depressed controls and chronically, 
treatment-resistant depressed patients on an ‘on-line’, behavioral measure of 
rumination (breathing focus task, BFT)? 
· What is the effect of MBCT on rumination measured with the BFT?
Assessment of mindfulness skills
· What are the psychometric properties of the Dutch Comprehensive Inventory of 
Mindfulness Experiences (CHIME)? 
Outline of this dissertation
This dissertation is divided into seven chapters. Following this general introduction 
(Chapter 1), Chapter 2 contains the study protocol of the RCT comparing MBCT with 
TAU in chronically, treatment-resistant depressed patients. It describes the rationale, 
design, sample size calculation, and measures of the RCT in detail. Chapter 3 presents 
the results of the RCT and discusses its conclusions in relation to the available literature. 
Chapter 4 and Chapter 5 both focus on potential working mechanisms of MBCT. 
Chapter  4 investigates cognitive reactivity as an outcome and working mechanism 
of MBCT in remitted depressed patients. Chapter 5 presents the effects of MBCT on 
a novel, on-line behavioral measure of rumination (breathing focus task) in patients 
with chronic, treatment-resistant depression. In Chapter 6, the validity of the Dutch 
translation of a new, comprehensive questionnaire to measure mindfulness skills 
is presented. Chapter 7 provides a summary of all mentioned studies, followed by a 
general discussion, directions for future research and practical implications. 
25
General introduction
1
REFERENCES
Alsubaie, M., Abbott, R., Dunn, B., Dickens, C., Keil, T., Henley, W., et al. (2017). Mechanisms of action 
in mindfulness-based cognitive therapy (MBCT) and mindfulness-based stress reduction 
(MBSR) in people with physical and/or psychological conditions: A systematic review. Clinical 
Psychology Review. 
Association, A. P. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®): American 
Psychiatric Pub.
Baer, R. A., Smith, G. T., Lykins, E., Button, D., Krietemeyer, J., Sauer, S., et al. (2008). Construct validity 
of the five facet mindfulness questionnaire in meditating and nonmeditating samples. 
Assessment, 15(3), 329-342. 
Barnhofer, T., Crane, C., Hargus, E., Amarasinghe, M., Winder, R., & Williams, J. M. G. (2009). 
Mindfulness-based cognitive therapy as a treatment for chronic depression: A preliminary 
study. Behaviour Research and Therapy, 47(5), 366-373. doi:10.1016/j.brat.2009.01.019
Batink, T., Peeters, F., Geschwind, N., van Os, J., & Wichers, M. (2013). How does MBCT for depression 
work? Studying cognitive and affective mediation pathways. PloS One, 8(8), e72778. 
Bergomi, C., Tschacher, W., & Kupper, Z. (2014). Konstruktion und erste Validierung eines 
Fragebogens zur umfassenden Erfassung von Achtsamkeit. Diagnostica. 
Berlim, M. T., & Turecki, G. (2007a). Definition, Assessment, and Staging of Treatment—Resistant 
Refractory Major Depression: A Review of Current Concepts and Methods. The Canadian 
Journal of Psychiatry, 52(1), 46-54. 
Berlim, M. T., & Turecki, G. (2007b). What is the meaning of treatment resistant/refractory 
major depression (TRD)? A systematic review of current randomized trials. European 
Neuropsychopharmacology, 17(11), 696-707. 
Bijl, R. V., Ravelli, A., & Van Zessen, G. (1998). Prevalence of psychiatric disorder in the general 
population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). 
Social Psychiatry and Psychiatric Epidemiology, 33(12), 587-595. 
Bohlmeijer, E., ten Klooster, P. M., Fledderus, M., Veehof, M., & Baer, R. (2011). Psychometric 
properties of the five facet mindfulness questionnaire in depressed adults and development 
of a short form. Assessment, 18(3), 308-320. 
Boland, R. J., Keller, M. B., Gotlib, I., & Hammen, C. (2002). Course and outcome of depression. 
Handbook of depression, 2, 23-43. 
Collins, P. Y., Patel, V., Joestl, S. S., March, D., Insel, T. R., Daar, A. S., et al. (2011). Grand challenges in 
global mental health. Nature, 475(7354), 27-30. 
Cuijpers, P., Huibers, M. J., & Furukawa, T. A. (2017). The Need for Research on Treatments of Chronic 
Depression. JAMA psychiatry. 
Cuijpers, P., van Straten, A., Andersson, G., & van Oppen, P. (2008). Psychotherapy for depression in 
adults: A meta-analysis of comparative outcome studies [Press release]
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., & et al. (2005). Cognitive therapy vs medications in 
the treatment of moderate to severe depression. Archives of General Psychiatry, 62(4), 409-
416. doi:10.1001/archpsyc.62.4.409
26
Chapter 1
Eisendrath, S. J., Gillung, E., Delucchi, K. L., Segal, Z. V., Nelson, J. C., McInnes, L. A., et al. (2016). A 
randomized controlled trial of mindfulness-based cognitive therapy for treatment-resistant 
depression. Psychotherapy and Psychosomatics, 85(2), 99-110. 
Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry, 
53(8), 649-659. 
Figueroa, C. A., Ruhé, H. G., Koeter, M. W., Spinhoven, P., Van der Does, A., Bockting, C. L., et al. 
(2015). Cognitive reactivity versus dysfunctional cognitions and the prediction of relapse 
in recurrent major depressive disorder. The Journal of clinical psychiatry, 76(10), 1306-1312. 
Geschwind, Peeters, Huibers, van Os, & Wichers. (2012). Efficacy of mindfulness-based cognitive 
therapy in relation to prior history of depression: randomised controlled trial. The British 
Journal of Psychiatry, 201(4), 320-325. doi:10.1192/bjp.bp.111.104851
Gu, J., Strauss, C., Bond, R., & Cavanagh, K. (2015). How do mindfulness-based cognitive therapy 
and mindfulness-based stress reduction improve mental health and wellbeing? A systematic 
review and meta-analysis of mediation studies. Clinical Psychology Review, 37, 1-12. doi:http://
dx.doi.org/10.1016/j.cpr.2015.01.006
Gu, J., Strauss, C., Crane, C., Barnhofer, T., Karl, A., Cavanagh, K., et al. (2016). Examining the Factor 
Structure of the 39-Item and 15-Item Versions of the Five Facet Mindfulness Questionnaire 
Before and After Mindfulness-Based Cognitive Therapy for People With Recurrent Depression. 
Psychological Assessment. 
Hollon, S. D., DeRubeis, R. J., Fawcett, J., Amsterdam, J. D., Shelton, R. C., Zajecka, J., et al. (2014). 
Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the 
rate of recovery in major depressive disorder: a randomized clinical trial. JAMA psychiatry, 
71(10), 1157-1164. 
Hölzel, L., Härter, M., Reese, C., & Kriston, L. (2011). Risk factors for chronic depression—a systematic 
review. Journal of Affective Disorders, 129(1), 1-13. 
Kabat-Zinn, J. (1994). Wherever you go. There you are: mindfulness meditation in everyday life. New 
York: Hyperion.
Kabat-Zinn, J., & Hanh, T. N. (2009). Full catastrophe living: Using the wisdom of your body and mind 
to face stress, pain, and illness: Delta.
Kazdin, A. E. (2007). Mediators and mechanisms of change in psychotherapy research. Annual 
Review of Clinical Psychology, 3, 1-27. 
Kazdin, A. E. (2009). Understanding how and why psychotherapy leads to change. Psychotherapy 
research, 19(4-5), 418-428. 
Kenny, M. A., & Williams, J. M. G. (2007). Treatment-resistant depressed patients show a good 
response to Mindfulness-based Cognitive Therapy. Behaviour Research and Therapy, 45(3), 
617-625. doi:10.1016/j.brat.2006.04.008
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., et al. (2003). The 
epidemiology of major depressive disorder: results from the National Comorbidity Survey 
Replication (NCS-R). JAMA, 289(23), 3095-3105. 
Kessler, R. C., Borges, G., & Walters, E. E. (1999). Prevalence of and risk factors for lifetime suicide 
attempts in the National Comorbidity Survey. Archives of General Psychiatry, 56(7), 617-626. 
27
General introduction
1
Koster, E. H., De Lissnyder, E., Derakshan, N., & De Raedt, R. (2011). Understanding depressive 
rumination from a cognitive science perspective: The impaired disengagement hypothesis. 
Clinical Psychology Review, 31(1), 138-145. 
Krägeloh, C. U., Bergomi, C., Siegert, R. J., & Medvedev, O. N. (2017). Response Shift After a 
Mindfulness-Based Intervention: Measurement Invariance Testing of the Comprehensive 
Inventory of Mindfulness Experiences. Mindfulness, 1-9. 
Krieger, T., Altenstein, D., Baettig, I., Doerig, N., & Holtforth, M. G. (2013). Self-compassion 
in depression: Associations with depressive symptoms, rumination, and avoidance in 
depressed outpatients. Behavior Therapy, 44(3), 501-513. 
Kruijt, A. W., Antypa, N., Booij, L., de Jong, P. J., Glashouwer, K., Penninx, B. W., et al. (2013). Cognitive 
reactivity, implicit associations, and the incidence of depression: a two-year prospective 
study. PloS One, 8(7), e70245. doi:10.1371/journal.pone.0070245
Kuyken, W., Warren, F. C., Taylor, R. S., Whalley, B., Crane, C., Bondolfi, G., et al. (2016). Efficacy of 
mindfulness-based cognitive therapy in prevention of depressive relapse: An individual 
patient data meta-analysis from randomized trials. JAMA psychiatry. doi:10.1001/
jamapsychiatry.2016.0076
Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 
to 2030. PLoS Medicine, 3(11), e442. 
Michalak, J., Hölz, A., & Teismann, T. (2011). Rumination as a predictor of relapse in mindfulness‐
based cognitive therapy for depression. Psychology and Psychotherapy: Theory, Research and 
Practice, 84(2), 230-236. 
Michalak, J., Schultze, M., Heidenreich, T., & Schramm, E. (2015). A randomized controlled trial 
on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive 
behavioral analysis system of psychotherapy for chronically depressed patients. Journal of 
Consulting and Clinical Psychology, 83(5), 951-963. doi:10.1037/ccp0000042
Moulds, M. L., Kandris, E., Williams, A. D., Lang, T., Yap, C., & Hoffmeister, K. (2008). An Investigation 
of the Relationship Between Cognitive Reactivity and Rumination. Behavior Therapy, 39(1), 
65-71. doi:10.1016/j.beth.2007.05.001
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007). Depression, chronic 
diseases, and decrements in health: results from the World Health Surveys. The Lancet, 
370(9590), 851-858. 
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014). A Review of the Clinical, Economic, 
and Societal Burden of Treatment-Resistant Depression: 1996–2013. Psychiatric Services, 
65(8), 977-987. doi:10.1176/appi.ps.201300059
Neff, K. D. (2003). The development and validation of a scale to measure self-compassion. Self and 
Identity, 2(3), 223-250. 
NICE. (2009). Depression: the Treatment and Management of Depression in Adults (Update) Vol. 2009. 
Retrieved from www.nice.org.uk/CG90 
Nolen-Hoeksema, S. (1991). Responses to depression and their effects on the duration of 
depressive episodes. Journal of Abnormal Psychology, 100(4), 569. 
28
Chapter 1
Nolen-Hoeksema, S. (2000). The role of rumination in depressive disorders and mixed anxiety/
depressive symptoms. Journal of Abnormal Psychology, 109(3), 504. 
Nolen-Hoeksema, S., Wisco, B. E., & Lyubomirsky, S. (2008). Rethinking rumination. Perspectives on 
Psychological Science, 3(5), 400-424. 
Peeters, F. P., Ruhe, H. G., Wichers, M., Abidi, L., Kaub, K., van der Lande, H. J., et al. (2016). The Dutch 
Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of 
the Maudsley Staging Method. Journal of Affective Disorders, 205, 365-371. 
Pincus, H. A. H. (2001). The societal costs of chronic major depression. Journal of Clinical Psychiatry, 
62, 5-9. 
Raes, F. (2011). The effect of self-compassion on the development of depression symptoms in a 
non-clinical sample. Mindfulness, 2(1), 33-36. 
Raes, F., Dewulf, D., Van Heeringen, C., & Williams, J. M. (2009). Mindfulness and reduced cognitive 
reactivity to sad mood: evidence from a correlational study and a non-randomized 
waiting list controlled study. Behaviour Research and Therapy, 47(7), 623-627. doi:10.1016/j.
brat.2009.03.007
Riso, L. P., Du Toit, P., Blandino, J. A., Penna, S., Dacey, S., Duin, J. S., et al. (2003). Cognitive aspects 
of chronic depression. Journal of Abnormal Psychology, 112(1), 72. 
Scher, C. D., Ingram, R. E., & Segal, Z. V. (2005). Cognitive reactivity and vulnerability: empirical 
evaluation of construct activation and cognitive diatheses in unipolar depression. Clinical 
Psychology Review, 25(4), 487-510. doi:10.1016/j.cpr.2005.01.005
Segal, Z. V., Kennedy, S., Gemar, M., Hood, K., Pedersen, R., & Buis, T. (2006). Cognitive reactivity 
to sad mood provocation and the prediction of depressive relapse. Archives of General 
Psychiatry, 63(7), 749-755. 
Segal, Z. V., Williams, J. M. G., & Teasdale. (2012). Mindfulness-based cognitive therapy for depression: 
Guilford Press.
Shahar, B., Britton, W. B., Sbarra, D. A., Figueredo, A. J., & Bootzin, R. R. (2010). Mechanisms of 
change in mindfulness-based cognitive therapy for depression: Preliminary evidence from a 
randomized controlled trial. International Journal of Cognitive Therapy, 3(4), 402-418. 
Southworth, F., Grafton, B., MacLeod, C., & Watkins, E. (2017). Heightened ruminative disposition 
is associated with impaired attentional disengagement from negative relative to positive 
information: support for the “impaired disengagement” hypothesis. Cognition and Emotion, 
31(3), 422-434. 
Spijker, J., Bockting, C. L. H., Meeuwissen, J. A. C., van Vliet, I. M., Emmelkamp, P. M. G., Hermens, M. 
L. M., et al. (2013). Multidisciplinaire Richtlijn Depressie (derde revisie, 2013) Richtlijn voor de 
diagnostiek, behandeling en begeleiding van volwassen patiënten met een depressieve stoornis. 
Utrecht: Trimbos-instituut.
Spijker, J., De Graaf, R., Bijl, R. V., Beekman, A. T., Ormel, J., & Nolen, W. A. (2002). Duration of major 
depressive episodes in the general population: results from The Netherlands Mental Health 
Survey and Incidence Study (NEMESIS). The British journal of psychiatry, 181(3), 208-213. 
29
General introduction
1
Strauss, C., Cavanagh, K., Oliver, A., & Pettman, D. (2014). Mindfulness-Based Interventions for 
People Diagnosed with a Current Episode of an Anxiety or Depressive Disorder: A Meta-
Analysis of Randomised Controlled Trials. PloS One, 9(4), e96110. 
Teasdale, J. D. (1988). Cognitive vulnerability to persistent depression. Cognition & Emotion, 2(3), 
247-274. 
Torpey, D. C., & Klein, D. N. (2008). Chronic depression: update on classification and treatment. 
Current psychiatry reports, 10(6), 458-464. 
Trevino, K., McClintock, S. M., Fischer, N. M., Vora, A., & Husain, M. M. (2014). Defining treatment-
resistant depression: a comprehensive review of the literature. Annals of Clinical Psychiatry, 
26(3), 222-232. 
van Aalderen, J. R., Donders, A. R. T., Giommi, F., Spinhoven, P., Barendregt, H. P., & Speckens, A. E. M. 
(2011). The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients 
with and without a current depressive episode: a randomized controlled trial. Psychological 
Medicine, 42(05), 989-1001. doi:10.1017/s0033291711002054
Van Dam, N. T., Earleywine, M., & Danoff-Burg, S. (2009). Differential item function across meditators 
and non-meditators on the Five Facet Mindfulness Questionnaire. Personality and Individual 
Differences, 47(5), 516-521. 
Van Dam, N. T., Sheppard, S. C., Forsyth, J. P., & Earleywine, M. (2011). Self-compassion is a better 
predictor than mindfulness of symptom severity and quality of life in mixed anxiety and 
depression. Journal of Anxiety Disorders, 25(1), 123-130. 
Van Dam, N. T., van Vugt, M. K., Vago, D. R., Schmalzl, L., Saron, C. D., Olendzki, A., et al. (2018). 
Mind the hype: A critical evaluation and prescriptive agenda for research on mindfulness 
and meditation. Perspectives on Psychological Science, 13(1), 36-61. 
Van der Does, A., & Williams, J. M. G. (2003). Leiden index of depression sensitivity-revised 
(LEIDS-R). Leiden University. 
Van der Gucht, K., Takano, K., Van Broeck, N., & Raes, F. (2015). A mindfulness-based intervention for 
economically disadvantaged people: Effects on symptoms of stress, anxiety, and depression 
and on cognitive reactivity and overgeneralization. Mindfulness, 6(5), 1042-1052. 
van der Velden, A. M., Kuyken, W., Wattar, U., Crane, C., Pallesen, K. J., Dahlgaard, J., et al. (2015). A 
systematic review of mechanisms of change in mindfulness-based cognitive therapy in the 
treatment of recurrent major depressive disorder. Clinical Psychology Review, 37, 26-39. 
Wiersma, J. E., van Oppen, P., Van Schaik, D., Van der Does, A., Beekman, A., & Penninx, B. (2011). 
Psychological characteristics of chronic depression: a longitudinal cohort study. Journal of 
Clinical Psychiatry, 72(3), 288-294. 
Winnebeck, E., Fissler, M., Gärtner, M., Chadwick, P., & Barnhofer, T. (2017). Brief training in 
mindfulness meditation reduces symptoms in patients with a chronic or recurrent lifetime 
history of depression: A randomized controlled study. Behaviour Research and Therapy, 99, 
124-130. 
Wittchen, H.-U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., et al. (2011). The size 
and burden of mental disorders and other disorders of the brain in Europe 2010. European 
Neuropsychopharmacology, 21(9), 655-679. 

Chapter 2
A randomized controlled trial of Mindfulness-
Based Cognitive Therapy (MBCT) versus 
treatment-as-usual (TAU) for chronic, treatment-
resistant depression: Study Protocol
Cladder-Micus, M. B., Vrijsen, J. N., Becker, E. S., Donders, R., Spijker, J., & Speckens, A. E. 
(2015). A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) 
versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study 
protocol. BMC psychiatry, 15(1), 275.
32
Chapter 2
ABSTRACT
Background: Major depression is a common psychiatric disorder, frequently 
taking a chronic course. Despite provision of evidence-based treatments, including 
antidepressant medication and psychological treatments like cognitive behavioral 
therapy or interpersonal therapy, a substantial amount of patients do not recover. 
Mindfulness-Based Cognitive Therapy (MBCT) has been found to be effective in 
reducing relapse in recurrent depression, as well as lowering symptom levels in acute 
depression. The effectiveness of MBCT for chronic, treatment-resistant depression has 
only been studied in a few pilot trials. A large randomized controlled trial is necessary 
to examine the effectiveness of MBCT in reducing depressive symptoms in chronic, 
treatment-resistant depression.
Methods/Design: A randomized-controlled trial is conducted to compare MBCT 
with treatment-as-usual (TAU). Patients with chronic, treatment-resistant depression 
who have received antidepressant medication and cognitive behavioral therapy 
or interpersonal therapy are included. Assessments take place at baseline and post 
intervention/TAU-period. The primary outcome are depressive symptoms. Secondary 
outcomes are: remission rates, quality of life, rumination, mindfulness skills and self-
compassion. Patients in the TAU condition are offered to participate in the MBCT after 
the post TAU-period assessment. From all completers of the MBCT (MBCT condition and 
patients participating after the TAU-period), follow-up assessments are taken at three 
and six months after the completion of the MBCT.
Discussion: This trial will result in valuable information about the effectiveness of 
MBCT in chronically, treatment-resistant depressed patients who previously received 
antidepressant medication and psychological treatment.
Trial registration: trialregister.nl NTR4843, registered 14th October 2014
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BACKGROUND
Major depression is one of the most common psychiatric disorders. It has a large impact 
on individual's wellbeing and leads to high societal costs (De Graaf, Ten Have, & Van 
Dorsselaer, 2010; Kessler, Berglund, Demler, & et al., 2003). The duration of a depressive 
episode is highly variable. Whereas the majority of people in the general population 
with a major depressive episode recovers within several months, approximately 20% 
of all depressed patients develop a chronic course of depression (Kessler et al., 2003; 
Spijker et al., 2002). The latter is associated with higher suicidality (Spijker, de Graaf, ten 
Have, Nolen, & Speckens, 2010), increased comorbidity with other psychiatric disorders, 
and impaired physical and psychosocial functioning (Blanco et al., 2010). According to 
DSM-IV criteria, a depressive episode is defined as chronic if the depressive episode 
persists for at least two years (American Psychiatric Association, 2000). However, results 
of a large prospective epidemiological study on the prevalence of major depression 
in the Dutch population show, that -even if treated in mental health care- the rate of 
recovery decreases after a few months. After one year, recovery rates virtually stagnate, 
meaning that if no recovery has taken place within 12 months the probability to develop 
a chronic course of depression- as defined in the DSM-IV- increases substantially (Spijker 
et al., 2002).
Not only a chronic course of symptoms but also several unsuccessful therapeutic 
interventions can be indicative of a severe depressive episode. Patients who do not 
respond to treatment are often described as ‘treatment-resistant’. However, up till 
now, an unified and clear definition of 'treatment-resistant depression’ is lacking. 
Definitions range from one single unsuccessful attempt at antidepressant medication 
(ADM) to several pharmacological interventions combined with electro-convulsive 
therapy (Berlim & Turecki, 2007; Birkenhäger & Ruhé, 2013). In most clinical studies, a 
depressive episode is regarded as treatment-resistant when successive treatment with 
two antidepressants has not led to a significant improvement of depressive symptoms. 
Interestingly, this definition does not take response to psychological treatment into 
account, while cognitive behavior therapy (CBT) or interpersonal therapy (IPT) are part 
of international treatment guidelines for recurrent and chronic depression (NICE, 2009). 
Importantly, research has shown that even when psychological and pharmacological 
treatment options are combined, a substantial amount of patients fails to respond 
(Spijker, van Straten, Bockting, Meeuwissen, & van Balkom, 2013; Torpey & Klein, 2008). 
This means that there is a dire need of new treatment options for chronic, treatment 
resistant depression.
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In recent years, mindfulness based interventions have been developed as a treatment 
focused on distress caused by long-lasting somatic and psychological disorders (Khoury 
et al., 2013). Mindfulness is defined as non-judgmental awareness of the present 
moment (Segal, Williams, & Teasdale, 2012) and was introduced by Kabat-Zinn (1990) 
as a treatment option for patients with chronic somatic conditions. Segal, Williams 
and Teasdale (2002) adapted the program for patients with recurrent depression, 
naming it 'Mindfulness Based Cognitive Therapy' (MBCT). MBCT is a group intervention, 
consisting of eight weekly 2.5 hours sessions and a silent day of 6 hours. It involves 
meditation exercises as well as cognitive behavioral techniques. MBCT is designed to 
address processes that are associated with the onset, maintenance and recurrence 
of depression, such as maladaptive automatic cognitive and behavioral patterns in 
reaction to negative emotions or thoughts. In first instance participants are taught to 
allow and acknowledge negative emotions and thoughts as they are, without having 
judgments about them or reacting to them. In this way, they start recognizing their own 
maladaptive automatic patterns. By creating a greater awareness of habitual behavioral 
and cognitive patterns (e.g. avoidance or rumination) participants learn to deliberately 
disengage from them. Another important part of MBCT is to develop self-compassion. 
MBCT differs from CBT in the sense that the focus of cognitive therapy is more on the 
content of thoughts, while MBCT focuses on the process of thinking.
In chronic depression, maladaptive automatic cognitive and behavioral patterns often 
have become habitual. Patients often experienced several episodes of depression and 
an early onset of the disorder. To learn to react in a different way to these maladaptive 
automatic cognitive and behavioral patterns and to develop a non-judgmental 
awareness of depressive symptoms might be especially useful for this population. 
Therefore MBCT might be effective in lowering depressive symptoms in chronic, 
treatment resistant depression.
A recent meta-analysis (Piet & Hougaard, 2011) shows that MBCT is effective in 
preventing relapse in patients with recurrent depression. Additionally, there is evidence, 
that MBCT not only decreases chance of relapse of depression, but that it lowers levels 
of residual or current depressive symptoms. The first studies investigating the effect 
of MBCT on residual symptoms in remitted depressed patients found significant 
improvements of depressive symptoms (Geschwind, Peeters, Huibers, van Os, & Wichers, 
2012; Kingston, Dooley, Bates, Lawlor, & Malone, 2007). More recently, a meta-analysis 
was conducted on the effects of MBCT in patients currently meeting diagnostic criteria 
for a major depressive disorder (2014). The authors concluded that MBCT reduces 
depressive symptoms in currently depressed patients and might be as effective as CBT. 
One of the studies (van Aalderen et al., 2011) included in the meta-analysis specifically 
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investigated possible differences of the effectiveness of MBCT between remitted but 
still symptomatic and currently depressed patients. The results indicate that MBCT was 
effective for both remitted and currently depressed patients.
First results indicate that MBCT might also be a promising treatment option for chronic 
depression. Kenny and Williams (2007) reported a decrease in depressive symptoms in 
a sample of currently depressed patients who experienced symptoms for one year or 
longer, preceded by three or more previous episodes. In line with that, Eisendrath et 
al. (2008) found a significant decrease in depressive symptoms after MBCT in currently 
depressed patients who previously received at least two different antidepressants 
before starting the MBCT training. In addition to these non-randomized studies, two 
randomized-controlled pilot trials demonstrated a significant reduction of depressive 
symptoms in chronically depressed patients. Barnhofer et al. (2009) found that after 
following MBCT less participants met full criteria for a major depressive episode 
compared to a control group. Another study (Strauss, Hayward, & Chadwick, 2012) 
investigated the effectiveness of person-based cognitive therapy, a therapy combining 
mindfulness techniques and cognitive therapy, in chronic depression and found 
significant improvement of depressive symptoms and mindfulness skills in the therapy 
group compared to the control group. Importantly, all of these studies report a good 
acceptance of the MBCT training procedures by chronically depressed patients.
In sum, there is preliminary evidence that MBCT might be effective in reducing depressive 
symptoms in chronic, treatment-resistant patients. However well-powered randomized 
controlled trials are necessary to systematically examine the effectiveness of MBCT 
compared to treatment as usual in this severely affected patient group. With the current 
ongoing trial we will hopefully contribute to the knowledge about treatment options 
for patients with persistent depressive symptoms. Taking into account the high risk for 
chronic depression if symptoms persist for more than one year (Spijker et al., 2002) we 
will recruit patients experiencing a depressive episode for 12 months or longer who 
underwent previous pharmacological and psychological treatment.
Aims
The aim of the current study is to investigate the effect of MBCT compared to treatment 
as usual (TAU) on depressive symptoms in patients with a current depressive episode 
persisting for at least 12 months, who previously received pharmacological treatment, 
as well as either CBT or IPT. We hypothesize that patients who receive MBCT in addition 
to TAU will report lower levels of depressive symptoms, higher quality of life, and less 
rumination, compared to TAU alone. In addition, we expect that mindfulness skills 
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and self-compassion will improve in the MBCT condition. Possible effects of level of 
treatment-resistance and experience of childhood trauma on treatment effect will also 
be investigated. 
METHODS/DESIGN
Design
This study is a multi-center open-labeled randomized controlled trial with two groups: 
MBCT+ TAU vs. TAU. The study has been approved by the Medical Ethics Committee 
Arnhem-Nijmegen (nr. 2012/339) for all participating sites. Before randomization, 
written informed consent is obtained from all participants. Primary and secondary 
outcome measures are assessed at baseline and after MBCT+TAU (8-12 weeks) or after 
a TAU-period (8-12 weeks). Participants allocated to the TAU condition are offered 
participation in the MBCT after completion of the TAU-period and first follow-up 
assessment. Of all participants who completed the MBCT, follow-up measures take place 
at three and six months after the end of treatment. For an overview of the recruitment 
and measurement points see figure 1. 
Participants
The study population consist of outpatients with a current depressive episode lasting for 
12 months or longer who previously received ADM, as well as either CBT or IPT. Patients 
are recruited at a university medical center (Radboudumc Center for Mindfulness) 
and at different locations of a regional mental health institution (Pro Persona) in The 
Netherlands. Patients can be referred by health care professionals, or can contact the 
research team themselves for participation. Patients receive an information letter and 
are contacted by phone one week later by the research team. Patients are informed that 
participation in the study is completely voluntary and that they can withdraw from the 
study at any time. Participants are free to receive additional treatment or to change their 
(dose of ) pharmacological medication during the study period.
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Figure 1. Flowchart of the recruitment and measurement points 
FU1 
8-12 weeks  
post-baseline 
Is patient interested in participation? 
Yes 
Recruitment via mental health care professionals, website and posters. 
Possible eligible patients receive an information letter by mail. After ~ 1 week patient 
is contacted by phone. Study procedure is explained. 
 
Patient is invited for the research interview, in which the in- and exclusion 
criteria are assessed in detail. Informed consent is taken. 
Eligible and informed consent obtained? 
Yes 
FU4 
6 months  
post-intervention 
FU3 
3 months  
post-intervention 
FU2 
~ 2 weeks  
post-intervention 
FU3 
6 months  
post-intervention 
FU2 
3 months  
post-intervention 
FU1 
~ 2 weeks  
post-intervention 
No Exclude 
No Exclude 
MBCT+ 
TAU 
MBCT+ 
TAU 
TAU 
MBCT+TAU condition 
Baseline  
Randomization 
 
TAU condition 
FIGURE 1. Consort flow diagram 
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Inclusion criteria:
· Age ≥ 18 
· A current diagnosis of major depressive disorder according to DSM-IV criteria with a 
duration of ≥12 months
· Moderate to high level of current depressive symptoms (Inventory of Depressive 
Symptomatology- Self Report, IDS-SR ≥ 21)
· At least one adequate trial of ADM during the current episode (defined as: 
appropriate doses of antidepressant medication for ≥ 4 weeks; or patient’s refusal 
to use medication in contrast to advise by a psychiatrist) 
· Previous psychological treatment during the current episode (defined as: ≥ 
10 sessions of CBT or IPT; or < 10 sessions if discontinued because of patient’s 
withdrawal)
Exclusion criteria: 
· Current psychotic symptoms 
· Bipolar disorder according to DSM-IV 
· Current alcohol or drugs dependence according to DSM-IV 
· Recent electro convulsive therapy (< 3 months)
· Current somatic disorder (partly) explaining depressive symptoms
· Physical-, language-, cognitive-, or intellectual impairments which interfere with 
participation in MBCT or assessments
· Previous MBCT training
Procedure
Assessment of eligibility, baseline measures and randomization
All patients who indicated their interest in the study are invited for a research interview. 
Written informed consent is obtained during this first appointment. To assess eligibility 
and to classify comorbid psychiatric disorders, participants are interviewed by a research 
psychologist or psychiatrists in training with the depression, anxiety, psychosis and 
addiction modules of the Mini International Neuropsychiatric Interview (MINI; Overbeek, 
Schruers, & Griez, 1999). In addition, the following disorder-related characteristics 
are assessed: duration of current major depressive episode, number of psychological 
treatment sessions (i.e. CBT and/or IPT) during current major depressive episode, 
duration and doses of pharmacological treatments during the current depressive 
episode, number of depressive episodes during lifetime and age of onset. On the base 
of these details the research assistant fills out the Dutch Measure for quantification 
of Treatment Resistant Depression (DM-TRD, Ruhé, van Rooijen, Spijker, Peeters, & 
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Schene, 2012; Spijker et al., 2013). After completion of the baseline questionnaires, a 
computer program is used to randomly allocate patients to either MBCT+TAU or TAU. 
A minimization strategy is used for severity of symptoms (IDS-SR ≥21 and ≤31 vs. > 31 
and ≤ 39 vs. > 39) and duration of major depressive episode (1-2 years vs. > 2 years). If 
the period between randomization and start of the MBCT training exceeds four weeks 
in the MBCT+TAU condition, a repeated baseline assessment takes place. 
Follow-up assessments
The first follow-up measure takes place after the MBCT training or the TAU-period. The 
MINI depression module is administered face-to-face or by phone and participants fill 
out the questionnaires either online or on paper. Participants are asked about changes in 
pharmacological or psychological treatment during the study period. Also participants 
deciding to discontinue MBCT are asked to participate in follow-up measures. In all 
MBCT completers (MBCT+TAU and participants of the TAU group who followed the 
MBCT after the TAU-period), the same follow-up measures are administered at three 
and six months after end of treatment. Due to logistic reasons it is not possible to keep 
assessors blind. To assess the inter-rater reliability of the MINI, all diagnostic interviews 
are audio taped and a randomly selected sample will be reassessed by an independent 
rater. For an overview of all measurement assessments see Table 1.
TABLE 1. Overview of measures and corresponding time points.
Measure Target Concept Baseline FU1 FU2 FU3 FU4
MINI interview Comorbid psychiatric disorders ●
DM-TRD Treatment-resistance ●
CTQ Childhood trauma ●
IDS-SR Depressive symptoms ● ● ● ● ●
MINI-depression module Diagnosis of major depression ● ● ● ● ●
RRS-EXT Rumination ● ● ● ● ●
FFMQ Mindfulness skills ● ● ● ● ●
SCS Self-compassion ● ● ● ● ●
WHOQOL-BREF Quality of life ● ● ● ● ●
Note. FU1=2 weeks post intervention (MBCT+TAU)/8-12 weeks post baseline (TAU) ; FU2=3 months post intervention (MBCT+ TAU)/2 weeks 
post intervention (TAU); FU3=6 months post intervention (MBCT+TAU)/3 months post intervention(TAU); FU4=6 months post intervention 
(TAU)
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Interventions
MBCT + TAU. The MBCT consists of eight weekly sessions of 2.5 hours in groups of 
8-15 patients and one additional day of silent practice between the 5th and 7th session. 
Participants are asked to do daily homework assignments. MBCT combines mindfulness 
meditation techniques, as sitting meditation and the body scan with elements of 
cognitive therapy such as psycho education and the identification of automatic negative 
thoughts. The MBCT manual described by Segal, Williams and Teasdale (2012) is used. 
Participants are enrolled in regular MBCT trainings provided at the Radboudumc Centre 
for Mindfulness and Pro Persona for (remitted) depressed patients. This means that the 
training groups not only consist of study participants but also of regular patients with a 
wide range of depressive symptoms.
MBCT trainings are taught by experienced mindfulness trainers who completed a 2-year 
post-graduate teacher training program at the Radboudumc Centre for Mindfulness. 
With this, they all meet the training criteria described in the MBCT good practice 
guidelines (UK Mindfulness-Based Teacher Trainer Network, 2011). Two MBCT sessions 
of each trainer are videotaped to verify adherence to the MBCT protocol. In addition to 
MBCT the participants receive TAU.
TAU. TAU may consist of any treatment the participant or current mental health care 
specialist sees as necessary. Participants are encouraged to continue treatment they 
followed prior to enrolling in the study. The number of treatment sessions and use of 
antidepressant medication are recorded.
Measurements
Primary outcome measure
Depressive symptoms. The primary outcome measure is the level of depressive 
symptoms measured with the Inventory of Depressive Symptomatology Self-Report 
(IDS-SR). The IDS-SR is a 30-item self report questionnaire and has good psychometric 
properties (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996). The IDS-SR has previously been 
used in research on MBCT in depression and has been shown to be sensitive to change 
(Geschwind et al., 2012).
Secondary outcome measures
Remission rates. Remission from depression according to DSM-IV criteria is assessed 
with the major depression module of the Mini International Neuropsychiatric Interview 
(MINI;Overbeek et al., 1999). 
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Quality of life. Perceived quality of life is measured using the 26 -item World Health 
Organization Quality of Life scale (WHOQOL-BREF; Skevington, Lotfy, & O'Connell, 2004). 
Psychometric properties were tested in a sample of Dutch psychiatric outpatients and 
are considered to be good (Trompenaars, Masthoff, Van Heck, Hodiamont, & De Vries, 
2005).
Rumination. Rumination is measured with the extended version of the Ruminative 
Response Scale (RRS-EXT; Raes & Hermans, 2007; Treynor, Gonzalez, & Nolen-Hoeksema, 
2003). The RRS-EXT distinguishes between a more reflective way of thinking (i.e. 
reflective pondering) and a more maladaptive way of thinking about symptoms (i.e. 
brooding) (Schoofs, Hermans, & Raes, 2010).
Mindfulness skills. Mindfulness skills are measured with the Five Facets Mindfulness 
Questionnaire (FFMQ; Baer et al., 2008). The FFMQ consists of 39 items which are divided 
in five subscales: observing, describing, acting with awareness, non-judging of inner 
experience and non-reactivity of inner experience. The Dutch version of the FFMQ has 
good psychometric properties (de Bruin, Topper, Muskens, Bögels, & Kamphuis, 2012; 
Veehof, Peter, Taal, Westerhof, & Bohlmeijer, 2011) and has previously been used in 
research on mindfulness skills in bipolar disorder (Deckersbach et al., 2012).
Self-compassion. Self-compassion is assessed with the Self Compassion Scale (SCS; 
Neff, 2003; Neff & Vonk, 2009). The SCS is a 26-item self report measure and consists of six 
components: self-kindness, self-judgment, common humanity, isolation, mindfulness, 
and over-identification. The scale has good psychometric properties and high scores on 
the SCS are related to psychological well-being (Neff & Vonk, 2009).
Possibly moderating variables
Treatment-resistance. The Dutch Measure for quantification of Treatment Resistant 
Depression (DM-TRD; Ruhé et al., 2012; Spijker, 2013) is used to investigate treatment-
resistance of the current depressive episode. With the DM-TRD several dimensions of 
treatment-resistance are scored by the clinician (duration, symptom severity, functional 
impairment, comorbid anxiety symptoms, prosocial stressors, treatment failures of 
pharmacological and psychological treatment) which leads to a total score ranging 
from 2-26. 
Childhood trauma. To assess the experience of traumatic childhood events, participants 
fill out the Childhood Trauma Questionnaire (CTQ-SF; Bernstein et al., 2003). This 28-item 
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questionnaire measures traumatic experiences and maltreatment during childhood. 
The CTQ-SF has previous been validated in a Dutch clinical sample (Thombs, Bernstein, 
Lobbestael, & Arntz, 2009).
Data handling
All study-related information is stored in secure folders with limited access. Paper-
based data collection forms only contain participant numbers to maintain participant 
confidentiality and are stored in a locked cabinet in an area with limited access. Electronic 
data files are password protected. The list linking participant number and personal 
information is stored in a separated password protected file. Paper-based data entry will 
be double checked. Data will be stored for 15 years after the end of inclusion. The study 
has low to negligibly risks therefore no data monitoring committee is assigned. Only the 
first author and principal investigators or persons assigned by them will have access to 
the final data set. Authors of the final trial report will have made substantial contribution 
to the design, conduction, interpretation and reporting of the trial. We will not use of 
professional writers. Study results will be presented via publications and presentations; 
study participants, funders and involved clinicians will receive a summary of the study 
results.
Statistical analyses
Power analysis and sample size. 
A power analysis was executed based on the findings of van Aalderen et al. (van Aalderen 
et al., 2011). Van Aalderen and colleagues (van Aalderen et al., 2011) reported an effect 
size of 0.53 (Cohen's d) in a sample of 69 currently depressed patients. Based on an alpha 
of 0.05 and power of 80%, estimating the correlation between baseline and first follow-
up measurements to be 0.5 and intending to use an ANCOVA controlling for baseline 
levels of depression, a needed sample size of 43 per condition was calculated. Expecting 
a drop-out of 8 patients, a total of 94 participants will be recruited. 
Analyses plan
The MBCT+TAU and TAU conditions will be compared on baseline sample characteristics 
to ensure that all possible meaningful characteristics were evenly distributed across the 
conditions. To examine treatment outcome, we will use both intention-to-treat and per-
protocol samples. Participants are considered completers of the MBCT if they attend at 
least four sessions of MBCT. To examine whether effects for participants experiencing 
a depressive episode for one to two years and participants meeting criteria for chronic 
depression according to the DSM-IV (≥ 2 years) are different, the primary and secondary 
analyses will be repeated in these subgroups.
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Primary analysis. The effect of condition (MBCT+TAU vs. TAU) on the primary outcome 
measure (depressive symptoms) will be examined using general linear models. 
Condition and baseline score of depressive symptoms will be included as independent 
variables, depressive symptoms at FU1 as the dependent variable. Because MBCT is 
delivered in mixed groups consisting of regular patients and a few study participants 
and previous studies did not yield an effect of therapy group (van Aalderen et al., 2011), 
we will not incorporate a random group effect. 
Secondary analyses. Effects on quality of life, rumination, mindfulness skills, and 
self-compassion will also be investigated using general linear models with the 
same independent variable as in the primary analysis. To investigate effects on 
remission rates a χ2 test will be performed. Moderating effects of level of treatment-
resistance and childhood trauma will be investigated by including an interaction 
effect (condition*moderator) in the models. Furthermore, exploratory analyses on 
rumination, mindfulness skills and self-compassion as possible underlying mechanisms 
of change will be conducted. Consolidation and moderation of treatment effect will be 
investigated in the whole sample of MBCT completers (MBCT+TAU and TAU) using end-
of-treatment assessments and follow-up assessments at three and six months after end 
of treatment. 
DISCUSSION
Despite the range of currently available treatments options such as antidepressant 
medication and cognitive behavioral or interpersonal therapy, a substantial number of 
currently depressed patients do not recover (Torpey & Klein, 2008). Chronic, treatment-
resistant depression is associated with a high personal as well as societal burden (Blanco 
et al., 2010; Spijker et al., 2010). Additional treatment options are required, to further 
reduce depressive symptoms and to improve quality of life in this population.
In previous pilot studies, MBCT appeared to be a promising treatment option for 
patients with chronic depression. Besides incorporating effective elements of cognitive 
behavioral therapy, MBCT focuses on acknowledging negative emotions and thoughts 
and disengaging from maladaptive automatic cognitive and behavioral patterns elicited 
by them. As chronic, treatment-resistant depression is characterized by perseverance of 
symptoms and a long treatment history, maladaptive automatic thinking patterns are 
likely to have become habitual. Therefore MBCT might be a very valuable additional 
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treatment for this group. In the current study we will build upon the previous pilot 
findings by studying the effect of MBCT on depressive symptoms in a large chronic, 
treatment-resistant sample in a randomized controlled trial. 
Strauss and colleagues (2014) argue that MBCT might be as effective as cognitive 
behavioral therapy in reducing depressive symptoms in currently depressed patients. 
The results of the current study will provide an indication of the effectiveness of MBCT 
over and above available pharmacological and psychological treatments such as CBT 
and IPT, in patients who previously received these types of psychological treatment.
In addition to the effects of MBCT on depressive symptoms, we will investigate if 
MBCT leads to less rumination and higher quality of life in this patient population. 
Moreover, this trial will inform clinicians and researchers if chronically, treatment-
resistant depressed patients are able to learn mindfulness skills and to develop more 
self-compassion by following a standard MBCT training. This large trial will also give 
more detailed information about the acceptability and effect sizes of MBCT in this target 
group. 
The ecological validity of the study will be high, as participants will be enrolled in 
standard Dutch MBCT courses offered at mental health care institutions. If the conclusion 
will show that MBCT is effective in reducing depressive symptoms in chronic, treatment-
resistant depression, this study could make a significant impact on treatment options 
for this severely depressed target group.
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ABSTRACT
Background: Chronic and treatment-resistant depression pose serious problems 
in mental health care. Mindfulness-Based Cognitive Therapy (MBCT) is an effective 
treatment for remitted and currently depressed patients. It is, however, unknown 
whether MBCT is effective for chronically, treatment-resistant depressed patients.
Method: A pragmatic, multi-center, randomized-controlled trial was conducted 
comparing treatment-as-usual (TAU) with MBCT+TAU in 106 chronically depressed 
outpatients who previously received pharmacotherapy (≥4 weeks) and psychological 
treatment (≥10 sessions).
Results: Based on the intention-to-treat analysis, participants in the MBCT+TAU 
condition did not have significantly fewer depressive symptoms than those in the TAU 
condition (-3.23[-6.99 to 0.54], d=0.35, p=.09) at post-treatment. However, compared 
to TAU, the MBCT+TAU group reported significantly higher remission rates (χ2(2)=4.25, 
phi=.22, p=.04,) lower levels of rumination (-3.85[-7.55 to -.15], d=.39, p=.04), a higher 
quality of life (4.42[.03 to 8.81], d=0.42, p=.048), more mindfulness skills (11.25[6.09 to 
16.40], d=0.73, p<.001), and more self-compassion (2.91[1.17 to 4.65], d=0.64, p=.001). 
The percentage of non-completers in the MBCT+TAU condition was relatively high 
(n=12, 24.5%). Per-protocol analyses revealed that those who completed MBCT+TAU had 
significantly fewer depressive symptoms at post-treatment compared to participants 
receiving TAU (-4.24[-8.38 to -.11], d=0.45, p=.04).
Conclusions: Although the ITT analysis did not reveal a significant reduction in 
depressive symptoms of MBCT+TAU over TAU, MBCT+TAU seems to have beneficial 
effects for chronic treatment-resistant depressed patients in terms of remission rates, 
rumination, quality of life, mindfulness skills, and self-compassion. Additionally, patients 
who completed MBCT showed significant reductions in depressive symptoms. Reasons 
for non-completion should be further investigated.
Trial registration: Dutch trial register, www.trialregister.nl, identifier: NTR4843, 
registered 14 October 2014
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INTRODUCTION
Major depressive disorder is one of the leading causes of disability worldwide (Lopez, 
Mathers, Ezzati, Jamison, & Murray, 2006). Despite evidence-based treatments, about 
20% of all depressed patients develop a chronic course (Kessler, Berglund, Demler, & 
et al., 2003), typically defined as a period of 2 years or longer of depressive symptoms 
(DSM-IV-TR, 2000). Chronic depression not only affects the personal life of a patient, but 
is also associated with high costs for society in terms of health care costs and workplace 
losses (Pincus, 2001). Unfortunately, a large number of chronically depressed patients do 
not respond to treatment (Torpey & Klein, 2008). Therefore novel treatment strategies 
for this severely ill population are much needed (Cuijpers, Huibers, & Furukawa, 2017). 
Surprisingly, no unified definition of treatment-resistant depression exists. Existing 
staging methods to measure treatment resistance mostly focus on the number of 
biological treatment steps (Trevino, McClintock, Fischer, Vora, & Husain, 2014). In line 
with these staging methods, most clinical trials define a depressive episode as treatment-
resistant if two or more trials with antidepressant medication were unsuccessful 
(Rush, Thase, & Dubé, 2003; Trevino et al., 2014). However, this definition conflicts with 
multidisciplinary treatment guidelines (NICE, 2009) which state that depressed patients 
with moderate to severe symptoms should receive a combination of psychological and 
pharmacological treatments. Therefore, a new staging method to measure treatment 
resistance was developed, called the ‘Dutch Measure for quantification of Treatment 
Resistance in Depression’ (DM-TRD) (Peeters et al., 2016). In contrast to previous 
staging methods (Fekadu, Wooderson, Donaldson, et al., 2009; Fekadu, Wooderson, 
Markopoulou, & Cleare, 2009; Petersen et al., 2005; Souery et al., 1999; Thase & Rush, 
1997), the DM-TRD not only focuses on biological treatments but also includes evidence-
based psychological treatments. For these reasons we have chosen to apply the criteria 
of the DM-TRD for treatment resistance in the current study. 
Mindfulness-Based Cognitive Therapy (MBCT) is an 8-week group training which 
combines mindfulness meditation techniques with elements of cognitive-behavioral 
therapy (Segal, Williams, & Teasdale, 2012). MBCT teaches participants to recognize 
and disengage from maladaptive automatic cognitive patterns, and to develop a 
non-judgmental and compassionate attitude towards their own cognitions and 
feelings. MBCT has been demonstrated to be effective in reducing relapse (Kuyken et 
al., 2016). In addition, it has been shown that MBCT reduces depressive symptoms in 
currently depressed patients (Strauss, Cavanagh, Oliver, & Pettman, 2014). Preliminary 
studies (Barnhofer et al., 2009; Eisendrath et al., 2008; Kenny & Williams, 2007) have 
even found beneficial effects of MBCT for patients with chronic or treatment-resistant 
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depression (Barnhofer et al., 2009; Eisendrath et al., 2008; Kenny & Williams, 2007). In 
line with these findings, in a recent randomized controlled trial (RCT) of Eisendrath and 
colleagues (2016) in treatment-resistant depressed patients, MBCT was demonstrated 
to be superior to an active control group matched on treatment intensity. However, 
partly contrasting results were found by Michalak and colleagues (Michalak, Probst, 
Heidenreich, Bissantz, & Schramm, 2016) in an RCT comparing MBCT with Cognitive 
Behavioural Analysis System of Psychotherapy (CBASP) and treatment-as-usual (TAU) 
in chronically depressed patients. CBASP is a psychological treatment with a strong 
interpersonal orientation that focuses on overcoming the learned helplessness of the 
patient by teaching patients that their own behavior affects others and themselves 
(McCullough, 2003). Michalak and colleagues (2016) concluded that MBCT was inferior 
to CBASP, and MBCT was superior to TAU only at one treatment site. 
Importantly, all available controlled studies about MBCT for treatment-resistant 
depression focused on pharmaco-resistant depressed patients (Eisendrath et al., 2008; 
Eisendrath et al., 2016). It therefore remains unclear whether MBCT is effective in 
chronically depressed patients who have been treated according to treatment guidelines 
(i.e. received evidence-based psychological treatment and pharmacotherapy) but have 
not responded. 
The aim of the current study was to investigate the effectiveness of MBCT+TAU 
versus TAU only for chronically depressed patients with current moderate to severe 
depressive symptoms who have not responded to previous pharmacotherapy and 
evidenced-based psychological treatments, i.e. cognitive behavioral therapy (CBT) or 
interpersonal therapy (IPT). The primary outcome measure was the level of depressive 
symptoms. Secondary outcome measures were remission rates, rumination, quality of 
life, mindfulness skills, and self-compassion. Additionally, we examined the following 
variables as potential moderators of treatment effect gender, age, childhood trauma, 
number of previous episodes, duration of current depressive episode, treatment-
resistance, baseline levels of depressive symptoms, rumination, mindfulness skills, and 
self-compassion.
METHOD
Design
This trial was an open-labeled, multicenter RCT comparing two groups: MBCT+TAU and 
TAU. Methods and procedures are fully described in the published protocol (Cladder-
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Micus et al., 2015) and are summarized below. All participants gave written informed 
consent and the study was approved by the Medical Ethical Committee Arnhem-
Nijmegen (nr. 2012/339). 
Participants 
Participants (N=106) were recruited at different locations of a local mental health 
institute (Pro Persona) and a university medical center (Radboud university medical 
center, Centre for Mindfulness). Participants were referred by mental health care 
professionals or recruited via flyers, posters, and websites. Clinicians were also explicitly 
asked to screen their caseload for potentially eligible participants. A depressive episode 
was defined as “chronic” if symptoms persisted for ≥ 12 months, because research has 
shown that chances of recovery decrease substantially after this period (Spijker et al., 
2002). Inclusion criteria were a) age ≥ 18; b) current depressive episode according to 
DSM-IV criteria with a duration of ≥ 12 months; c) moderate to high levels of depressive 
symptoms (Inventory of Depressive Symptomatology-Self-Report, IDS-SR ≥ 21); d) at least 
one adequate trial of antidepressant medication during the current episode (defined as: 
appropriate doses of antidepressant medication for ≥ 4 weeks; or patient’s refusal to use 
medication contrary to the advice of a psychiatrist); e) previous psychological treatment 
during the current episode (defined as: ≥ 10 sessions of Cognitive Behavioral Therapy 
(CBT) or Interpersonal therapy (IPT); or < 10 sessions if discontinued because of patient’s 
withdrawal). Exclusion criteria were: a) current psychotic symptoms; b) lifetime bipolar 
disorder; c) current alcohol or drug dependence; d) recent electro convulsive therapy 
(< 3 months ago); e) current somatic disorder partly explaining depressive symptoms; 
f ) physical-, linguistic-, cognitive, or intellectual impairments which might interfere 
with participation in MBCT or assessments; and g) previous MBCT training. Baseline 
characteristics can be found in Table 1. 
Procedure
Interested patients received an information letter and were contacted via telephone. 
During a subsequent research interview, the Mini International Neuropsychiatric 
Interview (MINI, Sheehan et al., 1998) was administered to diagnose depressive, 
anxiety, psychotic, and addictive disorders according to DSM-IV criteria. In addition, 
sociodemographic and clinical characteristics were assessed, including treatment-
resistance (DM-TRD, Peeters et al., 2016) and childhood trauma (Childhood Trauma 
Questionnaire, CTQ; Bernstein et al., 2003). The DM-TRD includes domains such 
as duration and severity of symptoms, comorbid anxiety disorders, functional 
impairments, previous biological treatments, and previous psychological treatments.
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TABLE 1. Demographic characteristics, clinical characteristics and baseline levels of 
symptoms in both conditions displayed as number (percentage) unless otherwise specified a
whole sample
n=106
TAU
n=57
MBCT
n=49
Demographic characteristics
Female
Age, M (SD), years
66 (62)
47.1 (10.25)
34 (60)
47.33 (10.9)
32 (65)
46.86 (9.53)
Education
low
medium
high
 
34 (32)
29 (27)
35 (33)
 
18 (32)
20 (35)
18 (32)
 
16 (32)
9 (18)
17 (35)
Marital status
single/widowed/divorced
married/cohabitating
 
45 (43)
44 (42)
 
28 (49)
24 (42)
 
17 (35)
20 (41)
Employment
Full time
Part time
Unemployed
Retired
 
10 (9.4)
19 (17.9)
67 (63.2)
3 (2.8)
 
7 (12.3)
7 (12.3)
40 (70.2)
1 (1.8)
 
3 (6.1)
12 (24.5)
27 (55.1)
1 (2)
Clinical characteristics
n=104 n=56 n=48
Previous episodes, M (SD) 2.69 (3.37) 2.68 (3.96) 2.71 (2.56)
Age of onset, M (SD), years 29.84 (13.16) 31.75 (12.70) 27.61 (13.48)
n=103 n=56 n=47
Duration episode2, M (SD), months 63.59 (70.74) 60.54 (65.42) 67.23 (77.76)
Current episode ≥ 2 years 85 (80) 45 (79) 40 (82)
Anxiety disorder 1 50 (47) 30 (53) 20 (41)
n=97 n=53 n=44
Psychological treatment sessions (CBT/IPT)2, M (SD) 36.29 (49.69) 32.94 (36.27) 40.32 (62.38)
Previous inpatient treatment 2
Inpatient 20 (19) 13 (23) 7 (14)
Day-hospital 15 (14) 8 (14) 7 (14)
> 2 AD’s current episode, % 38.7 36.8 40.8
Medication level at baseline
no AD 23 (22) 14 (25) 9 (18)
1 SSRI 20 (19) 12 (21) 8 (16)
1 TCA/SNRI/other AD 24 (23) 13 (23) 11 (22)
1 MAOI 3 (3) 1 (2) 2 (4)
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TABLE 1. Continued
whole sample
n=106
TAU
n=57
MBCT
n=49
2 AD’s 4 (4) 1 (2) 3 (6)
1 AD + antipsychotic 21 (20) 11 (19) 10 (20)
1 AD + lithium 7 (7) 4 (7) 3 (6)
n=106 n=57 n=49
Treatment-resistance( DM-TRD) , M (SD) 13.92 (2.73) 14.08 (2.71) 13.74 (2.77)
n=89 n=52 n=37
Childhood trauma (CTQ) , M (SD) 49.22 (19.48) 48.77 (17.80) 49.86 (21.64)
Baseline assessment, mean (SD)
Depression (IDS-SR) 41.11 (9.37) 42.21 (9.12) 39.83 (9.59)
n=100 n=57 n=43
Rumination (RRS)
brooding
reflective
56.82 (9.89)
13.54 (2.94)
10.79 (3.09)
56,89 (10.12)
13,57 (3.08)
10,80 (3.37)
56.75 (9.69)
13.51 (2.77)
10.79 (2.71)
Quality of life (WHOQoL-BREF)
physical 
psychological
social
environment
71.92 (10.24)
18.87 (4.07)
13.67 (3.07)
8.67 (2.34)
26.15 (4.03)
70,97 (8.97)
18,59 (3.28)
13,50 (2.95)
8,52 (2.23)
25,82 (3.90)
73.18 (11.72)
19.23 (4.94)
13.88 (3.23)
8.86 (2.49)
26.60 (4.22)
n=99 n=56 n=43
Mindfulness (FFMQ)
observing 
describing
acting/awareness
non-judging 
non-reacting
101.21 (15.27)
21.37 (5.67)
22.50 (6.57)
19.23 (4.86)
21.37 (6.40)
16.92 (3.91)
100.92 (15.34)
21.27 (5.73)
22.24 (5.64)
19.18 (4.79)
21.65 (6.78)
16.94 (4.24)
101.60 (15.35)
21.51 (5.66)
22.86 (7.69)
19.30 (5.04)
21.01 (5.92)
16.31 (3.50)
n=98 n=56 n=42
Self-compassion (SCS)
self-kindness
self-judging
common humanity
isolation
mindfulness
over identification
17.59 (4.61)
2.67 (1.11)
2.99 (1.26)
3.01 (1.09)
2.73 (1.07)
3.17 (1.15)
3.03 (1.23)
17.63 (5.16)
2.68 (1.14)
2.98 (1.28)
2.99 (1.13)
2.79 (1.23)
3.05 (1.45)
3.18 (1.34)
17.55 (3.88)
2.67 (1.09)
3.01 (1.27)
3.05 (1.06)
2.64 (0.81)
3.33 (1.15)
2.83 (1.10)
Note. Abbreviations: AD=antidepressant, CBT=cognitive behavioral therapy, IPT=interpersonal therapy, MAOI= monoamine-oxidase inhibitor, 
SNRI= serotonin–norepinephrine reuptake inhibitor, SSRI= serotonin, TCA= tricyclic antidepressant.
IDS-SR=Inventory of Depressive Symptomatology-Self Report, WHOQoL-BREF=World Health Organisation Quality of Life Questionnaire, 
FFMQ= Five Facets Mindfulness Questionnaire, SCS= Self-compassion Scale
1 at baseline, according to DSM-IV criteria. 2 current depressive episode. a there were no significant differences between the MBCT+TAU and 
TAU condition
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After completion of the baseline measures, participants were randomized to MBCT+TAU 
or TAU only by means of a web-based application that was specifically designed for this 
study by an independent statistician. Randomization was 1:1 to MBCT+TAU or TAU only, 
stratified for treatment centre and minimized for the severity of depressive symptoms 
(IDS-SR: 21-31; 32-39; > 40) and chronicity (1-2 years, ≥ 2 years), without using block 
randomization. If due to scheduling constraints the time between baseline assessment 
and start of MBCT exceeded four weeks, a second baseline assessment was conducted 
before MBCT started. Participants assigned to the TAU condition were offered MBCT 
after completion of post-treatment measures. Follow-up data were collected at three 
and six months after completing MBCT. Additionally, a subsample (N=86) was invited to 
participate in experimental tasks during baseline and post-treatment to assess biased 
information processing. These data focus on different research questions and will be 
presented separately. Data presented here was collected between January 2013 and 
April 2016.
Interventions
MBCT + TAU
MBCT was based on the manual by Segal, Williams and Teasdale (2002) and consisted of 
eight weekly 2.5 hour sessions and one day of practice (day of silence). Participants were 
enrolled in MBCT courses that were part of the regular treatment program, for patients 
with depressive disorders. The average number of study participants was 2.41 (SD= 1.55) 
per MBCT group of 8-12 patients. Mindfulness trainers were informed about enrollment 
of participants in the study, but were pressed to adopt an identical approach and 
procedure for all patients. Group members were not informed about study participation 
of individual fellow members, but participants were of course allowed to share this 
information at will. All mindfulness trainers were highly experienced in working with 
depressed patients and had completed a post-graduate 2-year mindfulness teacher 
training. Thereby they met the advanced criteria of good practice guidelines of the 
UK Network for Mindfulness-based teachers (Network, 2011). Teacher competence 
and adherence was assessed with the Mindfulness-Based Interventions-Teaching 
Assessment Criteria (MBI:TAC, Crane et al., 2012) based on two video recorded sessions 
per trainer. Two independent mindfulness trainers rated the trainers. Mutually agreed 
ratings of the trainers were ‘proficient’ (n=2), ‘proficient/competent’ (n=1), ‘competent’ 
(n=2), and ‘advanced beginner’ (n=1). Videos of two trainers (who trained respectively 
two and three participants) were unavailable. Participants received TAU in conjunction 
with MBCT. 
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TAU
Treatment-as-usual (TAU) was a naturalistic condition consisting of mental health care 
for depression, including antidepressant medication, psychological treatment, support 
by a psychiatric nurse, or day-hospital treatment. There were no significant differences 
between conditions in the mean number of treatment sessions, or in the number of 
patients who received these treatments; see Table 2. Medication levels at baseline 
can be found in Table 1. A minority of participants changed in medication level. This 
information is summarized in Table 2 and additional information can be found in the 
Appendix (Table 5).
Outcome measures
Primary outcome measure
The primary outcome was the level of depressive symptoms assessed with the Inventory 
of Depressive Symptomatology Self-Report (IDS-SR; Rush, Gullion, Basco, Jarrett, & 
Trivedi, 1996). The IDS-SR has good psychometric properties (Rush et al., 1996). The IDS-
SR has previously been used in research on MBCT and is sensitive to change (Geschwind, 
Peeters, Huibers, van Os, & Wichers, 2012). In the current sample, the internal consistency 
was α=.74. 
Secondary outcome measures
Remission was assessed with the depression module of the MINI, which investigates 
depressive symptoms according to DSM-IV criteria. Remission was defined as the 
absence of depressive symptoms during the last two weeks. Participants reporting 
some symptoms but not fulfilling DSM-IV criteria according to the MINI were classified 
as being in partial remission. The interviews were administered by trained research 
psychologists supervised by an experienced psychiatrist (AS) and were audio recorded. 
For logistical reasons it was not possible to keep the research psychologists blind to 
treatment allocation. A random sample (n= 25) of the recorded MINI depression 
modules was scored by an independent psychologist blind to condition, who was 
extensively trained in the administration of the MINI. This yielded a high inter-rater 
reliability (Cohen's kappa .88). Rumination was assessed with the Ruminative Response 
Scale (RRS-EXT, Raes & Hermans, 2007; Schoofs, Hermans, & Raes, 2010). Quality of life 
was assessed with the World Health Organization Quality of Life scale (WHOQoL-BREF, 
Skevington, Lotfy, & O'Connell, 2004). Mindfulness skills and self-compassion were 
assessed with the Five Facet Mindfulness Questionnaire (FFMQ, Baer et al., 2008) and 
the Self-Compassion Scale (SCS, Neff, 2003), respectively. More information about these 
secondary outcome measures can be found in the published study protocol (p.5-6, 
Cladder-Micus et al., 2015).
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Statistical analysis
The power calculation was based on a Cohen's d effect size of 0.53 for currently 
depressed patients as reported in a previous study (van Aalderen et al., 2011). Based 
on an alpha of .05 and power of 80%, estimating the correlation between baseline and 
post-treatment scores to be 0.5, and expecting a drop-out of 8 participants, a required 
sample size of 94 participants emerged (Cladder-Micus et al., 2015). For the main 
analysis, post-treatment scores of depressive symptoms were compared between the 
two conditions in an ANCOVA, controlling for baseline scores of depression, chronicity 
(1-2 years; ≥ 2 years), and treatment site. Similar analyses were conducted for the 
secondary outcome measures, controlling for baseline scores of the respective variable, 
chronicity (1-2 years; ≥ 2 years) and treatment site. A Cohen's d effect size was calculated 
based on the total group’s (n=106) standard deviation on the IDS-SR at baseline. A 
statistical significance level of .05 was adhered to for all analyses. Moderating effects of 
gender, age, childhood trauma, number of previous episodes, chronicity of depressive 
episode (1-2 years/ > 2 years), treatment-resistance, baseline levels of depressive 
symptoms, rumination, mindfulness skills, and self-compassion were explored in the 
ITT sample by incorporating interaction effects in the models. Post-treatment IDS-SR 
scores were missing for 10 participants (9.4%, TAU: n=5, MBCT+TAU: n=5). There were 
no differences in clinical or baseline characteristics between patients with and without 
post-treatment IDS-SR scores, except that the patients with missing scores reported a 
higher number of previous depressive episodes (M=5.00, SD=8.90, t (102)= -2.32, p= 
.02) than complete cases (M=2.45, SD=2.07). For two patients without post-treatment 
scores, follow-up scores were used. Analyses were based on an intention-to-treat 
(ITT) approach including all available data. Next, analyses were repeated in the per-
protocol (PP) sample, including participants of MBCT+TAU who attended ≥ 4 sessions 
and participants of TAU. Sensitivity analyses were performed by imputing missing data 
according to the Last Observation Carried Forward (LOCF) technique. IBM SPSS statistics 
22 was used to analyze the data. 
RESULTS
Patient flow
Of the 213 patients who were assessed for eligibility, 111 were interviewed and 106 
were randomized over MBCT+TAU (n= 49) and TAU (n= 57); see Figure 1. There were 
no significant differences in clinical characteristics or baseline scores between the 
conditions (see Table 1). Before entering the study, 102 participants had received 
>10 sessions of psychological treatment during the current episode, one participant 
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completed nine sessions during the current depressive episode and >10 during the 
previous episode, and three participants refused psychological treatment because they 
received > 10 sessions during the previous depressive episode. Five participants refused 
to use antidepressant medication during the current depressive episode against the 
advice of their psychiatrist. All other participants (n= 101) had been using adequate 
levels of antidepressant medication for at least four weeks. 26 (53.0 %) MBCT+TAU 
participants completed a second baseline because time from randomization to MBCT 
exceeded four weeks and no significant changes in depressive symptoms between the 
first and second baseline were observed (Mbaseline1=41.15, SDbaseline1=7.86, Mbaseline2=40.38, 
SDbaseline2=9.99; t (25)=.47, p=.64). None of the participants of the TAU condition took part 
in MBCT or other mindfulness-based training. Twelve participants of the MBCT+TAU 
condition (24.5%) attended fewer than four sessions of MBCT and were classified as non-
completers. The other participants (completers) attended on average 7.09 (SD=1.15) 
out of the 8 MBCT sessions. The most prevalent reason for drop-out was the occurrence 
or deterioration of physical problems (see Figure 1). Non-completers reported a 
shorter duration of the current depressive episode (M= 60.05 months, SD= 71.72) than 
completers (M=93.18 months, SD= 56.22; U= 246.5, p= .005) and they were more often 
unemployed (χ2 (5)=8.60, p=.04). There were no other significant differences in socio-
demographic or clinical characteristics between non-completers and completers (see 
Table 6 in the Appendix). No serious adverse events occurred.
Primary outcome
Depression scores were analyzed separately for the ITT sample and the PP sample. In 
both analyses, the MBCT+TAU condition showed lower levels of depressive symptoms 
than TAU, with small to medium effect sizes. However, the difference was only 
significant in the PP sample (-4.24, 95% CI [-8.38 to -.11], d= 0.45, p= .04) and not in the 
ITT sample (-3.23, 95% CI [-7.02 to .56], d= 0.35, p= .09); see Table 3. Sensitivity analyses 
using the LOCF sample led to similar findings. When participants who refused to take 
antidepressant medication (n= 5) were excluded from the analyses, results of the ITT 
sample (-3.01 95% CI [-6.8; 0.78], d=0.31, p=.12) and the PP sample (-4.59 95% CI [-8.8; 
-0.38], d=0.51, p=.03) were comparable to the main analyses.
Secondary outcomes 
Compared to TAU, a significantly larger proportion of MBCT+TAU participants reached 
remission (MBCT+TAU: 41.5%; TAU: 21.6%, Table 4). However, most cases were classified 
as partial remission (MBCT+TAU: 39.0%; TAU: 17.65%) and a minority as full remission 
(MBCT+TAU: 2.44%; TAU: 3.92%). Compared to TAU, the MBCT+TAU condition showed 
significantly less rumination (d= 0.39, p= .04) and significantly higher quality of life (d= 
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0.42, p= .048) at post-treatment, controlling for baseline scores. Additionally, participants 
with MBCT+TAU showed significantly more mindfulness skills (d= .73, p<.001) and 
significantly more self-compassion (d= 0.64, p= .001) than participants with TAU only. 
Analyses in the PP sample yielded comparable results (see Table 3 and Table 4)
Moderation analyses
There were no significant moderators for the effect of condition on depressive symptoms 
in the ITT sample, apart from baseline levels of rumination (F (1, 84)= 5.44, p= .02). 
Participants with higher baseline rumination showed a significantly larger decrease in 
depressive symptoms in the MBCT+TAU condition compared to TAU, while controlling 
for depressive symptoms on baseline. In an exploratory analysis, participants were 
grouped based on a previously published clinical mean of the RRS-EXT (Raes et al., 2009): 
in the group of participants scoring above the clinical mean for rumination, participants 
assigned to MBCT+TAU showed significantly lower depressive symptoms compared to 
TAU (-10.79 95% CI [-15.72 to -5.85], d= 1.64 p<.001; MBCT+TAU n=17, TAU n=22) post-
treatment while controlling for baseline depressive symptoms, whereas no difference 
between MBCT+TAU and TAU was observed in the group of participants scoring below 
the clinical mean (1.47 95% CI [-4.38 to 7.33], d= 0.24, p= .62; MBCT+TAU n=22, TAU 
n=30). Patients of the MBCT+TAU condition who scored high on treatment resistance 
(DM-TRD) tended to report higher levels of depressive symptoms post-treatment, 
however this difference was not significant (F (1, 89)= 3.05, p= .084).
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Research interviews (n=111)
Randomized (n=106)
Assessed for eligibility via telephone
(n=213)
Lost to post-treatment (n=5)
Not meeting inclusion criteria (n=3)
 depression in remission (n=2)
 previous MBCT (n=1)
Allocated to MBCT + TAU (n=49) 
 did not start MBCT (n= 3)
o physical symptoms (n=1)
o too early in the morning (n=1)
o practical reasons (n=1)
 attended fewer than 4 sessions (n=9)
o physical symptoms (n=4)
o too early in the morning (n=1)
o moving house (n=1)
o not known (n=3)
Not meeting inclusion criteria (n=35)
 depression <12 months (n=12)
 language or intellectual
impairments (n=7)
 previous MBCT (n=5)
 no previous CBT/IPT (n=5)
 moving house; abroad;
treatment elsewhere (n=3)
 inpatient admission or acute
psychotic symptoms (n=3)
Lost to post-treatment (n=5)
intention-to-treat sample (n=52)
per-protocol sample (n=52)
Allocated to TAU (n=57) 
Post-treatment
intention-to-treat sample (n=44)
per-protocol sample (n=34)
Analyses
Allocation
Declined to participate (n=67)
 competing concurrent treatment
(n=14)
 no interest in MBCT (n=11)
 practical reasons (work, child care,
transportation etc.) (n=9)
 too severe physical/mental
condition (n=7)
 do not want group treatment (n=5)
 not interested in research (n=4)
 gave no reason (n=17)
Declined to participate (n=2)
 competing concurrent treatment
(n=2)
Enrollment
FIGURE 1. Consort flow diagram
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DISCUSSION
The aim of the current study was to investigate the effectiveness of MBCT+TAU for 
chronically, treatment-resistant depressed patients, who had not improved during not 
only previous pharmacotherapy but also psychological treatment. The results of the 
ITT analysis did not confirm the expected reduction in depressive symptoms. However, 
completers of the MBCT+TAU did show a significant decrease in depressive symptoms 
compared to TAU. Further, according to the ITT analyses, more participants in the 
MBCT+TAU condition reached partial remission and MBCT+TAU participants reported 
less rumination and increased quality of life, mindfulness skills, and self-compassion 
compared to participants receiving TAU.
The finding that the decrease in depressive symptoms was significant only in the 
PP analysis and not in the ITT analysis, can be partially explained by the relatively 
high proportion of patients not completing MBCT (n=12, 24.5%). This percentage 
is comparable to other studies on MBCT in chronic (27.8%, Michalak, et al. 2015) or 
pharmaco-resistant depressed patients (22.98%, Eisendrath et al., 2016), but seems to 
be higher than in studies focusing on patients with recurrent depression (8.8%, van 
Aalderen et al., 2011). Compared to completers, non-completers reported a shorter 
duration of the current depressive episode and were more often unemployed. This 
could indicate that a longer duration might increase psychological burden and thereby 
motivates patients to acquire new skills. Additionally, a daily routine could be helpful in 
incorporating mindfulness skills into daily life. However, the sample of non-completers 
is too small to draw firm conclusions here. Although one might expect that the most 
severely depressed patients drop out of treatment, non-completers and completers 
did not differ in the severity of depressive symptoms, number of previous episodes, 
or age of onset. By contrast, a noticeable number of non-completers reported that 
physical problems (see Figure 1) interfered with participation and were the reason for 
discontinuing MBCT. 
MBCT+TAU had significant effects on rumination, quality of life, mindfulness skills and 
self-compassion. Following the course, MBCT+TAU participants reported less rumination 
and a higher quality of life. The increase in mindfulness skills and self-compassion 
might indicate that chronically, treatment-resistant depressed patients are able to 
learn mindfulness meditation techniques and to develop a more compassionate and 
friendlier attitude towards themselves. Although results of these secondary outcomes 
should be interpreted as preliminary, as the power analysis was focused on changes 
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in depressive symptoms, this may indicate that MBCT+TAU has effects that could be 
valuable for chronically, treatment-resistant depressed patients, even if no or only small 
changes in depressive symptoms are evoked.
This study is the first to investigate the effectiveness of MBCT+TAU for chronically, 
treatment-resistant depressed patients who did not benefit from pharmacotherapy 
and psychological treatment. The current study has high ecological validity because of 
its pragmatic design. Participants were moderately to severely depressed outpatients 
and were enrolled in MBCT trainings provided regularly at their local mental health care 
institution. Thereby this study provides much-needed insight into the effectiveness 
rather than efficacy of MBCT, which was formulated as an important research goal in a 
recent review paper of MBCT (Dimidjian & Segal, 2015). However, the effect sizes found 
in this study (ITT: d= 0.35; PP: d= 0.45) are smaller than in previous preliminary studies 
of chronic or treatment-resistant depressed patients (Barnhofer et al., 2009; Eisendrath 
et al., 2008; Kenny & Williams, 2007), as well as smaller than the effect size found in 
previous research on currently depressed patients (d= 0.53, van Aalderen et al., 2011), 
which was used for our power analysis. Both the relatively small effect size and the high 
drop-out rate from MBCT can likely be explained by the higher severity of symptoms 
in the current study sample compared to previous research (van Aalderen et al., 2011). 
As only completers showed a significant decrease in depressive symptoms, obstacles 
to completing treatment should be investigated in future research, for example by 
conducting qualitative interviews.
In addition to the effectiveness of MBCT, we also investigated possible moderators of 
treatment effect. Importantly, levels of rumination moderated the effect of MBCT+TAU 
compared to TAU on depressive symptoms. Participants with high levels of rumination 
benefitted more from MBCT+TAU than TAU. According to the underlying theoretical 
model, rumination is an important working mechanism of MBCT (Segal et al., 2002) 
and previous work has indicated that rumination might mediate the effect of MBCT 
on depressive symptoms (Shahar, Britton, Sbarra, Figueredo, & Bootzin, 2010; van der 
Velden et al., 2015). The current study indicates that MBCT could be particularly helpful 
for chronically, treatment-resistant depressed patients with high levels of rumination. 
However, because of the explorative nature of the moderation analysis, this finding 
should be interpreted as preliminary and requires replication and further investigation. 
In addition, the results of the current study showed no moderating effects of childhood 
trauma, baseline severity of depression, chronicity, or treatment resistance. Moderating 
effects of childhood trauma and severity of baseline symptoms were previously found 
in recurrent depressed patients (Ma & Teasdale, 2004; Williams et al., 2014). However, 
recent studies on MBCT in chronic or pharmaco-resistant depression found no 
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moderating effect of these variables (Eisendrath et al., 2016; Michalak et al., 2016), which 
is in line with our findings. Taken together, these results indicate that rumination might 
be an important moderator in chronic, treatment resistant depression, while levels of 
childhood trauma and severity of depressive symptoms at baseline appear to be of less 
influence.
A limitation of the current study is that MBCT was implemented as an add-on to TAU. 
The results in the MBCT+TAU condition could therefore be partially due to non-specific 
therapy effects, such as peer support, hope, and attention received from the therapist. 
Additionally, patients and investigators were not blind to treatment allocation, which 
might have been a potential source of bias. Future studies should compare MBCT to 
active treatments matched on treatment intensity and should also investigate long-
term effects and cost-effectiveness. Furthermore, due to the pragmatic design of the 
study, MBCT trainings were not in all cases immediately available after randomization. 
Participants who had to wait more that four weeks until the start of MBCT received 
a second baseline assessment. This means that the total duration of the study is not 
identical for the conditions. However, one should note that we found no difference in 
depressive symptoms between the first and second baseline assessment. In addition, 
research designs investigating potential mediators such as rumination, mindfulness 
skills, and self-compassion by including multiple assessments during the course of 
MBCT would give further insight into mechanisms of change. 
The current study provides several clinical and research implications. Even though effects 
on depressive symptoms were not significant in the ITT analysis, results of the secondary 
outcome measures indicated that MBCT might have beneficial effects for chronic, 
treatment-resistant patients on important factors other than depressive symptoms. 
In addition, the results of the PP analyses indicated that completers of MBCT+TAU 
did show a significantly greater reduction in depressive symptoms compared to TAU 
alone. Keeping in mind that the study sample represents a seriously ill population, 
small effects on depressive symptoms accompanied by effects on rumination, quality 
of life, mindfulness, and self-compassion may be valuable for an individual patient. In 
addition, the relatively low costs and rare side effects of MBCT compared with other 
treatment options for this population, e.g. intensive pharmacological treatment or 
electroconvulsive therapy, should be taken into account in treatment choice. However, 
it seems to be important to further investigate reasons why patients do not complete 
MBCT. Additionally, future research should further focus on rumination and other 
possible working mechanisms in order to provide researchers and clinicians with more 
information about the working mechanisms of MBCT and predictors of treatment 
success.
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APPENDIX
TABLE 5. Individual patient information about changes in antidepressant medication from 
baseline to post-measurement
gender age condition
Antidepressant medication
baseline post-measurement 
Discontinued (all antidepressant medication tapered to zero)
female 23 TAU Nortriptyline 100 mg, 
Quetiapine (nk)
-
male 59 TAU Trazodone 11mg -
male 46 MBCT+TAU Venlafaxine 75 mg -
female 34 MBCT+TAU Venlafaxine 300mg -
female 60 MBCT+TAU Mirtazepine 30 mg, 
Quetiapine 100mg 
-
male 43 MBCT+TAU Nortriptyline 150mg, 
Quetiapine 400mg
-
Decrease in medication level
male 50 TAU Nortriptyline 50mg, 
Quetiapine 25 mg
Nortriptyline 50 mg
male 45 MBCT+TAU Sertraline 200mg, 
Quetiapine 25 mg
Sertraline 200mg
female 41 MBCT+TAU Amitriptyline 25mg, 
Nortriptyline 50mg 
Amitriptyline 25 mg
male 54 MBCT+TAU Citalopram 45 mg, 
Quetiapine 60 mg
Citalopram 20 mg
Increase in medication level
female 47 TAU Fluoxetine 20mg 
 
Fluoxetine 20 mg, 
Quetiapine 100mg
male 67 TAU - Nortriptyline (nk)
female 45 TAU - Nortriptyline 100mg
female 57 TAU Venlafaxine 375mg Trazodone 100 mg, 
Venlafaxine 375mg
Note. A list of the order of medication levels can be found in Table 1. Abbreviations: MBCT= mindfulness-based cognitive therapy, TAU= 
treatment-as-usual, nk=not known
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TABLE 6. Demographic characteristics, clinical characteristics, and baseline assessment 
displayed as no. (percentage) unless otherwise specified for completers (≥ 4 sessions MBCT in 
MBCT condition; no MBCT in TAU condition) and non-completers (≤ 4 sessions MBCT).
whole 
sample
(n=106)
completers 
(n=94)
non-
completers
(n=12)
t-test/
χ2-test
Demographic characteristics
Female 66 (62) 59 (58) 7 (42) χ2(1)=.089, n.s.
Age, M (SD), years 47.1 (10.25) 47.47 (10.43) 44.33(8.54) t(104)=-.99, n.s.
Education χ2(2)=2.56, n.s.
low 34 (32) 31 (33) 3 (25)
medium 29 (27) 25 (27) 4 (33)
high 35 (33) 34 (36) 1 (8)
Marital status χ2(1)=.15, n.s.
single/widowed/divorced 45 (43) 41 (44) 4 (33)
married/cohabitating 44 (42) 39 (42) 5(42)
Employment χ2(4)=11.32, 
p=.03 (Fisher’s 
exact: p=.04)
Full time 10 (9) 10 (11) 0 (0)
Part time 19 (18) 19 (20) 0 (0)
Unemployed 67 (63) 58 (62) 9 (75)
Retired 3 (3) 3 (3) 0 (0)
Clinical characteristics
Previous episodes, M (SD) 2.69 (3.37) 2.75 (3.45) 2.18 (2.09) t(102)= -.53,n.s.
Age of onset, M (SD), years 29.84 (13.16) 29.65 (13.17) 31.33 (13.61) t(104)=.42, n.s.
Duration episode1, M (SD), months 63.59 (70.74) 93.18 (56.22) 60.05 (71.71) U=246.5, p=.005
Current episode ≥ 2 years 85 (80) 73 (69) 12 (100) χ 2(1)=3.34, n.s.
Anxiety disorder 2 50 (47) 44 (46.8) 6 (50) χ2(1)=.043,n.s.
Psychological treatment 
sessions (CBT/IPT)1, M (SD)
36.29 (49.69) 38.38 (52.52) 21.5 (14.68) t(95)=-1.10, n.s.
Previous inpatient treatment 1 χ2(2)=1.30, n.s.
Inpatient 20 (19) 19 (15) 1 (8)
Day-hospital 15 (14) 14 (20) 1 (8)
> 2 AD’s current episode, % 38.7 36.2 58.3 χ2(1)=2.2, n.s.
(Fisher’s 
exact: n.s.)
Medication level at baseline χ2(6)=4.69, n.s.
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TABLE 6. (Continued)
whole 
sample
(n=106)
completers 
(n=94)
non-
completers
(n=12)
t-test/
χ2-test
no AD 23 (22) 20 (21) 3 (25)
1 SSRI 20 (19) 19 (20) 1 (8)
1 TCA/SNRI/other AD 24 (23) 23 (25) 1 (8)
1 MAOI 3 (3) 2 (2) 1 (8)
2 AD’s 4 (4) 3 (3) 1 (8)
1 AD + antipsychotic 21 (20) 18 (19) 3 (25)
1 AD + lithium 7 (7) 6 (6) 1 (8)
Childhood trauma (CTQ) , M (SD) 49.22 (19.48) 49.62 (19.28) 46.10 (21.85) t(87)= -.54, n.s.
Treatment resistance (DM-TRD) , M (SD) 13.92 (2.73) 13.86 (2.75) 14.29 (2.74) t(104)=.50, n.s.
Baseline assessment
Depression (IDS-SR), M (SD) 41.11 (9.37) 40.85 (9.09) 43.17 (11.82) t(104)=.80, n.s.
Rumination (RRS), M (SD) 
brooding
reflective
56.82 (9.89)
13.54 (2.94)
10.79 (3.09)
56.79 (9.72)
13.56 (2.94)
10.81 (3.10)
57.12 (12.08)
13.33 (3.04)
10.55 (3.16)
t(98)= .12, n.s.
t(98)= -.22, n.s.
t(98)= -.24, n.s.
Quality of life (WHOQoL), M (SD) 71.92 (10.24) 72.05 (9.83) 70.55 (14.45) t(98)= -.42, n.s.
Mindfulness (FFMQ), M (SD) 101.21 
(15.27)
101.42 (15.92) 99.17 (15.76) t(97)= -.42.n.s.
Self-compassion (SCS), M (SD) 17.59 (4.61) 17.54 (4.71) 18.19 (3.61) t(96)= .38, n.s.
Note. Abbreviations: AD=antidepressant, CBT=cognitive behavioral therapy, FFMQ= Five Facets Mindfulness Questionnaire, IDS-SR=Inventory 
of Depressive Symptomatology-Self Report, IPT=interpersonal therapy, MAOI= monoamine-oxidase inhibitor, SCS= Self-compassion Scale, 
SNRI= serotonin–norepinephrine reuptake inhibitor, SSRI= serotonin, TCA= tricyclic antidepressant, WHOQoL=World Health Organisation 
Quality of Life Questionnaire.
1 current depressive episode, 2 according to DSM-IV criteria, assessed during baseline
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ABSTRACT
Major depressive disorder is a prevalent condition with high relapse rates. There is 
evidence that cognitive reactivity is an important vulnerability factor for the recurrence 
of depression. Mindfulness-based interventions are designed to reduce relapse rates, 
with cognitive reactivity as one of the proposed working mechanisms. In a randomized 
controlled trial we compared the effect of Mindfulness-Based Cognitive Therapy (MBCT) 
with treatment-as-usual (TAU) on cognitive reactivity in recurrently depressed patients 
(N = 115). Depressive symptoms, cognitive reactivity, and mindfulness skills were 
assessed pre and post treatment. Patients in the MBCT group reported a significantly 
greater reduction in cognitive reactivity than those in the TAU group (d = .51). The 
reduction of cognitive reactivity appeared to mediate the association between MBCT/
TAU and decrease of depressive symptoms, using pre and post scores. The current study 
provides evidence that MBCT reduces cognitive reactivity and preliminary evidence 
that cognitive reactivity is a working mechanism of MBCT.
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INTRODUCTION
Despite evidence-based treatments for major depression, residual depressive symptoms 
are very common and relapse rates are high (Zajecka, Kornstein, & Blier, 2013). This 
means that not only recovery from an initial depressive episode, but also reducing 
the vulnerability to relapse is very important. According to the cognitive model of 
depression (Beck, 2008), one of the core factors that characterizes depressed individuals 
is the underlying negative beliefs about themselves. These negative beliefs, for example 
"If I make a mistake, this means I am a failure", are called dysfunctional attitudes. 
Importantly, dysfunctional attitudes tend to persist latently, even after remission from a 
depressive episode, and can be easily activated by a sad mood (Scher, Ingram, & Segal, 
2005). The ease with which these dysfunctional attitudes are activated by sad mood 
states is defined as cognitive reactivity (Van der Does, 2002). 
Cognitive reactivity is not only an important factor in the onset (Kruijt et al., 2013) and 
maintenance of depressive symptoms (Struijs, Groenewold, Voshaar, & de Jonge, 2013), 
but especially important for depressive relapse/recurrence. Patients who experienced 
several depressive episodes reported higher cognitive reactivity compared with patients 
with just one previous episode (Elgersma et al., 2015). In addition, in prospective 
studies, those with higher post-treatment levels of cognitive reactivity appeared to 
have an earlier relapse/recurrence (Figueroa et al., 2015; Segal et al., 2006). However, 
non-replications of the effect of cognitive reactivity on relapse rates also exist (e.g. van 
Rijsbergen, et al., 2013). 
There are two common methods for measuring cognitive reactivity: the first consists of 
a mood induction accompanied by a scale to measure dysfunctional beliefs (Segal et 
al., 2006); the second consists of a self-report measure, the Leiden Index of Depression 
Sensitivity Revised [LEIDS-R] (Van der Does, 2002), asking the participant to indicate 
typical reactions to a sad mood. The LEIDS-R addresses cognitive reactions to a negative 
swing in mood and has been shown to differentiate between previously depressed and 
never-depressed individuals (Van der Does, 2002). 
As cognitive reactivity seems to be related to the onset, maintenance, and recurrence of 
major depression, it is worth investigating whether cognitive reactivity can be reduced 
by psychological interventions. Previous studies have shown that cognitive behavioural 
therapy, but not pharmacological treatment, results in a reduction in cognitive reactivity, 
indicating that a reduction in cognitive reactivity is not a sheer effect of a reduction of 
depressive symptoms (Segal et al., 2006). 
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Another promising candidate to reduce cognitive reactivity in recurrent depression is 
Mindfulness-Based Cognitive Therapy (MBCT). MBCT was designed to prevent relapse 
in remitted depressed patients, and combines elements of cognitive therapy and 
mindfulness practices. The aim of MBCT is to teach participants to experience emotions, 
thoughts, and bodily sensations in a non-judgmental and compassionate way. 
Participants learn to become more aware of dysfunctional automatic patterns, such as 
depressive rumination and cognitive avoidance, and thereby to disengage from them 
(Segal, Williams, & Teasdale, 2002). Thereby MBCT teaches the ability to decenter from 
negative cognitive thoughts and disengage from dysfunctional cognitive processes, 
rather than to try to avoid them. MBCT has been shown to reduce relapse rates for 
depression, to effectively reduce residual depressive symptoms as well as symptom 
severity in current depression (Kuyken, Warren, Taylor, & et al., 2016; Strauss, Cavanagh, 
Oliver, & Pettman, 2014). Only recently, research has focused more on the working 
mechanisms of MBCT (Gu, Strauss, Bond, & Cavanagh, 2015; van der Velden et al., 2015).
There is preliminary evidence that mindfulness-based interventions might result 
in a reduction in cognitive reactivity. Trait mindfulness skills seem to be negatively 
correlated with cognitive reactivity in college students (Raes, Dewulf, Van Heeringen, 
& Williams,2009, Study 1). In a non-randomized controlled study, participants receiving 
MBCT showed a greater reduction in cognitive reactivity than those on a MBCT waiting 
list acting as controls (Raes et al. 2009, Study 2). This finding was replicated in a study 
offering a mindfulness-based intervention to economically disadvantaged individuals 
with depressive symptoms. Cognitive reactivity decreased more over the course of the 
mindfulness-based intervention than during their own control period on the waiting 
list (Van der Gucht, Takano, Van Broeck, & Raes, 2014). Furthermore, Raes et al. (2009) 
also found a mediating effect of mindfulness skills on the relationship between MBCT 
and cognitive reactivity, indicating that it is an increase in mindfulness skills, rather than 
another non-specific therapy effect, that influences cognitive reactivity. Somewhat 
conflicting results of the effect of MBCT on cognitive reactivity have been found by 
Kuyken et al. (2010) in a sample of remitted depressed patients. Participants receiving 
MBCT showed increased cognitive reactivity post treatment compared with those on 
maintenance antidepressant medication. It was, however, found that although cognitive 
reactivity was predictive of relapse/recurrence in the antidepressant medication group, 
it no longer appeared to be predictive of relapse/recurrence in the MBCT group, possibly 
indicating a protective effect of MBCT. These somewhat conflicting results could also be 
partly explained by the fact that no baseline measure of cognitive reactivity was included 
and that the mood-induction method was used, whereas the other two studies made 
use of the LEIDS-R. In a systematic review on working mechanisms of mindfulness-based 
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interventions Gu et al. (2015) reported preliminary evidence of cognitive reactivity as 
a possible working mechanism of the effect of mindfulness-based interventions on 
symptoms, but also mentioned that more evidence is needed.
In summary, there is ample evidence that MBCT reduces relapse/recurrence rates in 
recurrent depression, and some evidence that it might also reduce residual depressive 
symptoms. One of the possible working mechanisms is cognitive reactivity. However, 
randomized controlled studies are needed to further investigate this relationship. The 
aim of this study is to fill this gap by investigating the effect of MBCT on cognitive 
reactivity in remitted depressed patients participating in a randomized controlled trial 
comparing MBCT with treatment-as-usual (TAU). It is hypothesized that MBCT will result 
in a reduction in cognitive reactivity. Additionally, the mediating effect of cognitive 
reactivity on depressive symptoms will be investigated. 
METHODS
Study population and procedure
This study is part of a randomized controlled trial comparing MBCT with TAU in patients 
with three or more previous depressive episodes (N = 205) who were either in remission 
or currently depressed (van Aalderen et al., 2011). Measurements of cognitive reactivity 
were available for 174 participants, which had not been presented previously. In line with 
previous studies (Kuyken et al., 2010), we only selected those participants who were in 
full or partial remission at baseline according to DSM-IV criteria (n = 115) and excluded 
currently depressed participants (n = 59). This decision was based on the fact that the 
LEIDS-R was developed to be used in remitted depressed patients. The instruction of the 
LEIDS-R to imagine a slightly sad mood (see also measurement description) probably 
leads to different effects in remitted versus currently depressed patients. Exclusion 
criteria were: (1) one or more previous (hypo)manic episodes according to DSM-IV 
criteria; (2) current alcohol or drug abuse; (3) urgent need for psychiatric treatment; (4) 
problems hampering participation in a group; and (5) problems hampering completion 
of the questionnaires. Participants taking antidepressant medication were required to 
be on a stable dose for at least 6 weeks prior to inclusion and were asked to maintain this 
dose during the study period. After baseline measurements were taken, participants 
were randomized to either the MBCT or the TAU group. Post-measurements were taken 
after finishing MBCT (MBCT group) or after a 3-month waitlist period (TAU group). 
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The trial was approved by the local Medical Ethical Committee. All participants gave 
written informed consent. For a detailed description of all measurements and a 
CONSORT flowchart see van Aalderen et al. (2011)
Measures
Cognitive reactivity. The LEIDS-R (Van der Does, 2002) is a 34-item questionnaire 
measuring cognitive reactivity. It consists of six subscales: hopelessness/suicidality; 
acceptance/coping; aggression; control/perfectionism; harm avoidance; and 
rumination. Participants are instructed to imagine being in a sad or down but not 
seriously depressed mood. An example item is "When I feel sad, I spend more time 
thinking about what my moods reveal about me as a person". Participants are asked 
to indicate on a 5-point scale (from "not at all" to "very strongly") whether the items 
reflect their thoughts when experiencing a sad mood. Adequate validity and reliability 
(Cronbach's α=.92) are reported (Solis, Antypa, Conijn, Kelderman, & Van der Does, 
2016).
Depressive symptoms. The Hamilton Rating Scale for Depression (HAMD; Hamilton 
1960) is a 17-item standardized interview to measure the number and severity of 
depressive symptoms on a scale of 0-52. The HAMD has good psychometric properties 
with good internal consistency (Cronbach's α= 0.789) and high inter-rater reliability 
(ICC=0.937) (Trajković et al., 2011). Additionally, self-reported levels of depression were 
investigated with the Beck Depression Inventory (BDI). The BDI is a 21-item self-report 
questionnaire to measure depressive symptoms. The scores indicate the following: 0–9 
minimal depression; 10–18 mild depression; 19–29 moderate depression; 30–63 severe 
depression. The BDI has good psychometric properties with a high internal consistency 
(Cronbach's α=.86) in psychiatric patients (Beck, Steer, & Carbin, 1988).
Mindfulness skills. The Kentucky Inventory of Mindfulness (KIMS), is a self-report 
questionnaire measuring mindfulness skills with 39 items. The KIMS consists of four 
subscales: observe; describe; act with awareness; and accept without judgment. The 
KIMS has good psychometric properties in recurrent depression (Baum et al., 2010) with 
high internal consistency (subscales ranging from Cronbach's α=.72 to .88).
Interventions
MBCT. Participants followed a standardized 8-week MBCT training based on the manual 
of Segal, Williams and Teasdale (2002). The course consisted of weekly 2.5-hour group 
sessions and 1 day (6 hours) of silent meditation, and took place at the Radboudumc 
Centre for Mindfulness located at the Radboud university medical center in Nijmegen, 
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the Netherlands. Treatment groups consisted of eight to twelve participants. Mindfulness 
trainers were all experienced in working with groups of psychiatric patients, had 
received at least 1.5 years of mindfulness training and were experienced meditators 
with experience ranging from 2 to 20+ years.
TAU. TAU consisted of a waitlist-control group receiving mental health care from 
general practitioners or specialized mental health care providers. Therefore, TAU was a 
naturalistic condition consisting of (in general high-quality) mental health care in the 
Netherlands, as for example, antidepressant medication or individual psychotherapy. 
Participants were asked not to change their medication during the study period.
Statistical analyses
As the goal of the current study was to investigate specific effects of MBCT on cognitive 
reactivity and cognitive reactivity as a working mechanism, we based our analysis on 
the per-protocol sample, meaning that all participants attended at least four sessions 
of MBCT. A linear mixed model was used to compare post-measurement scores of 
cognitive reactivity between the groups (MBCT vs TAU), controlling for baseline 
cognitive reactivity scores and baseline depressive symptoms. To take clustering 
of the data into account, we added a random group effect. Cohen's d effect size was 
computed. The same model was used to verify previously examined (van Aalderen et 
al., 2011) effects of condition on depressive symptoms and mindfulness skills in this 
sample. To explore whether reductions in cognitive reactivity mediate the effect of 
condition (MBCT vs TAU) on depressive symptoms, a mediation analysis was conducted 
with condition (MBCT vs TAU) as independent variable, change in depressive symptoms 
(from pre to post MBCT/post TAU) as dependent variable, and change in cognitive 
reactivity (from pre to post MBCT/post TAU) as the hypothesized mediator. For all 
change scores, standardized residualized change scores were used (Kuyken et al., 2010). 
A nonparametric bootstrapping method was used to assess the indirect effect based 
on 1000 bootstrapped samples using bias corrected and accelerated 95% confidence 
intervals (BCa CI) as provided by Hayes [(2013) SPSS PROCESS macro version 2.13]. 
To estimate the effect size of the indirect effect, κ2 was computed which represents a 
"ratio to the maximum possible indirect effect" (Preacher & Kelley, 2011). We also tested 
the reverse model, using cognitive reactivity as the outcome variable, and change in 
depressive symptoms as mediator (not predicted by the theoretical model) to gain 
indications about causality in the absence of temporal order of variables.
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RESULTS
Participant characteristics
The demographic and baseline characteristics of participants are presented in Table 1. 
The groups (MBCT/TAU) did not differ on most demographic characteristics (gender, 
age, tertiary education, number of previous depressive episodes), cognitive reactivity, 
mindfulness skills, and depressive symptoms assessed with clinical interview (HAMD) at 
baseline. However, participants in the MBCT group reported a higher age of onset and 
somewhat lower baseline levels of depressive symptoms on the self-report questionnaire 
(BDI) than those in the TAU group. No follow-up assessments were available for two 
participants, so they were excluded from the analyses. They had significantly lower 
levels of cognitive reactivity on baseline (p = .02), but did not differ on other measures. 
TABLE 1. Participant characteristics at baseline
Total sample 
(N = 115)
Mean (SD)
MBCT 
(n = 63)
Mean (SD)
TAU 
(n = 52)
Mean (SD) MBCT vs TAU†
Demographic characteristics
Female 70.4% 68.3% 73% χ2(1) = .318, p=.573
Age (years) 47.53 (11.67) 46.84 (11.58) 48.37 (11.83) t(113 )= .696, p=.488
Tertiary education 56% 58% 52% χ2(1) = .535, p=.465
Age of onset (years) 22.93 (10.70) 25.32 (11.44) 20.12 (9.09) t(109) = -2.67,p=.010*
Number of depressive episodes 6.86 (6.46) 7.18 (7.52) 6.47 (4.95) t(110) = -.577, p=.565
Symptoms at baseline
Cognitive reactivity (LEIDS-R) 79.46 (21.64) 81.48 (22.09) 77.02 (21.04) t(113) = -1.1, p=.274
Depressive symptoms-
Clinician rated (HAMD)
7.75 (5.08) 7.73 (5.47) 7.77 (7.17) t(113) = 0.41, p=.967
Depressive symptoms- 
self report (BDI)
13.12 (7.43) 11.76 (7.18) 14.77 (7.47) t(113) = 2.195, p=.030*
Mindfulness skills (KIMS) 74.13 (15.96) 75.24 (15.63) 72.76 (15.79) t(112) = --.837, p=.404
†Due to missing values the degrees of freedom differ between the analyses
*Significant at p<.05 level
Effect of MBCT vs. TAU on cognitive reactivity
Controlling for cognitive reactivity at baseline, depressive symptoms at baseline (HAMD), 
and age of onset, patients in the MBCT group showed significantly less cognitive 
reactivity compared with the TAU group at the end of treatment (group difference: - 
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11.02, 95% CI[ - 18.29, - 3.75], F (1, 56.99) = 9.22, p = .004). This effect represents a medium 
effect size, Cohen's d = .51. Excluding age of onset showed similar results with a slightly 
larger effect size (group difference: - 13.08, 95% CI[ - 20.27, - 5.88], F (1, 53.93) = 13.29, p = 
.001, Cohen's d = .60). Controlling for self-reported levels of depressive symptoms (BDI) 
instead of clinical rated symptoms (HAMD) led to similar effects. Paired sample t-tests 
revealed that the MBCT condition showed a significant decrease in cognitive reactivity 
over time (baseline M = 82.67, post M = 72.47; t(60) = 4.52, p<.001), whereas the TAU 
condition showed a significant increase in cognitive reactivity (baseline M = 77.02, post 
M = 82.92; t(51) = -2.23, p = .03).
Effect of MBCT vs. TAU on depressive symptoms and mindfulness skills
Controlling for baseline scores and age of onset, patients in the MBCT group showed 
significantly less depressive symptoms (HAMD) (group difference: - 2.88, 95% CI [ - 4.76, 
- 1.01], F (1,107) = 9.26, p = .003, Cohen's d = .57) and more mindfulness skills (group 
difference: + 13.96, 95% CI [9.331, 18.60,], F (1, 105) = 35.702, p<.001, Cohen's d = .87) 
compared with the TAU group at the end of treatment. Similar effects on depressive 
symptoms were observed when using self-reported symptoms (BDI) instead of clinician-
rated symptoms (HAMD). Paired sample t-tests revealed that the MBCT group showed a 
significant decrease in depressive symptoms (baseline HAMD M = 7.73, post HAMD M = 
5.95, t(62) = 2.60, p = .012) and significant increase in mindfulness skills (baseline KIMS 
M = 75.36, post KIMS M = 86.68; t(60) = -5.87, p<.001) whereas no changes in the TAU 
group were observed (depressive symptoms: baseline HAMD M = 7.77, post HAMD M = 
8.83; p = .21; mindfulness skills: baseline KIMS M = 72.76, post KIMS M = 70.77, p = .16)
Mediation of depressive symptoms through cognitive reactivity
Figure 1 depicts that condition had a significant effect on change in cognitive reactivity, 
b = -.785, BCa CI [-1.129, -.4418], change in cognitive reactivity in turn had a significant 
effect on change in depressive symptoms, b=.2294, BCa CI [.0358, .4231]. A significant 
indirect effect (because zero is not included in the 95% bias corrected confidence 
intervals) of condition on change in depressive symptoms through change in cognitive 
reactivity was observed, b = -.1802, BootBCa CI [-.3705, -.0501]. This mediation effect 
represents a medium effect size, κ2 = .09, BCa CI [.0245, .1672]. Adding age of onset as a 
covariate in the model, led to similar results with a significant indirect effect, b = -.152 
BCa CI [-.3221, -.0294]. When testing the reversed model, using change in depressive 
symptoms as mediator and change in cognitive reactivity as outcome, a significant 
but slightly smaller indirect effect b = .124 BootBCa CI [-.2461, -.0357], κ2 = .07, BCa CI 
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[.0165, .1203] was observed. Similar effects in all mediation analyses were observed 
when using self-reported depressive symptoms (BDI) instead of symptoms rated by the 
clinician (HAMD).
 
 
  
 
 
 
 
b =.2294 [.0358, .4231] b = -.785 [-1.129, -.4418] 
direct effect: b=-.418 [-.8041, -.0308] 
indirect effect: b=-.1802 [-.3705, -.0501], κ2=.09 
Δ cognitive 
reactivity 
MBCT/ 
TAU 
Δ depressive 
symptoms 
Figure 1. Mediation model FIGURE 1. Mediation model
DISCUSSION
The aim of this study was to investigate the effect of MBCT on cognitive reactivity in 
recurrently depressed patients in remission by using a randomized controlled design. 
Our results show that participants of the MBCT course demonstrated a significant 
reduction in cognitive reactivity. In contrast, the participants of the TAU group showed 
a significant increase in cognitive reactivity, possibly indicating that the MBCT even 
inhibited a natural increase in cognitive reactivity over time. Furthermore, by using 
baseline and post-treatment scores, we found that cognitive reactivity partially 
mediated the effect on depressive symptoms.
Cognitive reactivity is an important factor in the relapse/recurrence of depressive 
episodes (Beck, 2008; Figueroa et al., 2015). Therefore, it is important to investigate which 
treatments can reduce cognitive reactivity. The current results indicate that MBCT might 
be more effective than TAU in reducing cognitive reactivity. These results are in line with 
previous non-randomized studies on the effect of mindfulness-based interventions on 
cognitive reactivity (F Raes et al., 2009; Van der Gucht et al., 2014). Our findings are partly 
in contrast with results by Kuyken et al. (2010) who found increased cognitive reactivity 
in participants receiving MBCT. However, in their study, cognitive reactivity was only 
related to relapse in the TAU group, indicating that MBCT diminished the toxic effect 
of the relationship between cognitive reactivity and outcome. Importantly, in contrast 
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to Kuyken et al. (2010), we used the LEIDS-R instead of a mood-induction method. In 
a recent comment, Raes (2015) argued that both methods possibly tap into different 
stages of cognitive reactivity: the mood-induction method would then measure 
dysfunctional thoughts more as products of the mind, whereas the LEIDS-R specifically 
investigates dysfunctional thinking as a mental process in reaction to sad mood. This 
could partly explain the different results, as MBCT is not aiming at changing negative 
thoughts, but instead teaches participants to react differently on negative mood or 
initial dysfunctional thoughts. 
Next to the effect of MBCT on cognitive reactivity as an outcome, we found a mediating 
effect of cognitive reactivity on the reduction in depressive symptoms indicating that 
cognitive reactivity is a working mechanism of MBCT. This is in line with the theoretical 
rationale of MBCT (Segal et al., 2002) and previous findings (Gu et al., 2015). However, 
because we also found a significant effect when testing the "reversed model" (change 
in depressive symptoms mediating change in cognitive reactivity), which would 
not be predicted by the theoretical model of MBCT, conclusions should to be drawn 
with caution. Changes in cognitive reactivity and depressive symptoms seem to be 
interrelated when measured simultaneously. Longitudinal studies taking the temporal 
order of variables into account are needed to investigate the mediating effect of 
cognitive reactivity on depressive symptoms. 
Our results suggest that we might consider how to strengthen the effect of MBCT on 
the reduction in cognitive reactivity. We might, for example, emphasize this mechanism 
even more in the psycho-educational part of the MBCT course. Or we might increase 
the practice of recognizing negative mood and accompanying thoughts during sitting 
meditations in the second half of the course. 
It is important to keep in mind, however, that cognitive reactivity is not the only proposed 
working mechanism of MBCT. Other assumed mechanisms of change in MBCT include 
for example mindfulness skills, self-compassion, and psychological flexibility (Gu et al., 
2015). Kuyken et al. (2010) reported an interaction between cognitive reactivity and 
self-compassion skills, showing that in remitted depressed patients participating in the 
MBCT course the negative prognostic value of cognitive reactivity was mitigated by an 
increase in self-compassion. The interaction between different working mechanisms 
goes beyond the scope of this study, but future research should focus on disentangling 
the mechanisms of change of MBCT and their interconnectedness by combining the 
results of clinical randomized controlled trials with other designs, such as dismantling 
designs, individual difference designs and experimental manipulations (van der Velden 
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et al., 2015). Thereby we could learn more about the exact working mechanisms of 
MBCT and could use this knowledge to improve the curriculum and to be better able to 
predict which patients would benefit most from MBCT.
Several strengths and limitations of this study should be noted. First of all, the current 
study is one of the first to specifically investigate the effects of MBCT on cognitive 
reactivity in recurrently depressed patients by using a randomized controlled design 
with pre and post measures of cognitive reactivity, adding important knowledge to the 
existing literature. Previous research has shown that levels of cognitive reactivity predict 
relapse rates (Figueroa et al., 2015; Kuyken et al., 2010). Figueroa et al. (2015) calculated 
that a 20-point increase on the LEIDS-R resulted in a 10-15% higher chance of relapse. 
Relating their figures to the current study would indicate that a decrease in LEIDS-R 
of 11 points could have a substantial effect on relapse rates, which should be further 
investigated.
The limitations of this study give several directions for future research. First, it should 
be noted that we compared MBCT with a waitlist control group receiving treatment as 
usual. Therefore, we do not know how much of the effect is based on specific aspects of 
mindfulness training or non-specific therapy effects as peer support, hope or activation. 
In addition, the proposed mediator and outcome were measured simultaneously. 
Finding a variable statistically mediating an effect does not prove that it is a working 
mechanism, however, it is an important step in narrowing down the possible variables 
of influence (Kazdin, 2007). Therefore, further longitudinal research is needed to draw 
conclusions about causality. Whereas the focus of the current study was on investigating 
cognitive reactivity as an outcome and mediator of MBCT in a pre-post design, it 
would be important to also investigate the predictive effect of cognitive reactivity on 
relapse rates compared with a control group in longitudinal designs. Finally, as already 
noted, we used the LEIDS-R questionnaire (Van der Does, 2002) to measure cognitive 
reactivity rather than a mood-induction method (e.g. Kuyken, et al., 2010). The LEIDS-R 
investigates the ease in which the participant reacts to a sad mood with dysfunctional 
beliefs. This is based on the assumption that dysfunctional beliefs tend to persist in 
remitted depressed patients (Scher et al., 2005) and can be activated by low mood 
states, which forms a vulnerability factor for relapse. However, it is therefore not possible 
with the current design to differentiate whether the overall level of dysfunctional beliefs 
was reduced after the MBCT or whether, in particular, the reaction to a sad mood with 
dysfunctional beliefs decreased. It would be valuable if future research investigated the 
effect of MBCT on cognitive reactivity as well as on overall levels of dysfunctional beliefs, 
independent of mood or stress. In addition, future research directly comparing the 
differences and similarities of the LEIDS-R and the mood-induction method to measure 
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cognitive reactivity would be valuable. The significant advantages of the LEIDS-R are 
its applicability in clinical practice and that it excludes the possibility of a failing mood 
induction; however, it requires insight in one's own cognitive processes. It would also 
be useful if future research explored whether the LEIDS-R successfully excludes social 
desirable answers and answers merely based on knowledge obtained during MBCT, 
rather than actual behaviour.
Taken together, the present study provides evidence that MBCT reduces cognitive 
reactivity based on a randomized controlled design in recurrently depressed patients in 
remission. Furthermore, the results add preliminary evidence to the existing literature 
about the theoretical assumption that the reduction in cognitive reactivity decreases 
depressive symptoms and is therefore a working mechanism of MBCT.
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ABSTRACT
It has been found that Mindfulness-based cognitive therapy (MBCT) reduces 
rumination in remitted and currently depressed patients. However, less is known about 
the effects of MBCT on rumination in chronically and treatment-resistant depressed 
patients. Typically, questionnaires are used to assess rumination, but this introduces 
the risk of response and recall biases. A recent systematic review (van der Velden et 
al., 2015) proposes to also include behavioural measures. A behavioural measure that 
has previously been used to assess rumination in dysphoric students is the breathing 
focus task (BFT). The first aim of this research was to investigate whether the BFT can be 
used in chronically, treatment-resistant depressed patients to measure rumination. We 
therefore administered the BFT in patients with chronic, treatment-resistant depression 
(n=73) and compared them with never-depressed controls (n=106). Patients reported 
significantly more negative thought intrusions and subsequent sad mood. Secondly we 
tested in a randomized-controlled trial whether MBCT in combination with treatment-
as-usual (MBCT+TAU, n=26) compared with TAU (n=36) reduces rumination assessed 
with the BFT in chronically, treatment-resistant depressed patients. Negative thought 
intrusions significantly decreased in the MBCT+TAU condition, compared with TAU. 
The results show that MBCT reduces rumination assessed with a behavioural task in 
chronically, treatment-resistant depressed patients.
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INTRODUCTION
Mindfulness-based cognitive therapy (MBCT) is an 8-week group training for depression 
that combines mindfulness meditation techniques with elements of cognitive 
behavioural therapy (Segal, Williams, & Teasdale, 2012). During MBCT participants 
are taught to react to thoughts, emotions and bodily sensations in a non-judgmental 
and compassionate way. In the past years, several studies have shown that MBCT 
effectively reduces chances of relapse in remitted depressed patients (Kuyken et al., 
2016). Furthermore, research has shown that MBCT significantly decreases depressive 
symptoms in patients with current major depression (Strauss, Cavanagh, Oliver, & 
Pettman, 2014) and recent studies tested its applicability to more complex forms of 
depression, such as chronic and treatment-resistant depression (Eisendrath et al., 2016; 
Cladder-Micus, Speckens, Vrijsen, Donders, Becker, & Spijker, in press; Michalak, Probst, 
Heidenreich, Bissantz, & Schramm, 2016). 
It is assumed that MBCT decreases depressive symptoms by reducing dysfunctional 
cognitive processes, such as depressive rumination (Segal et al., 2012). Depressive 
rumination is defined as the repetitive dwelling on negative emotions and their causes 
and implications (Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008). Research has shown 
that a ruminative response style is related to the onset and duration of a depressive 
episode (Michalak, Hölz, & Teismann, 2011; Nolen-Hoeksema, 2000). Moreover, 
rumination is more pronounced in chronically depressed patients compared with 
patients with shorter, non-chronic depressive episodes (Riso et al., 2003; Wiersma et al., 
2011). Previous research found that rumination is significantly related to the experienced 
quality of life in depressed patients, above and beyond depressive symptoms (Kuehner 
& Buerger, 2005). Reducing rumination in chronically depressed patients is therefore a 
valuable treatment outcome.
Training in mindfulness meditation might influence rumination through several 
pathways. According to the ‘impaired disengagement hypothesis’ (Koster, De Lissnyder, 
Derakshan, & De Raedt, 2011), prolonged rumination is partly due to impaired attentional 
disengagement from negative information. During mindfulness meditation attentional 
processes are trained through focused attention meditation and open monitoring 
meditation (Lutz, Slagter, Dunne, & Davidson, 2008). During focused attention meditation 
attention is directed and sustained on a selected object (e.g. sensations of breathing). 
It is assumed that focused attention meditation increases attentional control (van Vugt, 
2015). Open monitoring meditation is characterized by the absence of an explicit focus 
and a non-reactive monitoring of thoughts, feelings and bodily sensations. Participants 
learn to become more aware of their automatic cognitive and behavioural reactions to 
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thoughts, perceptual stimuli, or feelings (Lutz et al., 2008). The combination of greater 
awareness of thoughts and higher attentional control might increase the ability to shift 
attention and thereby to disengage from ruminative thoughts (Koster et al., 2011). As 
chronically and treatment-resistant depressed patients typically show elevated levels 
of rumination (Nolen-Hoeksema, 2000; Riso et al., 2003; Torpey & Klein, 2008) training 
attentional control during MBCT might be especially effective in this group.
Previous research concluded that MBCT significantly reduces rumination in recurrently 
depressed patients (Geschwind, Peeters, Huibers, van Os, & Wichers, 2012; van Aalderen 
et al., 2011; Van Vugt, Hitchcock, Shahar, & Britton, 2012). In addition, several studies found 
that rumination mediates the effect of MBCT on depressive symptoms (Shahar, Britton, 
Sbarra, Figueredo, & Bootzin, 2010; van Aalderen et al., 2011) which would support the 
assumption that rumination is a working mechanisms of MBCT. However, because these 
studies used pre-post designs the temporal order of change in depressive symptoms 
and rumination remains unclear, which is essential before conclusions about casual 
relations can be drawn (Kazdin, 2007). Surprisingly, given the prevalence of rumination 
in chronic depression (Nolen-Hoeksema, 2000; Riso et al., 2003; Torpey & Klein, 2008) 
only few studies investigated the effect of MBCT on rumination in chronic or treatment-
resistant depression. Whereas one randomized controlled trial (Cladder-Micus, et al., in 
press) and a pilot study (Eisendrath et al., 2008) found effects of MBCT on rumination in 
chronic and treatment resistant-depression, another randomized controlled trial found 
no effect (Eisendrath et al., 2016). In a systematic review van der Velden et al. (2015) 
integrated the results of published and unpublished reports about the effects of MBCT 
on rumination and concluded that the results are inconsistent. Therefore van der Velden 
et al. (2015) suggest to combine measures of self-report with laboratory measures of 
rumination to study the effects of MBCT on rumination. In sum, the specific effects 
of MBCT on rumination are currently not clearly understood, especially in chronic or 
treatment-resistant depression. As this group consists of patients with especially high 
disease burden, finding effective ways to reduce rumination might significantly improve 
their well-being. Furthermore, it has been argued (van der Velden , et al., 2015) that 
experimental measures of rumination are needed to increase our understanding of the 
effects of MBCT on rumination.
Typically, rumination is assessed with validated questionnaires, such as the Ruminative 
Response Scale (Nolen-Hoeksema & Morrow, 1991). To specifically investigate levels 
of state rumination (i.e. rumination during a specific period of time) rather than trait 
rumination (i.e. the general tendency to ruminate), previous research used measures 
such as the ‘momentary ruminative self-focus’ questionnaire (MRSI; Mor, Marchetti, 
& Koster, 2013) or visual analogue scales (VAS) (Ciesla, Reilly, Dickson, Emanuel, & 
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Updegraff, 2012; Hilt & Pollak, 2012; Key, Campbell, Bacon, & Gerin, 2008; Puterman, 
DeLongis, & Pomaki, 2010; Zoccola & Dickerson, 2012). All of these measures rely on self-
report and require sufficient insight in one’s own (typical) cognitive reaction. Although 
self-report has several advantages, it is not always in accordance with actual behaviour 
(Wilson & Dunn, 2004) and it therefore has been argued that psychological studies 
should place a greater emphasis on observing behaviour instead of solely relying on 
self-report (Baumeister, Vohs, & Funder, 2007). Furthermore, most measures of state 
rumination rely on retrospective recall, a process that is typically biased in depressed 
individuals (Ben-Zeev, Young, & Madsen, 2009; Gotlib & Joormann, 2010; Solhan, Trull, 
Jahng, & Wood, 2009). To be able to disentangle effects of memory bias from other 
cognitive processes, the distinction between ‘on-line’ and ‘off-line’ measures can be 
helpful. On-line measures assess behaviour concurrent to task performance, whereas 
off-line measures assess behaviour after it happened (Veenman, 2011). Examples of on-
line measures are ‘think-aloud protocols’ to investigate metacognition in mathematical 
problem solving (Azevedo, Moos, Johnson, & Chauncey, 2010; Jacobse & Harskamp, 
2012) and reaction time paradigms to assess interpretation bias in anxiety disorders 
(Garner, Mogg, & Bradley, 2006; Hirsch, Clark, & Mathews, 2006). Most of the currently 
available measures of rumination can be categorized as off-line measures, because they 
require participants to retrospectively indicate their level of rumination. 
The Breathing Focus Task (BFT) is an on-line behavioural task that assesses repetitive 
negative thinking. The task was originally developed by Borkovec and colleagues 
(Borkovec, Robinson, Pruzinsky, & DePree, 1983) and has been adapted by Hirsch 
and colleagues (Hayes, Hirsch, Krebs, & Mathews, 2010; Hirsch, Hayes, & Mathews, 
2009) to assess worry in general anxiety disorder. Recently, the BFT has been utilized 
to assess rumination in a student sample (Southworth, Grafton, MacLeod, & Watkins, 
2017). During the BFT participants are asked to focus on their breathing and to report 
distracting thoughts. In the original task also a worry or negative mood induction is 
used (e.g. Hirsch et al., 2009). Because the task assesses the number of dysfunctional 
negative thoughts during task performance, it minimizes influences of retrospective 
biases and reduces response bias. Although the advantages of an on-line task above 
using questionnaires are especially relevant in clinical samples, the BFT has not been 
used in clinically depressed individuals.
The overall goal of the current research was to investigate the effects of MBCT on 
rumination with an on-line behavioural measure in chronically, treatment-resistant 
depressed patients. Because the BFT has never been used in this population, the first 
aim was to investigate whether chronically, treatment-resistant depressed patients 
show more negative thought intrusions on the BFT compared with never-depressed 
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individuals, as would be expected from previous studies using self-report. Therefore, 
thought intrusions of the BFT and effects on mood were compared between a never-
depressed sample and a chronically, treatment-resistant depressed patient sample in a 
cross-sectional design. Secondly, scores on the BFT of the same chronically, treatment-
resistant depressed patient sample was assessed in a randomized-controlled trial (RCT) 
comparing MBCT with treatment-as-usual. These data were used for the main aim of 
the study to investigate whether MBCT affects rumination. We hypothesized that MBCT 
would lead to a decrease of on-line behavioural rumination. A better understanding 
of the effects of MBCT on rumination in chronically, treatment-resistant depressed 
patients would allow more specific predictions about the effects of MBCT and therefore 
better patient care.
METHOD
This study is part of an RCT with 106 participants assessing the effects of MBCT versus 
treatment-as-usual (TAU) in chronic, treatment-resistant depression (Cladder-Micus 
et al., 2015; Cladder-Micus et al., in press, Dutch trial register [part of the Cochrane 
Collaboration], www.trialregister.nl : NTR4843). Patients were randomized to an 8-week 
MBCT training in combination with TAU (MBCT+TAU) or TAU alone. The procedure of 
the RCT regarding the clinical effectiveness is described in detail the published study 
protocol (Cladder-Micus et al., 2015) and is summarized below. The study protocol 
of the RCT was approved by the Medical Ethics Committee Arnhem-Nijmegen. 
Additionally, data of never-depressed controls were collected. The study protocol to test 
never-depressed controls was considered as exempt from review by the Medical Ethics 
Committee Arnhem-Nijmegen.
Participants & Procedure
Patients with chronic, treatment-resistant depression
Participants were outpatients of a mental health clinic (Pro Persona) or an academic 
hospital (Radboud University Medical Center) in the Netherlands. Inclusion criteria 
were: a) age ≥ 18; b) current depressive episode according to DSM-IV criteria with a 
duration of ≥ 12 months; c) moderate to high levels of depressive symptoms (Inventory 
of Depressive Symptomatology-Self-Report, IDS-SR ≥ 21); d) previous psychological 
treatment during the current episode (defined as: ≥ 10 sessions of Cognitive Behavioural 
Therapy or Interpersonal therapy ; or < 10 sessions if discontinued because of patient’s 
withdrawal); e) at least one adequate trial of antidepressant medication during the 
current episode (defined as: appropriate doses of antidepressant medication for ≥ 4 
weeks; or patient’s refusal to use medication contrary to the advice of a psychiatrist). 
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Exclusion criteria were: : a) current psychotic symptoms; b) lifetime bipolar disorder; 
c) current alcohol or drug dependence; d) recent electro convulsive therapy (< 3 
months ago); e) current somatic disorder partly explaining depressive symptoms; f ) 
physical-, linguistic-, cognitive, or intellectual impairments which might interfere with 
participation in MBCT or assessments; and g) previous MBCT training.. All patients gave 
written informed consent during a research interview. On baseline and post-treatment 
(MBCT+TAU,TAU), questionnaires and clinical interviews were administered (Cladder-
Micus et al., 2015). Of the 106 participants a subsample of 86 participants (based on 
study entry1) was invited to additionally take part in a 1.5hour neuropsychological 
test battery including tasks on attention, memory, interpretation, cognitive control 
and rumination. There was no significant difference in baseline depressive symptoms 
between the whole sample (N=106) and the subsample (n=86) who was invited to 
take part in the experimental test battery ,t(104)= -.89, p=.37. At the end of the test 
battery participants performed the BFT. Of 73 participants who agreed to perform the 
BFT at baseline, 62 participants (MBCT+TAU: 26, TAU: 36) also performed the task post-
treatment. Patients who refused or agreed to take part in the neuropsychological test 
battery did not differ on levels of depressive symptoms, t(84)=-.01, p=.99. There was also 
no difference in depressive symptom levels between patients with or without missing 
data at post-treatment, t(72)=-.07, p=.94. Neuropsychological data collection took place 
between November 2013 and April 2016. 
Never-depressed controls
Never-depressed control participants (N=108) were recruited from the community via 
flyers, websites and waitlists of mindfulness-based stress reduction (MBSR) courses 
provided for the general public. Exclusion criteria were: a) current of lifetime depressive 
episode according to DSM-IV criteria; b) current anxiety disorder according to DSM-
IV criteria; c) current or lifetime psychotic symptoms; d) current alcohol or drugs 
dependence according to DSM-IV; f ) physical-, language-, cognitive-, or intellectual 
impairments which interfere with assessments; g) previous mindfulness training or 
other mediation practice. We ensured that participants recruited via MBSR courses 
participated in the current study before attending the first MBSR session. Two individuals 
with excessive high scores on depressive symptoms (IDS-SR >21) were excluded, leaving 
106 participants for the analyses. The group was matched in age and gender to the 
patient sample. Interested individuals were telephonically screened for in- and exclusion 
criteria using the structured clinical interview for DSM-IV (SCID) axis I disorders (van 
Groenestijn, Akkerhuis, Kupka, Schneider, & Nolen, 1999). Before the neuropsychological 
1.  Data collection of the experimental test battery started while the RCT was ongoing. Therefore, the first 20 
participants were not invited to perform the BFT.
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test session, participants completed an online version of the questionnaires at home. 
The neuropsychological test session was identical for patients and never-depressed 
controls, except for two additional tasks that were added for the controls at the end of 
the session. These two tasks are not part of the current investigation. Participants gave 
written informed consent at the beginning of the neuropsychological test session and 
passive informed consent at the beginning of the online questionnaires. Participants 
received a gift card (€20) for their time and effort. Data collection of this sample took 
place between March 2014 and February 2016.
Measures
Questionnaires
Trait rumination. Trait rumination was assessed with the extended version of the 
Ruminative Response Scale (RRS-EXT; Raes & Hermans, 2007; Raes et al. 2009). The 
RRS-EXT distinguishes between two subscales: reflective pondering and brooding. The 
questionnaire consists of 26-items. Example items are ‘I think about how alone I feel’ 
or ‘I think about why I always react the way I do’. Participants are asked to indicate the 
frequency of ruminative thoughts (1 = almost never to 4 = almost always) when feeling 
down or depressed. Previous research reported appropriate reliability and validity 
(Schoofs, Hermans, & Raes, 2010). In the current study the reliability was high (α=.87 in 
patients; α=.91 in never-depressed controls).
Depressive symptoms. Depressive symptoms were investigated with the Inventory 
of Depressive Symptomatology Self-Report (IDS-SR). The IDS-SR is a 30-item self report 
questionnaire and has good psychometric properties (Rush et al., 2006; Rush, Gullion, 
Basco, Jarrett, & Trivedi, 1996). The IDS-SR has previously been used in research on MBCT 
and has been shown to be sensitive to change (Geschwind et al., 2012). The reliability in 
the current study was appropriate (α=.78 in patients; α=.71 in never-depressed controls).
Mindfulness skills. Mindfulness skills were assessed with the Five Facets Mindfulness 
Questionnaire (FFMQ; Baer et al., 2008).The FFMQ consists of 39 items which are divided 
in five subscales: observing, describing, acting with awareness, non-judging of inner 
experience and non-reactivity of inner experience. The Dutch version of the FFMQ has 
good psychometric properties (de Bruin, Topper, Muskens, Bögels, & Kamphuis, 2012; 
Veehof, Peter, Taal, Westerhof, & Bohlmeijer, 2011). In the current study, reliability of the 
total score was high (α=.82 in patients; α=.86 in never-depressed controls). The reliability 
of the subscales was high ranging from α=.79 to α=.89, except for the subscale non-
reactivity of inner experience, which showed lower reliability (α=.63 in patients; α=.70 
in never-depressed controls).
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Behavioural on-line assessment of rumination: breathing focus task
The BFT (Borkovec et al., 1983; Hirsch et al., 2009) typically consists of two assessment 
phases and a worry induction (Hayes et al., 2010) or negative mood induction 
(Southworth et al., 2017). Due to ethical concerns when using a negative mood 
induction in a clinical sample, only the first assessment phase of the BFT was used in 
the current study. Participants were asked to focus on their breathing for five minutes, 
while noticing distracting thoughts (i.e. thought intrusions). During this period a 
computer generated tone sounded 12 times at random intervals of 20-30 seconds. After 
each tone participants were required to verbally report whether they were focused on 
their breathing or distracted by a thought intrusion. When distracted by a thought, 
participants reported a short word label (e.g. “cannot concentrate”), and classified the 
thought as negative, positive or neutral. When focused on their breathing participants 
responded by saying “breath” (Dutch: “adem”). Participants were not explicitly informed 
that the task is designed to measure rumination. Prior to the five-minute breathing 
period, participants practiced to focus on their breathing (20 seconds) and practiced 
to respond to three tones while focusing on the breath (45 seconds). After the five-
minute breathing period, participants filled in a self-report measure of state rumination 
consisting of a VAS (percentage of time spend ruminating, 1-100%). Additionally, 
participants rated on three VAS the percentage of time they were able to focus on the 
breath (0-100%), the percentage of time they were distracted by positive thoughts (0-
100%), and how difficult it was to focus on the breath (very difficult-not at all difficult). 
The number of negative thought intrusions (ranging from 0-12) reflects the individual 
state rumination of a participant2. In case participants only reported the valence of an 
intrusion but no description, intrusions were still included in the scoring. 
Mood ratings 
Three VAS were used to assess sadness, anxiety and tension before and after the BFT. 
The scales ranged from 0 to 100, with either sad, anxious, or tense on the right side and 
safe, relaxed, or happy on the left side. 
Interventions
MBCT + TAU. MBCT was based on the manual described by Segal, Williams and Teasdale 
(2002) and consisted of eight weekly 2.5 hours sessions and one day of practice 
2.  At the end of the BFT participants were asked to provide a more detailed description of the thoughts 
reported during the five minute breathing period, which were audio-taped. A subsample of the detailed 
descriptions (n=63) was rated by an independent assessor. The assessor blindly rated the descriptions as 
negative, positive or neutral. The correlation between the number of participant-rated and assessor-rated 
negative thought intrusions was very high (r=.93, p<.001). Analyses based on the assessor-ratings revealed 
comparable results and are available on request from the first author.
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(day of silence). All mindfulness teachers were highly experienced in working with 
depressed patients and met the advanced criteria of the internationally agreed good 
practice guidelines of the UK Network for Mindfulness-based teachers (UK Network 
of Mindfulness-Based Teacher Trainers, 2015). In conjunction with MBCT participants 
received TAU. 
TAU. Treatments-as-usual was a naturalistic condition consisting of mental health care 
for depression, including antidepressant medication, psychological treatment, support 
by a psychiatric nurse, or day-hospital treatment. 
Statistical analyses
Patients with chronic, treatment-resistant depression versus never-depressed 
controls
Independent sample t-tests and χ2 tests were used to compare demographic variables 
between the groups. Whenever visual inspection revealed non-normality, non-
parametric tests were used. First, the total number of thought intrusions was compared 
between the groups, after which the number of negative thought intrusions, positive 
and neutral thought intrusions were investigated separately. Secondly, self-reported 
state rumination (VAS) was compared between the groups and its correlation with 
negative thought intrusion was computed. Third, effects of the BFT on mood were 
analyzed. Finally, Pearson and Spearman correlations between the number of negative 
thought intrusions and trait rumination, mindfulness skills and depressive symptoms 
were investigated. Effect sizes of non-parametric tests were calculated as: r=z/√N.
MBCT+TAU versus TAU
All analyses were based on an all available data, irrespective whether participants 
attended all sessions of the MBCT (intention-to-treat sample). Independent sample 
t-tests and χ2 tests were used to compare demographic variables and baseline scores 
between the conditions (MBCT+TAU, TAU). The sum scores of all thought intrusions, 
negative intrusions, positive intrusions, and neutral intrusions were compared between 
the conditions by using mixed model ANOVAs. In line with previous research (Hayes 
et al., 2010; Hirsch et al., 2009), the number of negative intrusions was considered as 
the primary outcome. We also tested effects on self-reported state rumination (VAS). 
Furthermore, we computed Pearson correlations between change in negative thought 
intrusion from baseline to post-treatment and change in self-reported state rumination, 
trait rumination, depressive symptoms, and mindfulness skills.
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RESULTS
Patients with chronic, treatment-resistant depression versus never-
depressed controls
The first aim of the study was to investigate whether never-depressed control 
participants differed from chronically, treatment-resistant depressed patients on the 
BFT. The groups were comparable on age and gender, however the average level of 
education was higher in never-depressed controls, see Table 1.
TABLE 1. Demographic characteristics and scores on questionnaires of patients with chronically, 
treatment-resistant depression and never-depressed controls. Presented in mean (SD) unless 
otherwise specified
Patients
 (N=73)
Never-depressed 
controls (N=106) t-test/χ2-test
demographics
age, years 46.9 (10.12) 45.9 (12.5) t(176)=.56, p=.58
gender, female/male 43 F/20 M 72 F/34 M χ2(1)=1.26, p=.26
level of education (1-7) 4.4 (1.8) 5.5 (1.5) t(171)=-4.67, p<.001
questionnaires
depressive symptoms (IDS-SR) 41.34 (9.67) 5.39 (3.82) t(176)=34.52. p<.001
trait rumination (RRS-EXT) 58.11 (9.54) 31.75 (8.30) t(173)=19.34, p<.001
mindfulness skills (FFMQ) 98.94 (15.15) 139.98 (15.99) t(173)=-16.92, p<.001
Abbreviations:, RRS-EXT= Extended Version Ruminative Response Scale, FFMQ= Five Facets Mindfulness Questionnaire, IDS-SR= Inventory of 
Depressive Symptomatology Self-Report
Breathing Focus Task
Means, standard deviations and medians (as used in the non-parametric tests) of the 
group comparisons are displayed in Table 2 and graphically illustrated in Figure 1. The 
total number of thought intrusions (irrespective of valence) was significantly higher in 
the patient group compared with the never depressed control group. When including 
the level of education as a covariate in an ANCOVA, comparable results were found, 
F(2,170)=41.03, p<.001, =.19. Because data of thought intrusions grouped in valences 
(negative, positive, neutral) were not normally distributed, Mann-Whitney U-tests were 
applied. Results showed that the number of negative thoughts in the patient group 
was significantly higher compared with the never-depressed controls (p<.001) with a 
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large effect size of r=-.54.3 In contrast, no differences in the number of positive (p=.62) 
or neutral thought intrusions (p=.86) were observed, see Figure 1. Patients spent a 
significantly lower percentage of time focused on the breathing (p<.001) and found 
it more difficult to focus on the breathing (p<.001). On the self-report measure of 
rumination (VAS) patients reported higher rumination than never-depressed controls 
(p<.001) with a large effect size of r=.61. There was no difference between the groups in 
the percentage of time they were distracted by positive thoughts.
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FIGURE 1. Means of negative, positive, and neutral thought intrusions on the breathing focus 
task for both groups. Error bars display standard error of the mean, *** p<.001
Effects on mood
Changes in mood (sadness, anxiety, tension) from pre to post BFT were investigated 
with Wilcoxon Signed Rank Tests, because data was not normally distributed. The 
means, standard deviations and medians of the mood ratings are displayed in Table 
3. Depressed patients showed a significant increase in sadness (p=.002, z=3.08, r=.38, 
medium to large effect) and no change in anxiety (p=.10) or tension (p=.83). In contrast, 
the never-depressed control group showed no change in sadness (p=.83) or anxiety 
(p=.06), but a significant decrease in tension, p<.001, z=-3.80, r=-.37, medium to large 
effect.
3.  In order to control for differences in level of education between the groups, an ANCOVA with group 
(chronically, treatment-resistant depressed, never-depressed controls) as between subject-factor and level of 
education as covariate on the number of negative thought intrusions was conducted. Results (F(1,170)=59.03, 
p<.001,  =.26) indicate a significant difference between the groups, while controlling for level of education.
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Correlations 
Correlations between the measures are presented in Table 4. The number of negative 
thought intrusions was significantly correlated with self-reported state rumination in 
both samples. However, only in the never-depressed sample but not in the depressed 
sample a significant correlation between negative thought intrusions and trait 
rumination was found. Likewise, only the never-depressed control sample showed a 
correlation between self-reported state rumination (VAS) and trait rumination whereas 
the depressed patient sample showed no significant correlation between the state 
and trait measures. In both samples the number of negative thought intrusions was 
significantly negatively correlated with mindfulness skills.
TABLE 4. Correlations between state and trait measures in patients with chronic, treatment-
resistant depression and never-depressed controls 
Patients with chronic, treatment-resistant depression
IDS-SR RRS-EXT
RRS-
brooding
RRS-
reflective FFMQ BFT
VAS 
rumination
IDS-SR -
RRS-EXT .35** -
RRS-brooding .21 .77** -
RRS-reflective .04 .68** .34** -
FFMQ -.33** -.22 -.31** .19 -
BFT .09 -.06 -.09 -.08 -.26* -
VAS-rumination -.01a -.11a -.17 a -.002a -.31* a .64** a -
VAS-sadness1 .32** .09 .003 -.03 -.33** .24* .04
Never-depressed controls
IDS-SR RRS-EXT
RRS-
brooding
RRS-
reflective
FFMQ
BFT
VAS 
rumination
IDS-SR -
RRS-EXT .49** -
RRS-brooding .55** .84** -
RRS-reflective .26* .83** .57** -
FFMQ -.42** -.23* -.31** -.04 -
BFT .13 a .41** a .40** a .35** a .-20* a -
VAS-rumination .29** a .44** a .41** a .40** a -.38** a .46** a -
VAS-sadness1 .23*a .33*a .33*a .29** a -.37** a .31* a .39** a
Note. a Spearman correlation, * p<.05, **p<.001, 1 prior to BFT, Abbreviations: BFT= Breathing Focus Task, RRS-EXT= Extended Version 
Ruminative Response Scale, FFMQ= Five Facets Mindfulness Questionnaire, IDS-SR= Inventory of Depressive Symptomatology Self-Report, 
VAS= Visual Analogue Scale
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In neither of the two samples, the number of negative thought intrusions was correlated 
with depressive symptoms. By comparison, the self-reported state rumination measure 
(VAS) was significantly correlated with depressive symptoms in the never-depressed 
control sample but not in the depressed sample.
MBCT+TAU versus TAU
This paragraph describes analyses related to the second –and main - aim of the study: 
to investigate whether MBCT influences rumination assessed with the BFT. On baseline 
there were no differences between the conditions (MBCT+TAU, TAU) on demographic 
variables and baseline scores, see Table 5.
TABLE 5. Characteristics per condition on baseline. Presented in Mean (SD) unless otherwise 
specified
MBCT+TAU 
(n=26)
TAU
 (n=36) t-test/χ2-test
demographic characteristics
age, years 47.9 (9.7) 46.1 (10.5) t(71)=-.75, p=.455
gender, female/male 21 F/13 M 21 F/18 M χ2(1)=.466, p=.50
level of education (1-7) 4.2 (1.9) 4.4 (1.8) t(66)=.44, p=.66
trait measures
depressive symptoms (IDS-SR) 40.39, (10.20) 42.50 (9.30) t(71)=.92, p=.36
trait rumination (RRS-EXT) 56.80 (9.70) 59.06 (9.31) t(68)=.99, p=.33
mindfulness skills (FFMQ) 100.91 (16.08) 96.95 (14.39) t(68)= -1.09, p=.28
state measures
negative intrusions (BFT) 3.44 (2.59) 3.05 (2.85) t(71)=-.601, p=.55
self-reported state rumination (VAS %) 45.6 (30.0) 41.5 (26.3) t(63)= -.598, p=.55
sadness (VAS) 62.4 (21.5) 57.5 (18.0) t(67)=-1.02, p=.31
anxiety (VAS) 39.9 (30.0) 39.9 (22.9) t(67)=.004, p=.99
tension (VAS) 58.4 (26.9) 55.3 (22.6) t(67)=-.52, p=.60
Note. Abbreviations: BFT= Breathing Focus Task, FFMQ= Five Facets Mindfulness Questionnaire, IDS-SR= Inventory of Depressive 
Symptomatology Self-Report, MBCT= Mindfulness-based cognitive therapy, RRS-EXT= Extended Version Ruminative Response Scale,, 
TAU=treatment-as-usual, VAS= Visual Analogue Scale
Breathing Focus Task
In order to test whether MBCT+TAU resulted in a reduction of the total number of thought 
intrusions on the BFT compared with TAU, a mixed model ANOVA was conducted on the 
total number of thought intrusions (irrespective of valence) with time (baseline, post-
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treatment) as within-subject factor and condition (MBCT+TAU, TAU) as between-subject 
factor. Results showed a significant main effect of time, F(1,60)=20.00, p<.001,  =.25 and 
a significant time*condition interaction, F(1,60)=6.46, p=.014, =.097. This means that 
both conditions showed a reduction in total thought intrusions from baseline to post-
treatment, and that this decrease was larger in the MBCT+TAU condition than in the TAU 
condition, see Figure 2. 
Secondly, mixed model ANOVA’s with time (baseline, post-treatment) as within-subject 
factor and condition (MBCT+TAU, TAU) as between-subject factor were conducted for 
each valence (negative, positive, neutral) separately. There was a main effect of time 
on negative thought intrusions, F(1,60)=22.17, p<.001, =.27 and, more importantly, 
a significant interaction between time and condition, F(1,60)=5.04, p=.03, =.08, 
with MBCT+TAU participants showing a larger decrease in negative thoughts than 
participants receiving TAU, see Figure 2. We included change in depressive symptoms 
during MBCT+TAU or TAU (IDS post score -IDS pre score) as covariate in the analysis 
to assess independence of clinical improvement. When including change in depressive 
symptoms in the model, comparable results for the time*condition interaction were 
found, F(1,58)=4.23, p=.04, =.07, indicating that the decrease in negative thought 
intrusions was independent of change in depressive symptoms. No main effect of 
time was found for positive, F(1,60)=.024, p=.88, =.00 or neutral thought intrusions, 
F(1,60)=.33, p=.57, =.01, and no significant time*condition interactions were observed 
(positive: F(1,60)=0.024, p=.88, =.00; neutral: F(1,60)=.12, p=.73, =.002), see Figure 2. 
Taken together, these results indicate that participants of the MBCT+TAU condition 
showed a larger decrease in negative thought intrusions than those of the TAU condition, 
whereas no change over time or differences between the conditions on positive or 
neutral thought intrusions were observed. 
There was a main effect of time on the percentage of time participants reported to 
be able to focus on the breathing, F(1,57)=13.95, p<.001, but no time *condition 
interaction, F(1,57)=2.29, p=.14.Specifically, the percentage of time participants were 
able to focus on the breathing increased from baseline to post-treatment, however no 
significant differential effect for TAU (M
baseline
=48.68, SD
baseline
=25.15, M
post-treatment
=54.82, 
SD
post-treatment
=24.81) or MBCT+TAU (M
baseline
=48.68, SD
baseline
=27.37, M
post-treatment
=63.20, 
SD
post-treatment
=19.57) was found. There were no main or interaction effects regarding the 
self-reported difficulty to focus on the breathing or the time being distracted by positive 
thoughts (all F < 1, p>.05).
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FIGURE 2. Mean number of negative, positive, and neutral thoughts during the breathing focus 
task per condition on baseline and post-treatment. The total score is the sum of all thought 
intrusions. Error bars represent standard errors. Abbreviations: BFT= breathing focus task, MBCT= 
Mindfulness-based cognitive therapy, TAU=treatment-as-usual, n.s.= non significant, *=p<.05
Effects on self-reported state rumination
To test whether MBCT+TAU resulted in a reduction of self-reported state rumination 
(VAS), a mixed model ANOVA with time (baseline, post-treatment) as within-subject 
variable and condition (MBCT+TAU, TAU) as between-subject variable was conducted. 
There was a significant effect of time, F(1, 57)=12.5, p<.001,  =.18, but no time*condition 
interaction, F(1,57)=2.73, p=.10,  =.05, indicating that both conditions decreased in self-
reported state rumination (MBCT+TAU: M
baseline
=47.12, SD
baseline
=30.11, M
post-treatment
=27.68, 
SD
post-treatment
=21.89; TAU: M
baseline
=43.53, SD
baseline
=26.71, M
post-treatment
=36.47, SD
post-
treatment
=24.93), but that there was no significant differential effect of condition. 
Correlations 
Change in negative thought intrusions from baseline to post-treatment was significantly 
positively correlated with change in self-reported state rumination in both conditions 
(MBCT+TAU: r=.44, p=.03; TAU: r=.51, p=.002). In neither of the conditions, change in 
negative thought intrusions from baseline to post-treatment was correlated with 
change in depressive symptoms (MBCT+TAU r=.22, p=.29; TAU: -.09, p=.58), change in 
trait rumination (MBCT+TAU: r=-.14, p=.51; TAU: r=.12, p=.49) or change in mindfulness 
skills (MBCT+TAU: r=-.09, p=.68; TAU: r= -.14, p=.43). 
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DISCUSSION
The first aim of the current research was to investigate whether the BFT could be used as 
an on-line behavioural measure to assess rumination in chronically, treatment resistant 
depressed patients. Compared with never-depressed controls from the community, 
patients with chronic, treatment-resistant depression reported significantly more 
negative thought intrusions on the BFT. Importantly, the groups did not differ in 
the number of positive or neutral thought intrusions, indicating that the difference 
between patients and controls was valence-specific. Furthermore, the number of 
negative thought intrusions significantly correlated with a more traditional measure of 
state rumination (i.e. VAS). As expected based on previous results (Hayes et al., 2010), 
the group of chronically, treatment-resistant depressed patients showed an increase in 
sadness after performing the BFT. 
Interestingly, only in the never-depressed control sample but not in the depressed 
sample, the measures of state and trait rumination were significantly correlated. It is 
unlikely that this is due to ceiling effects, because the variation in scores was larger in 
the depressed samples than in the group of never-depressed controls. Previous research 
found that state and trait measures of rumination were not correlated in college 
students (LeMoult, Arditte, D’Avanzato, & Joormann, 2013). It is therefore surprising that 
we found a correlation within the never-depressed sample but not within the patient 
sample. Further research is needed to test the relationship between state and trait 
measures of rumination. Possibly, the relationship between the general tendency to 
ruminate and state rumination is different for chronically, treatment-resistant depressed 
patients compared to healthy individuals.
In both patients and controls rumination assessed with the BFT was correlated with 
sad mood, but not with depressive symptoms. By comparison, the self-report state 
rumination measure (VAS) showed a significant correlation with sad mood and 
depressive symptoms in the never-depressed sample. This might indicate that the BFT 
is less influenced by depressive symptoms than the self-report measure of rumination. 
There is a need for state rumination measures that are independent of depressive 
symptoms because this would allow testing specific hypothesis about the effects of 
interventions on rumination and depressive symptoms (LeMoult et al., 2013). The BFT 
might partly fill this need.
The second – and main – aim of this study was to investigate whether MBCT influences 
rumination in patients with chronic, treatment-resistant depression. The results show 
that participants of MBCT+TAU compared with TAU show a decrease of negative 
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thought intrusions on the BFT. No changes of positive or neutral thought intrusions were 
observed. As expected, this reduction in negative thought intrusions on the BFT was 
significantly correlated with a more traditional self-report measure of state rumination 
(i.e. VAS). In contrast, no effect of MBCT+TAU compared with TAU on self-reported state 
rumination (VAS) was observed, which might indicate that the BFT could be a more 
sensitive measure than a VAS to assess state rumination. 
Against our expectation, we found no correlation between the reduction of negative 
thought intrusions and change in depressive symptoms or mindfulness skills. This could 
partly be explained by the fact that mindfulness skills and depressive symptoms were 
assessed with questionnaires, whereas rumination was assessed with a behavioural 
task. Different measurement methods tend to correlate less than two measures using 
the same method (Podsakoff, MacKenzie, Lee, & Podsakoff, 2003). 
Strengths, limitations and future research
This paper describes the first randomized controlled trial showing that rumination 
assessed with an on-line, behavioural measure changes due to MBCT in chronically, 
treatment-resistant depressed patients. This result is in line with the theoretical model 
of MBCT, which proposes that MBCT influences depressive rumination (Segal et al., 
2012). The current study thereby provides further information about the specific effects 
of MBCT, which was formulated as an important research goal in the field of mindfulness 
research (Dimidjian & Segal, 2015). One of the strengths of on-line measures is that the 
results are less influenced by memory biases during retrospective recall (Veenman, 
2011). Furthermore, although one could argue that even scores of the BFT are based 
on self-report, response biases are diminished because the participant is not explicitly 
asked whether he or she is ruminating. Therefore, the BFT provides a more direct 
reflection of change in rumination compared with studies using off-line measures, as for 
example questionnaires. The original BFT includes a worry or negative mood induction. 
Our results show that the BFT can be used in depressed patients without including an 
induction, which shortens the procedure and reduces ethical concerns. Although the 
task asks for a certain level of introspection and insight in one’s own cognitive processes, 
our results show that chronically depressed patients are able to perform the task with 
the standard amount of practice. The BFT could therefore be a valuable instrument for 
future research on rumination, especially if one is interested in effects independent of 
memory biases. This could be especially valuable in research on working mechanisms 
of treatments.
Of course the current study is not without limitations. It is important to realize that 
we assessed the effects of MBCT in a pre-post design. Therefore the temporal order of 
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change in rumination and depressive symptoms remains unclear (Kazdin, 2007). Further 
research is needed to test whether the observed reduction on rumination affects 
depressive symptoms and is therefore a working mechanism of MBCT. Furthermore, it 
is important to keep in mind that the current study provides insights about the effects 
of MBCT for patients with chronic, treatment-resistant depression. Whether comparable 
results are observed in patients with mild or remitted depression should be assessed 
in future research. The BFT not only requires sufficient insight into one’s own cognitive 
processes, but also the willingness to share these thoughts. Especially responses of 
never-depressed participants, who are not used to discuss personal thoughts with 
a mental health professional, could be influenced by social desirability. Finally, a 
standardized scoring of the BFT would make it easier to compare results of different 
studies. In line with studies published by the developers of the BFT (Borkovec et al., 
1983; Hirsch et al., 2009) we used the number of negative thought intrusions. However, 
alternative scorings have been published (Southworth et al., 2017) and future research 
directly comparing different scoring methods would be valuable. 
Conclusion
Taken together the current study shows that MBCT affects state rumination assessed 
with an on-line behavioural measure in chronically, treatment-resistant depressed 
patients. It therefore adds evidence to the theoretical assumption that MBCT reduces 
depressive rumination (Segal et al., 2012).
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ABSTRACT
The present study describes the validation of the Dutch Comprehensive Inventory of 
Mindfulness Experiences (CHIME) and the development of a short form. The psychometric 
properties of the CHIME were examined, including its factor structure, internal 
consistency, and convergent and discriminant validity in a group of 481 participants 
consisting of clinical and non-clinical samples. In addition, a 24-item short form (CHIME-
SF) was developed and its psychometric properties were assessed in the same sample. 
Confirmatory factor analyses showed an acceptable model fit of an 8-factor structure of 
the CHIME with the following subscales: awareness of internal experiences, awareness 
of external experiences, acting with awareness, accepting and non-judgmental attitude, 
nonreactive decentering, openness to experiences, awareness of thought’s relativity, 
and insightful understanding. The CHIME-SF showed a good model fit and the subscales 
of the CHIME and CHIME-SF showed high corrected correlations (r
c
=.69-.88). The CHIME 
and the CHIME-SF proved to be sensitive to change. The results indicate that the Dutch 
version of the CHIME and CHIME-SF are valid instruments to assess mindfulness skills in 
clinical and non-clinical populations. 
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INTRODUCTION
Mindfulness is defined as bringing one’s attention to the moment-to-moment 
experience in a nonjudgmental and accepting way (Kabat-Zinn, 1990) and has been 
receiving increasing interest within clinical and nonclinical settings. During the last 
three decades, several mindfulness-based interventions, such as mindfulness-based 
stress reduction (MBSR) (Kabat-Zinn, 1990) and mindfulness-based cognitive therapy 
(MBCT) (Segal, Williams, & Teasdale, 2013) have been developed and their efficacy has 
been established in a large number of studies (Khoury et al., 2013; Kuyken et al., 2016).
Consequently, the assessment of mindfulness has increasingly received attention 
and several self-reporting questionnaires have been developed. These include 
the Mindfulness Attention Awareness Scale (Brown & Ryan, 2003), the Freiburg 
Mindfulness Inventory (Walach, Buchheld, Buttenmuller, Kleinknecht, & Schmidt, 
2006), the Kentucky Inventory of Mindfulness Skills (Baer, Smith, & Allen, 2004), the 
Southampton Mindfulness Questionnaire (Chadwick et al., 2008), the Cognitive and 
Affective Mindfulness Scale (Feldman, Hayes, Kumar, Greeson, & Laurenceau, 2007), 
the Five Facet Mindfulness Questionnaire (FFMQ; Baer, Smit, Hopkins, Krietemeyer, & 
Toney, 2006), the Philadelphia Mindfulness Scale (Cardaciotto, Herbert, Forman, Moitra, 
& Farrow, 2008) and the Toronto Mindfulness Scale (Lau et al., 2006). Bergomi, Tschacher, 
and Kupper (2013b) examined these eight validated mindfulness questionnaires in 
detail and identified nine distinguishable aspects of mindfulness skills covered in these 
instruments. These aspects include: (1) observing, attending to experiences; (2) acting 
with awareness; (3) non-judgment, acceptance of experiences; (4) self-acceptance; (5) 
willingness and readiness to expose oneself to experiences, non-avoidance; (6) non-
reactivity to experience; (7) non-identification with own experiences; (8) insightful 
understanding; and (9) labelling, describing. Bergomi et al. concluded that none of the 
available instruments covered all aspects, as each questionnaire was based on a slightly 
different definition of mindfulness and emphasized different aspects of mindfulness 
skills (Bergomi et al., 2013a). In addition, several studies imply that the comprehension 
of mindfulness scales is influenced by meditation experience (Baer et al., 2006; Baer et al., 
2008; Curtiss & Klemanski, 2014). In a recent study, Gu et al. (2016) examined the factor 
structure of the FFMQ in participants taking part in MBCT. Based on the results they 
propose to exclude the subscale ‘observing’ when comparing scores before and after 
mindfulness interventions, as scores are likely to be inflated by a better understanding 
of the construct. Taken together, none of the available mindfulness questionnaires 
covers the whole range of the mindfulness construct and is equally applicable for 
samples varying in meditation experience.
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Taking these limitations into account, Bergomi and colleagues (Bergomi et al., 2013b; 
Bergomi, Tschacher, & Kupper, 2014) developed the Comprehensive Inventory of 
Mindfulness Experiences (CHIME). The CHIME is based on a thorough literature review 
and comparing of the existing mindfulness questionnaires. The CHIME not only covers a 
broad range of the mindfulness aspects, but the developers also paid special attention to 
make the scale more comprehensible for community samples irrespective of meditation 
experience. Psychometric properties of the CHIME were evaluated as good in samples 
consisting of community members and participants of MBSR (Bergomi et al., 2014). 
Importantly, a recent study investigated whether scores of the CHIME are dependent 
on a better understanding or response shift due to a mindfulness intervention. The 
results showed that scores of the CHIME were only minimally influenced by a better 
or changed understanding of the concept of mindfulness (Krägeloh, Bergomi, Siegert, 
& Medvedev, 2017). Therefore, the CHIME has potential to be a useful instrument in 
mindfulness research. However, as the CHIME was validated in German, it is not yet 
available in Dutch. Furthermore, even though the sensitivity to change of the CHIME 
has already been demonstrated in a non-clinical sample of MBSR participants (Bergomi 
et al., 2014), but has not yet been tested in a clinical sample receiving MBCT within a 
mental health care institution. 
The purpose of this study was to translate the CHIME questionnaire into Dutch and 
to evaluate its psychometric properties. The factor structure, internal consistency 
and validity of the Dutch CHIME were investigated in a mixed sample consisting of 
one clinical and two non-clinical samples. Furthermore, the sensitivity to change of 
the CHIME before and after a mindfulness intervention (MBCT/MBSR) was evaluated 
in the clinical and one of the non-clinical samples. The second aim of this study was 
to develop a short form of the CHIME, with similar content validity and psychometric 
properties to the full version. A shorter version of the CHIME is particularly relevant for 
research settings where time constraints make the use of the long form less feasible or 
the questionnaire is administered on multiple occasions.
METHOD
The study was divided in three stages. First the German version of the CHIME was 
translated into Dutch according to a standardized procedure (Guillemin, Bombardier, 
& Beaton, 1993). Second, the model fit, validity and sensitivity to change of the 
translated version were tested. Third, a short-form of the CHIME was developed and its 
psychometric properties were evaluated.
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Translation procedure
The procedure of the translation consisted of four steps. First the German version of the 
CHIME was translated into Dutch by two independent native Dutch speakers (forward 
translation). One of the translators had a background in psychiatry and was a mindfulness 
trainer (HvR); the other translator had a background in human resource management 
and no experiences with mindfulness. These two translations were combined in one 
version by consensus. 
Second, two native German speakers, living in the Netherlands and Belgium, 
independently re-translated this Dutch version into German (back translation). One of 
the back-translators had a background in management science and was an experienced 
mindfulness trainer; the other back-translator had a background in psychology and 
mindfulness research (MCM). The back-translators were blind to the original German 
version.
Third, the back-translations were compared to the original version and a final Dutch 
version was created after several consensus meetings. During this phase, the translation 
was also evaluated by two native Flemish speakers (FR & KVdG) to ensure that the 
questionnaire would be suitable within both the Dutch and Flemish language area. 
Additionally, eight students and members of the Department of Psychiatry of the 
Radboudumc with a wide range of mindfulness experiences were asked to fill in the 
questionnaire and to report any difficulties with the phrasing of the items. Based on 
these evaluations the final Dutch version of the CHIME was developed. 
Participants 
A total of 481 persons participated in the current study, consisting of three different 
samples: one clinical sample, and two non-clinical samples. All participants gave 
informed consent to voluntarily participate and anonymity was guaranteed. 
Demographic characteristics are presented in Table 1.
The first sample (clinical sample) consisted of 232 patients who participated in a MBCT 
course for patients with recurrent depressive disorder provided at the department of 
psychiatry at the Radboud University Medical Center, Nijmegen, The Netherlands. All 
trainers teaching MBCT at the Radboud University Medical Center were experienced in 
working with depressed patients and completed a 2-year mindfulness teacher training. 
Before the MBCT course participants completed questionnaires on mindfulness skills 
and theoretically related and unrelated constructs. 149 (64.2%) completed the same 
measures after the course. These questionnaires were administered as routine outcome 
monitoring (ROM), and were used for research purposes in anonymized form. 
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The second sample (non-clinical sample 1) consisted of 127 persons participating in a 
MBSR course for the general public at the Radboud University Medical Center, Nijmegen, 
The Netherlands. Before and after the MBSR course, participants completed an online 
questionnaire on mindfulness skills and theoretically related and unrelated constructs. 
Measures were administered to answer several research questions, the measures that 
are used for this research are described below. 93 (73.2%) participants completed the 
measures after the MBSR. 
The third sample (non-clinical sample 2) consisted of 122 participants who had followed 
an MBCT/MBSR course in Flanders in the past. This sample was recruited using snowball 
sampling via e-mail. An email with detailed information was sent to mindfulness trainers 
in Flanders, requesting circulation of this invitational email to former MBCT/MBSR 
attendees. In this email, the address of a website where participants could complete the 
questionnaire was included.
TABLE 1. Demographic characteristics
Clinical sample Non-clinical sample 1 Non-clinical sample 2
N 232 127 122
Mindfulness intervention MBCT MBSR MBCT/MBSR
Age, M (SD), in years 46.9 (13.45) 42.1 (12.27) 49.0 (11.4)
18-25 5.6% 7.9% 2.5%
26-35 17.2% 29.9% 13.1%
36-45 25.9% 19.7% 21.3%
46-55 20.3% 24.4% 32.0%
56-65 22.0% 18.1% 25.4%
.>65 9.1% 0% 5.7%
Gender
male 29.7% 19.7% 19.7%
female 70.3% 80.3% 80.3%
Note. MBCT=Mindfulness-based cognitive therapy, MBSR=Mindfulness-based stress reduction
Measures
Comprehensive Inventory of Mindfulness Experiences (CHIME). The CHIME is a 37-
item questionnaire with eight subscales (Bergomi, Tschacher, & Kupper, 2013a; Bergomi 
et al., 2013b, 2014): awareness of internal experiences (inner awareness), awareness of 
external experiences (outer awareness), acting with awareness (acting with awareness), 
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accepting and non-judgmental attitude (acceptance), nonreactive decentering 
(decentering/nonreactivity), openness to experiences (openness), awareness of thought’s 
relativity (relativity), and insightful understanding (insight). The CHIME does not cover 
the aspect ‘labelling, describing’ as research has shown that this aspect is related to 
mindfulness skills rather than being a part of mindfulness skills (Bergomi et al., 2013b). 
Items are scored on a 6-point Likert scale, ranging from 1 (almost never) to 6 (almost 
always). The CHIME was administered in all samples.
Five Facet Mindfulness Questionnaire Short Form (FFMQ-SF). In the clinical and 
non-clinical sample 1 mindfulness skills were also assessed with the Dutch version of 
the 24-item Five Facet Mindfulness Questionnaire Short Form (FFMQ-SF) (Bohlmeijer, 
ten Klooster, Fledderus, Veehof, & Baer, 2011). The FFMQ-SF consists of five subscales: 
observing, describing, acting with awareness, non-judging of inner experience and 
non-reactivity to inner experience. The FFMQ-SF is positively related to well-being and 
openness to experience and inversely related to measures of psychological symptoms, 
experiential avoidance, and neuroticism (Bohlmeijer et al., 2011). In the current study 
Cronbach’s alpha was α=.86 in the clinical sample and α =.74 in non-clinical sample 1.
Self-Compassion Scale (SCS). The SCS is a 26-item questionnaire measuring self-
compassion. The Dutch version of the SCS has good psychometric properties and high 
scores on the SCS are related to psychological well-being (Neff & Vonk, 2009). A Dutch 
12-item short form of the SCS was developed by Raes, Pommier, Neff, and Van Gucht 
(2011), which has good psychometric properties, high internal consistency and a nearly 
perfect correlation with the long form of the SCS. The 26-item version was used in the 
clinical sample, the 12 item version was used in non-clinical sample 1. In the current 
study Cronbach’s alpha was α=.93 in the clinical sample and α=.86 in non-clinical 
sample 1.
Penn State Worry Questionnaire (PSWQ). The PSWQ was developed to measure 
aspects of clinically significant worry (Meyer, Miller, Metzger, & Borkovec, 1990). The 
questionnaire was administered in the clinical and non-clinical sample 1. It measures 
the tendency, intensity, and uncontrollability of worry and consists of 16 items rated 
on a 5-point Likert scale, with values ranging from 1 = not at all typical of me to 5 = very 
typical of me (i.e., “I am always worrying about something”, or “I have been a worrier all 
my life”). The Dutch version of the PSWQ has a high internal consistency in clinical as well 
as in nonclinical samples (Kerkhof et al., 2000; Van Rijsoort, Vervaeke, & Emmelkamp, 
1997). Cronbach’s alpha value was α=.99 in the clinical sample and α=.95 in non-clinical 
sample 1.
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Beck Depression Inventory-II (BDI-II). The 21-item BDI-II is widely used to assess the 
severity of depressive symptomatology (Beck, Steer, & Brown, 1996; Dutch version: van 
der Does, 2002). Each item is a list of four statements about a symptom of depression, 
arranged in order of severity. Items are rated on a 4-point scale ranging from 0 (not at 
all) to 3 (extreme form of each symptom), which corresponds to each statement. Items 
are summed to give a single total score, which ranges from 0−63; a score of 0–13 is 
considered to reflect minimal depression, 14–19 mild depression, 20–29 moderate 
depression, and 30–63 severe depression. The questionnaire was administered in the 
clinical sample and the Cronbach’s alpha was α=.91.
Maslach Burnout Inventory (MBI). The emotional exhaustion subscale of the validated 
Dutch version of the Maslach Burnout Inventory was used to measure burnout in 
non-clinical sample 1 (Maslach & Jackson, 1986; Schaufeli & Van Dierendonck, 2000). 
Emotional exhaustion is seen as the core component of burnout and contained of 8 
items. Items are score on a 7-point Likert scale (0 = never, 6= every day). Cronbach’s alpha 
was α=.89 in non-clinical sample 1. 
Intervention
The MBCT and MBSR programs were based on the original programs by Kabat-Zinn 
(1990) and Segal et al. (2013) and consisted of eight weekly 2.5-hr group sessions, 
one silent day, and daily 45-min home practice. Mindfulness exercises, such as body 
scan, gentle yoga, sitting and walking meditation were practiced. Participants received 
teachings on stress and/or depression, and were invited to share their experiences. In 
total 96.5% of the whole sample attended a MBCT/MBSR course provided by a certified 
mindfulness trainer, of the remaining 3.5% no information regarding the trainer was 
available.
Statistical analysis
The data of all three samples were used to investigate the factor structure of the 
CHIME. For descriptive statistics, internal consistency, sensitivity to change analyses 
and correlations SPSS (version 22) was used, whereas SPSS AMOS was used to perform 
confirmatory factor analyses (CFA's) and to test measurement invariance. To compute a 
corrected correlation to evaluate the CHIME-SF, Levy’s formula (Levy, 1967) was used as 
incorporated in the Shortform Version 1.1 software developed by Barrett (2005).
Factor structure
Based on the original validation study, the model fit of different CFA models was 
evaluated (Bergomi et al., 2014). For these analyses data of all three samples were 
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included (n=481). Of the clinical sample and non-clinical sample 1 the first measurement 
(i.e. before attending MBSR/MBCT) was used. First, the model fit of a 1-factor model 
with all items loading on one factor was tested to evaluate whether the items of the 
CHIME measure one unidimensional construct of mindfulness. Secondly, a correlational 
and a hierarchical 8-factor model were examined. In the correlational 8-factor model, 
it is assumed that the items load on eight subscales, which in turn are correlated. This 
model showed the best fit in the original validation study (Bergomi et al., 2014). In 
the hierarchical 8-factor model, it is assumed that the items load on subscales, which 
in turn load on an overall mindfulness factor. Third, based on the original validation 
study, we examined the model fit of a correlational and hierarchical 7+2-factor model. 
In the correlational 7+2 factor model it is assumed that the factors ‘inner awareness’ 
and ‘outer awareness’ load on the an ‘awareness’ factor, which in turn is correlated with 
the remaining six subscales. In the hierarchical 7+2 factor-model it is assumed that 
the factors ‘inner awareness’ and ‘outer awareness’ load on an ‘awareness’ factor, which 
together with the remaining six factors loads on one general mindfulness factor. 
In all models, items were restricted to load on one factor only, error terms were not 
allowed to correlate and the loading of one item per factor was fixed to 1. The overall 
model chi-square statistic (χ2), where smaller values indicate a better fit, was investigated. 
In addition, the following indices were used to evaluate the models: root mean square 
error of approximation (RMSEA), the standardized root mean square residual (SRMR), 
the comparative fit index (CFI). In line with the original validation study (Bergomi et al., 
2014) the following cut-offs were used to evaluate the fit of the models: RMSEA ≤ .08, 
SRMR ≤ .10 and CFI ≥ .90. In addition, we examined the ratio of the chi-square statistic 
to its degree of freedom (χ2/df), for which values below a value of 5 were considered as 
an acceptable model fit (Bohlmeijer et al., 2011; Watkins, 1989). 
Because we combined data of clinical and non-clinical participants for the main analyses 
we also tested measurement invariance between clinical (=232) and non-clinical groups 
(non-clinical sample 1 and non-clinical sample 2, n=249). We tested configural and 
metric invariance. Configural invariance means that the global factor structure, i.e. the 
number of factors and number of factor loadings for each factor are the same for clinical 
and non-clinical groups (Byrne, 2010). To test metric invariance we constraint factor 
loadings to be the same in both groups. Metric invariance therefore indicates that the 
items contribute to the latent constructs to a similar degree across groups. Models were 
compared by changes in chi-square (p <.05).
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Internal consistency and intercorrelations of the subscales
Internal consistency of the CHIME subscales was evaluated with Cronbach's alpha. A 
higher score of Cronbach’s alpha indicates greater internal consistency (Cicchetti, 1994; 
Tavakol & Dennick, 2011). Person correlations between the subscales were calculated. 
It was assumed that subscales would be small (< r=.3) to moderately (r=.3-.5) correlated 
but not strongly (> r=.5), as it is hypothesized that the subscales measure related but 
unique aspects of mindfulness.
Convergent and discriminant validity of the CHIME
Pearson correlations between the CHIME subscales and other measures collected 
before the MBCT/MBSR were computed for the clinical and non-clinical sample 1. It was 
hypothesized that the subscales of the CHIME should show moderate or strong positive 
correlations with another measure of mindfulness skills (FFMQ). It was hypothesized 
that especially subscales representing similar factors would show moderate to strong 
correlations. We therefore hypothesized a moderate to strong positive correlation 
between the subscales ‘decentering/nonreactivity’ (CHIME) and ‘non-reactivity of 
inner experience’ of the FFMQ, and moderate to strong positive correlations between 
‘acting with awareness’ (CHIME) and the subscale ‘acting with awareness’ of the FFMQ 
(convergent validity). Additionally, we hypothesized that the subscales of the CHIME 
would show moderate to high positive correlations with a measure of self-compassion 
(SCS). In contrast, we hypothesized small to moderate negative correlations between 
subscales of the CHIME and questionnaires measuring depression, worry or burnout 
(discriminant validity).
Sensitivity to change
To assess the ability of the CHIME to detect changes in mindfulness skills, paired-samples 
t-tests on subscales of the CHIME before and after following an 8-week MBCT course 
(clinical sample) or an 8-week MBSR course (non-clinical sample 1) were conducted. A 
Cohen’s d effect size based on the baseline standard deviation was computed. Effect 
sizes between .20 and .50 were considered small, effect sizes between .50 and .80 
moderate, and effect sizes greater than .80 large (Cohen, 1988). 
Development of the short form
The steps taken to develop the short form were based on the guidelines by Marsh, Ellis, 
Parada, Richards, and Heubeck (2005). Criteria for the development of the CHIME short 
form (CHIME-SF) included that (1) the CHIME-SF should retain the content coverage 
of the CHIME; (2) each subscale should include three items; (3) the reliability of each 
subscale of the CHIME-SF should be acceptable; (4) the CHIME-SF should show a similar 
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factor structure as the CHIME with an acceptable or good model fit; (5) the CHIME-SF 
should be comparable to the CHIME in terms of sensitivity to change and discriminant 
and convergent validity. For each subscale three items were selected that best reflected 
the underlying construct, based on the standardized factor loadings in the correlated 
8-factor model, minimal cross-loadings as evidenced by the CFA modification indices, 
and low error correlations with other items. Additionally, the content of all items was 
subjectively evaluated in order to maintain the coverage of the original subscale to 
avoid sacrificing important items by relying exclusively on statistical measures (Smith, 
McCarthy, & Anderson, 2000). By using the same evaluation criteria as for the CHIME, 
the model fit of the CHIME-SF of a 1-factor model and a hierarchical and correlational 
8-factor model were evaluated and compared to the CHIME. Configural and metric 
invariance of the correlational 8-factor model across the clinical and non-clinical 
group was tested. To compare the CHIME and the CHIME-SF, Pearson correlations were 
computed. Because both versions were based on a single administration, corrected 
correlations (r
c
) were computed to control for spuriously inflated correlations due to 
shared measurement error (Levy, 1967). Corrected correlations were computed by using 
the Shortform Version 1.1 developed by Barrett (2005). Additionally, convergent and 
discriminant validity and sensitivity to change of the CHIME-SF were investigated. 
RESULTS
Factor structure of the CHIME
Table 2 presents the fit indices for the CFA model tested for the CHIME. The single-
factor model of the CHIME showed a poor fit to the data, indicating that all items of 
the CHIME as a group do not measure a unidimensional construct of mindfulness. Both 
the hierarchical and correlational 8-factor models showed a satisfactory fit, however, 
in line with the original validation study (Bergomi et al., 2014), the correlational model 
performed slightly better than the hierarchical. However, one item (item 3) had a low 
factor loading (.29), indicating that this item contributed minimally to the subscale 
‘insight’, see table S1 in the appendix. In accordance with the original validation study 
we also examined a correlational and hierarchical 7+2-factor models, these showed 
similar model fits to the 8-factor models. 
These findings show that the CHIME measures eight distinct but related aspects of 
mindfulness skills, of which two factors (inner awareness and outer awareness) can be 
combined as an overall factor measuring awareness. The eight distinct factors can be 
considered as facets of an overall mindfulness factor. 
130
Chapter 6
To test whether the factor structure of the CHIME is stable across clinical and non-
clinical groups configural and metric invariance was investigated. First, the model fit 
of the correlational 8-factor model was tested separately for the clinical sample and 
non-clinical group. In both samples the model had a satisfactory fit (clinical sample: 
χ2=1037.90, df=601, χ2/df=1.73, CFI=0.89, RMSEA=0.056 [90% CI 0.05, 0.062], SRMR=0.07; 
non-clinical sample: χ2=1346.54, df=601, χ2/df =2.24, CFI=0.84, RMSEA= 0.071 [90% CI 
0.066, 0.076], SRMR= 0.08). When testing the correlational 8-factor model in a multiple 
group analysis a satisfactory model fit was found: χ2=2384.44, df=1202, χ2/df =1.98, 
CFI=0.86, RMSEA=0.045 [90% CI 0.043, 0.048]. This shows that the global factor structure 
is the same for the clinical and non-clinical group (configural invariance). Next we 
constraint the factor loadings to be the same across both groups (metric invariance), 
which revealed a satisfactory model fit, χ2=2416.93, df=1231, χ2/df =1.96, CFI=0.861, 
RMSEA=0.045 [90% CI 0.042, 0.047]. Model comparisons showed no significant 
difference between the configural model and metric model (∆χ2=32.49, p=.29). This 
indicates that in the correlational 8-factor model each item contributes to the latent 
constructs to a similar degree across the clinical and non-clinical group.
TABLE 2. CFA Fit Indices for the models tested for the CHIME and the CHIME-SF (N=481).
Model χ2 df χ2/df CFI RMSEA (90% CI) SRMR
CHIME 
 One-factor 4170.07 629 6.63 0.61 0.108 (0.105, 0.111) 0.10
 8-factor correlated 1534.90 601 2.55 0.90 0.057 (0.053, 0.060) 0.06
 8-factor hierarchical 1736.10 621 2.80 0.88 0.061 (0.058, 0.065) 0.08
 7+2-factor correlated 1543.17 606 2.63 0.90 0.057 (0.053, 0.060) 0.06
 7+2-factor hierarchical 1633.25 620 2.55 0.89 0.058 (0.055, 0.062) 0.07
CHIME-SF
 One-factor 2294.35 252 9.11 0.62 0.130 (0.125, 0.135) 0.10
 8-factor correlated 486.13 224 2.17 0.95 0.049 (0.043, 0.055) 0.05
 8-factor hierarchical 632.22 244 2.59 0.93 0.058 (0.052, 0.063) 0.07
Note. CHIME = Comprehensive Inventory of Mindfulness Experiences; CHIME-SF= Comprehensive Inventory of Mindfulness Experiences Short 
Form; χ2 = chi-square; df = degrees of freedom; CFI = comparative fit index; RMSEA = root mean square error of approximation; CI = confidence 
interval; SRMR = standardized root mean square residual.
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Internal consistency and intercorrelations of the subscales
Correlations between the eight subscales of the CHIME are displayed in Table 3. All 
subscales were significantly related with Pearson correlations ranging from .17 to .69, 
indicating that the subscales measure related but distinct facets of mindfulness skills. 
The reliability of the subscales measured with Cronbach's alpha and highly acceptable, 
ranging from α=.71 for acting with awareness to α=.89 for acceptance (see Table 3).
Convergent and discriminant validity of the CHIME
Pearson correlations between the CHIME and convergent and discriminant measures 
are displayed in Table 4. In general, the correlations met the predictions about their 
direction and magnitude. However, the correlations were stronger in the clinical sample 
compared with the non-clinical sample. As expected, the subscale ‘decentering/non-
reactivity’ was strongly, positively correlated with the subscale ‘reacting’ of the FFMQ 
(clinical sample r=.77; non-clinical sample 1 r=.72). The subscale ‘acting with awareness’ 
was moderately, positively correlated with the subscale ‘acting with awareness’ of 
the FFMQ (clinical sample r=.49; non-clinical sample 1 r=.38). In the clinical sample, 
all subscales of the CHIME showed significant positive correlations with a measure of 
self-compassion (SCS). All subscales except from ‘inner awareness’ showed significant 
negative correlations with measures of depression (BDI-II) and worry (PSWQ). That the 
subscale ‘inner awareness’ was not significantly correlated with measures of depression 
(BDI-II) and worry (PSWQ) indicates that this subscale measures a construct distinct to 
negative mental health. The same results were found in non-clinical sample 1, except 
that in addition ‘openness’ was not significantly correlated with measures of self-
compassion (SCS), depression (BDI-II) or worry (PSWQ) and that ‘relativity’ showed no 
correlation with depression (BDI-II) and worry (PSWQ).
Sensitivity to change
The scores on all subscales of the CHIME increased significantly over the course of an 
MBCT/MBSR training in both the clinical and non-clinical sample 1 (see Table 5). Effect 
sizes (Cohen’ s d) were small to moderate, ranging from .33 (openness) to .70 (insight) in 
the clinical sample and .20 (acting with awareness) to .66 (decentering/non-reactivity) 
in the non-clinical sample.
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Evaluation of the CHIME-SF
Based on statistical and content-related considerations described above, 24 items were 
selected for the CHIME-SF. The items of the CHIME-SF can be found in the Appendix. As 
with the CHIME, a 1-factor model assuming that all items load on one unidimensional 
construct, showed a poor fit with the data, whereas both 8-factor models showed a 
good model fit, with the correlational 8-factor model performing slightly better than 
the hierarchical model (see Table 2). To test configural invariance, the model fit of the 
correlational; 8-factor model was tested separately for the clinical and non-clinical 
group. After that the model fit in a multiple group analysis was tested. In both separate 
analyses (clinical group: χ2=349.16, df=224, χ2/df =1.55, CFI=0.94, RMSEA= 0.049 [90% CI 
0.039, 0.059], SRMR= 0.06; non-clinical group: χ2=455.99, df=224, χ2/df =2.04, CFI=0.91, 
RMSEA= [90% CI 0.056, 0.073], SRMR=0.06) and the multiple group analysis (χ2=805.14, 
df=448, χ2/df =1.79, CFI=0.93, RMSEA=0.04 [90% CI 0.036, 0.045]) the model fit was 
satisfactory. Model comparisons of the configural and metric invariance models showed 
no significant change in χ2 (∆χ2= 11.99, p=0.74). This indicates configural and metric 
invariance of the CHIME-SF across clinical and non-clinical groups.
The uncorrected and corrected correlations between the CHIME and the CHIME-SF 
were high: for ‘inner awareness’ the correlation was r=.91 (r
c
=.74), for ‘outer awareness’ 
r=.98 (r
c
=.88), for ‘acting with awareness’ r=.95 (r
c
=.72), for ‘acceptance’ r= .97 (r
c
=.86), for 
‘decentering/nonreactivity’ r=.94 (r
c
=.86), for ‘openness’ r=.97 (r
c
=.69), for ‘relativity’ r=.95 
(r
c
=.75), for ‘insight’ r=.93 (r
c
=.82). This shows that the CHIME-SF and the CHIME measure 
highly related constructs. 
When investigating the sensitivity to change, the CHIME-SF performed very similar to 
the CHIME, with significant increases on all subscales and comparable effect sizes (Table 
5). 
The internal consistency of the CHIME-SF ranged from α=.65 for ‘openness’ to α=.88 
for ‘decentering/nonreactivity’, see Table 6. In order to investigate whether the CHIME-
SF and CHIME represent the same content, correlations with other measures were 
compared. The correlations of the CHIME-SF with other measures (Table 7) were very 
comparable to those of the CHIME (Table 4). This indicates that the CHIME and CHIME-SF 
show comparable discriminant and convergent validity (Table 7).
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DISCUSSION
This study had three aims. First, the CHIME was translated into Dutch according to a 
standardized procedure. Secondly, the psychometric properties and sensitivity to 
change of the Dutch CHIME were evaluated. The third aim was to develop a short form 
of the CHIME with similar psychometric properties and validity. 
The CHIME was translated according to a standardized procedure and the model fit was 
evaluated in a large mixed sample (N=481) consisting of one clinical sample and two 
non-clinical samples. The CFA showed an acceptable model fit for the correlated 8-factor 
structure of the CHIME. This result is in line with the results of the original validation 
study of the German CHIME and confirms that the Dutch version of the CHIME measures 
eight distinct but related aspects of mindfulness skills. However, one item (item 3) 
had a low factor loading (<.40), indicating that this item contributed minimally to the 
subscale ‘insight’. Nevertheless, internal consistency of this subscale (Cronbach’s α=.79) 
is considered sufficient for research purposes. Future research should evaluate whether 
this item is also problematic in other populations and if adaptation of the CHIME is 
necessary. We found configural and metric invariance across the clinical and non-clinical 
participants which indicates that the global factor structure of the CHIME is stable 
across these groups. In line with the original validation study (Bergomi et al., 2014), 
the CHIME’s construct validity was confirmed by the correlations with discriminant and 
convergent constructs. The correlations with a distinct mindfulness skills questionnaire, 
self-compassion, measures of psychopathology (depressive symptoms, burnout), and 
worry met the predictions about their direction and magnitude. Sensitivity to change 
analysis showed significant effects of mindfulness-based interventions on the CHIME 
with small to moderate effect sizes. The largest changes were found for the subscales 
Acceptance, Decentering/Nonreactivity and Insight, which is again consistent with the 
original validation study (Bergomi et al., 2014). These results were found in both the 
clinical and a non-clinical sample, indicating that the CHIME is an adequate measure to 
assess change in mindfulness skills in patients as well as in community samples. 
Evaluation of the short form
The evaluation of the CHIME–SF indicated that the short form we developed was 
sufficiently reliable and valid. CFA showed good model fit for the correlated 8-factor 
structure and was even better compared to the long version CHIME. This may be 
explained by the fact that items with low factor loadings (including item 3) were 
eliminated. Furthermore, the internal consistency, convergent and divergent validity 
and sensitivity to change of short form also remained similar to the full-length form. 
In addition, high corrected correlations were found between the short form and 
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the full-length form. This indicates that the content validity and the psychometric 
properties were sufficiently preserved in the short form. Therefore the CHIME-SF is a 
useful instrument to assess mindfulness skills in research contexts with limited space 
for questionnaires. However, as in general full versions cover the assessed concept more 
broadly, the full CHIME should be preferred if time allows.
Limitations and suggestions for future research
A limitation of this study is that the full and the short form were assessed in the same 
samples. To compare the forms we used corrected correlations, however the factor 
structure of the CHIME-SF should be confirmed in an independent sample. Second, 
the test retest reliability of the Dutch CHIME should be assessed to make sure that the 
increase in scores after a mindfulness intervention is not due to measurement error. Third, 
although we found indications for configural and metric invariance of the CHIME and 
CHIME-SF across clinical and non-clinical participants, further studies should investigate 
scalar and residual invariance before mean scores of patients and community samples 
can be compared. Forth, it would be valuable to further investigate the sensitivity to 
change and whether changes in the CHIME are correlated with changes in psychiatric 
symptoms or well-being. Although the current sample was rather large, response rate 
after the MBCT/MBSR was not optimal which may have resulted in selection bias with an 
overrepresentation of participants who benefitted from the mindfulness intervention. 
Finally, our samples included relatively few men. Translating the CHIME into other 
languages would increase the accessibility of the questionnaire.
Overall conclusion
Overall, this study indicates that the Dutch version of the CHIME is a valid measure to 
assess mindfulness skills. The CHIME covers aspects of mindfulness that are not included 
in the FFMQ, reflected in the subscales openness, relativity, and insight. Therefore the 
CHIME could be particularly useful in research on the differential effects of mindfulness 
facets and their association with related measures. Furthermore, the short form (CHIME-
SF), showed good psychometric properties. This indicates that the CHIME-SF can be 
used to assess change in mindfulness skills in clinical and non-clinical samples. The 
CHIME-SF could especially be useful in research designs including a large number of 
other instruments or repeated measures. 
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APPENDIX 
TABLE S1. Standardized factor loadings of all items in the 8-factor hierarchical CFA model of 
the CHIME
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34 SF .72
14 .66
29 SF .66
5 .64
1 SF .54
21 SF .89
9 SF .84
27 SF .77
18 .72
12 SF .81
26 SF .74
17 SF .52
10 .40
32 .86
11 SF .85
36 SF .77
2 SF .75
7 .74
25 SF .86
13 .85
28 .81
20 SF .79
8 SF .76
16 .41
19 SF .74
22 .63
30 SF .59
33 SF .54
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TABLE S1. (Continued)
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23 SF .77
35 SF .65
4 .43
24 SF .87
6 SF .79
15 SF .76
37 .59
3 .29
Note. Abbreviations: SF=included in short form
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TABLE S2. Dutch CHIME questionnaire. Deze vragenlijst gaat over verschillende aspecten van 
mindfulness in het dagelijks leven. U wordt gevraagd om spontaan te antwoorden, zonder al te 
lang over uw antwoord na te denken. Er zijn geen juiste of foute antwoorden, uw persoonlijke 
ervaring is belangrijk. Beantwoord a.u.b. elke vraag. De stellingen hebben betrekking op de 
afgelopen twee weken.
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1. Wanneer mijn stemming verandert, 
dan merk ik dat onmiddellijk.
SF □ □ □ □ □ □
2. Tijdens de hoogte- en dieptepunten in het 
leven, ben ik vriendelijk voor mezelf.
SF □ □ □ □ □ □
3. In het dagelijks leven, merk ik het op wanneer 
een bepaalde situatie vooral door mijn eigen 
negatieve instelling moeilijk wordt.
□ □ □ □ □ □
4. Ik ben me ervan bewust dat mijn oordeel over situaties 
of personen gemakkelijk kan veranderen.
□ □ □ □ □ □
5. Als ik zit of lig, neem ik sensaties in mijn lichaam waar. □ □ □ □ □ □
6. Ik moet glimlachen wanneer ik merk hoe ik me dingen 
soms veel ingewikkelder voorstel dan ze eigenlijk zijn.
SF □ □ □ □ □ □
7. Ik ben hard voor mezelf wanneer ik een fout maak. □ □ □ □ □ □
8. Als ik vervelende gedachten of beelden heb, 
voel ik me daarna relatief snel weer rustig.
SF □ □ □ □ □ □
9. Ik neem kleuren en vormen in de natuur 
duidelijk en bewust waar.
SF □ □ □ □ □ □
10. Ik breek dingen of laat iets vallen uit onoplettendheid 
of omdat ik aan iets anders denk. 
□ □ □ □ □ □
11. Ik heb oog voor mijn fouten en moeilijkheden 
zonder mezelf te veroordelen.
SF □ □ □ □ □ □
12. Ik kan me gemakkelijk blijven concentreren op wat ik doe. SF □ □ □ □ □ □
13. Als ik vervelende gedachten of beelden heb, kan ik ze 
gewoon opmerken zonder er meteen in mee te gaan.
□ □ □ □ □ □
14. Wanneer ik met andere mensen spreek, merk 
ik op welke gevoelens ik daarbij heb.
□ □ □ □ □ □
15. Als ik het mezelf onnodig moeilijk gemaakt heb, 
kan ik er met enige humor naar kijken.
SF □ □ □ □ □ □
16. In moeilijke situaties kan ik me een moment 
inhouden, zonder direct te reageren.
□ □ □ □ □ □
17. In het dagelijks leven word ik door veel 
herinneringen, beelden of dagdromen afgeleid.
SF □ □ □ □ □ □
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18. Wanneer ik met de auto of de trein reis, ben ik me bewust 
van de omgeving, bijvoorbeeld het landschap.
□ □ □ □ □ □
19. Ik probeer bezig te blijven zodat ik me van bepaalde 
gedachten en gevoelens niet bewust word. 
SF □ □ □ □ □ □
20. Wanneer ik door gedachten en gevoelens in beslag word 
genomen, merk ik dat snel op en kan ik er afstand van nemen.
SF □ □ □ □ □ □
21. Ik heb aandacht voor sensaties, zoals de zon op 
mijn gezicht en de wind door mijn haar.
SF □ □ □ □ □ □
22. Ik probeer mezelf af te leiden als ik 
onaangename gevoelens heb.
□ □ □ □ □ □
23. In het dagelijks leven ben ik me ervan bewust dat veel 
gedachten interpretaties zijn, die niet noodzakelijk 
overeen komen met de werkelijkheid.
SF □ □ □ □ □ □
24. Ik kan glimlachen als ik zie hoe ik van een 
kleinigheid een probleem gemaakt heb.
SF □ □ □ □ □ □
25. Ik kan mijn gedachten en gevoelens waarnemen 
zonder erin verstrikt te raken.
SF □ □ □ □ □ □
26. Bij het lezen moet ik stukken opnieuw lezen 
omdat ik aan iets anders dacht.
SF □ □ □ □ □ □
27. Ik neem geluiden in mijn omgeving, zoals kwetterende 
vogels of voorbij rijdende auto’s, bewust waar.
SF □ □ □ □ □ □
28. Ik neem mijn gevoelens en gedachten waar en kan 
ze tegelijkertijd van enige afstand bekijken.
□ □ □ □ □ □
29. Ik neem veranderingen in mijn lichaam duidelijk waar, 
bijvoorbeeld een snellere of langzamere adem.
SF □ □ □ □ □ □
30. Ik hou er niet van om boos of angstig te zijn en 
probeer zulke gevoelens aan de kant te schuiven.
SF □ □ □ □ □ □
31. In het dagelijks leven, ben ik me ervan bewust dat mijn 
kijk op de dingen subjectief is en niet noodzakelijk 
met de feiten overeen hoeft te komen.
SF □ □ □ □ □ □
32. Ook wanneer ik een grote fout gemaakt heb, ga ik 
op een begripvolle manier met mezelf om.
□ □ □ □ □ □
33. Wanneer ik pijn heb, probeer ik die sensatie 
zoveel mogelijk te vermijden.
SF □ □ □ □ □ □
34. In het dagelijks leven, ben ik me ervan bewust 
hoe ik me op dat moment voel.
SF □ □ □ □ □ □
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TABLE S2. (Continued)
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35. In het dagelijks leven, ben ik me ervan bewust dat 
mijn eigen opvattingen, die ik op dat moment zeer 
serieus neem, aanzienlijk kunnen veranderen.
SF □ □ □ □ □ □
36. Ik neem mezelf mijn fouten en zwakheden kwalijk. SF □ □ □ □ □ □
37. Wanneer ik mezelf het leven onnodig moeilijk 
maak, merk ik dat snel daarna op.
□ □ □ □ □ □
Scoring
1) Gewaar innerlijke ervaringen (inner awareness): 1, 5, 14, 29, 34
2) Gewaar externe ervaringen (outer awareness): 9, 18, 21, 27
3) Bewust handelen (acting with awareness): 10, 12, 17, 26
4) Niet oordelende, accepterende houding (acceptance): 2, 7, 11, 32, 36
5) Niet reactieve, gedecentreerde houding (decentereing/nonreactivity): 8, 13, 16, 20, 
25, 28
6) Open, niet-vermijdende houding (openess):19, 22, 30, 33
7) Relativeren van gedachten (relativity): 4, 23, 31, 35
8) Inzicht (insight): 3, 6, 15, 24, 37
Reversed scored: 7, 10, 17, 19, 22, 26, 30, 33, 36
SF= included in short form
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The overall goals of the studies included in this dissertation were a) to investigate 
the effectiveness of MBCT for chronic, treatment resistant depression, b) to explore 
cognitive reactivity and rumination as potential working mechanisms of MBCT and 
c) to investigate the psychometric properties of the Dutch translation of a novel, 
comprehensive questionnaire to assess mindfulness skills. This chapter summarizes 
and discusses the studies in relation to the existing literature. In addition, strengths and 
limitations are identified and directions for future research and clinical implications are 
given.
SUMMARY
Chapter 2 describes the rationale, design and methods of the RCT comparing MBCT 
with treatment-as-usual (TAU) for chronically, treatment-resistant depressed patients. 
All participants were depressed for at least 12 months, despite of at least 10 sessions 
of evidence-based psychological treatment, such as CBT or IPT and treatment with 
at least one antidepressant (> 4 weeks) during the current episode. At the beginning 
of the study all participants were moderately to severely depressed. Before and after 
the MBCT or treatment-as-usual (TAU), depressive symptoms, rumination, quality of 
life, mindfulness skills and self-compassion were assessed. In addition, remission rates 
were investigated with a psychiatric interview according to DSM-IV criteria. Chapter 3 
presents the findings of this RCT. In total, 106 participants were included in the study. 
Results of the intention-to-treat analyses including all available data show that there was 
no significant difference in reduction of depressive symptoms between the conditions. 
However, at post-treatment more participants of the MBCT condition compared with 
TAU reached (partial) remission from their depressive disorder. In addition, participants 
of the MBCT group showed significant less rumination, a higher quality of life, more 
mindfulness skills, and more self-compassion compared with TAU. The percentage of 
participants who dropped out of the MBCT was higher than expected, i.e. 24.5%. When 
only including completers of the MBCT in the analysis ('per-protocol analysis'), the 
MBCT condition did show a significant reduction in depressive symptoms compared 
with TAU. Severity of symptoms, treatment-resistancy and childhood trauma did not 
moderate the effect of MBCT or TAU on depressive symptoms. However, baseline levels 
of rumination did moderate the effect of MBCT on depressive symptoms. Participants 
with high levels of rumination on baseline showed significantly lower depressive 
symptoms post-treatment when allocated to MBCT compared with TAU. This implies 
that chronically, treatment-resistant depressed patients who experienced high levels 
of rumination seemed to benefit most of MBCT. Chapter 4 and 5 both investigated 
dysfunctional cognitive processes as potential working mechanisms of MBCT. In chapter 
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4, data of another RCT in remitted depressed patients (N=115) were analyzed to test 
whether MBCT compared with a waitlist-group affects cognitive reactivity. As previous 
analyses showed that MBCT reduces depressive symptoms in this sample, we also 
investigated whether cognitive reactivity mediated the effect of MBCT on depressive 
symptoms. Results showed that after MBCT, cognitive reactivity was indeed significantly 
diminished in the MBCT group and that cognitive reactivity mediated the effect of MBCT 
on depressive symptoms. This provides preliminary evidence for cognitive reactivity as 
a potential working mechanism of MBCT. Chapter 5 investigated the effects of MBCT on 
rumination in a sub-sample (n=62) of the RCT described in chapter 2 and 3. Rumination 
is typically assessed with self-report questionnaires. Although easy to administer, 
questionnaires might be influenced by memory and response bias. In chapter 5, we 
therefore utilized a new, on-line behavioral measure of rumination, called the 'breathing 
focus task' (BFT). Because the BFT has never been used in a clinically depressed sample, 
we first compared the chronically, treatment-resistant depressed sample (n=62) with 
a never-depressed sample (n=106) matched on age and gender. Results show that 
chronically, treatment-resistant depressed patients have significantly more negative 
-but not more neutral or positive- thought intrusions on the BFT compared with the 
never-depressed controls. Higher levels of negative thought intrusions were associated 
with a self-report measure of rumination and patients showed an increase in sad mood. 
Secondly, the scores on the BFT of the chronically, treatment-resistant depressed sample 
were compared before and after MBCT and TAU. As expected, the MBCT group showed 
a significantly larger decrease in negative thought intrusions after treatment than the 
TAU group. This study supports the hypothesis that MBCT reduces state rumination. 
In chapter 6, the validity of the Dutch translation of a new questionnaire to assess 
mindfulness skills is presented. Recent studies have questioned whether the factor 
structure of one of the most frequently used questionnaires to assess mindfulness skills 
(FFMQ) is independent of meditation experience. Bergomi et al. (2014) developed a new 
questionnaire (Comprehensive Inventory of Mindfulness Experiences; CHIME) based 
on all available mindfulness questionnaires and reformulated items to make sure that 
the understanding of items is independent of mindfulness experiences. However, the 
CHIME was not yet available in Dutch. We translated the CHIME to Dutch and tested 
its factor structure, internal consistency, and its discriminant and convergent validity 
in a sample (N=481) consisting of clinical and non-clinical subsamples. Furthermore, 
a short version of the CHIME (CHIME-SF) was developed and the CHIME and CHIME-
SF were administered before and after MBCT or MBSR training. Results show that the 
psychometric properties of the CHIME were acceptable and that the CHIME and CHIME-
SF were both sensitive to change.
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GENERAL DISCUSSION
Effectiveness of MBCT for patients with chronic, treatment-resistant 
depression
The RCT described in chapter 2 and 3 was conducted to answer the question whether 
MBCT is an effective treatment for patients with chronic, treatment-resistant depression. 
The results reveal that the answer to this question is not an unequivocal yes or no.
The main hypothesis tested in the RCT was that MBCT would decrease depressive 
symptoms. The results of the intention-to-treat analysis show that MBCT compared 
to TAU did not lead to a significant decrease in depressive symptoms. However, when 
analyzing data of participants who completed the MBCT (per-protocol sample) there 
was a significant effect on depressive symptoms with a small to medium effect size. This 
indicates that MBCT seemed to reduce depressive symptoms effectively in participants 
who were able or willing to complete the MBCT training. When comparing the current 
results with previous studies it is important to keep the specific characteristics of the 
different study populations in mind. The study of van Aalderen et al. (2011) on which we 
based our power analysis focused on remitted and currently depressed patients with 
recurrent depression. Most of the currently depressed participants in the study of van 
Aalderen et al. (2011) were considerably less severely depressed than participants in the 
current RCT. The present results indicate that the effect of MBCT seems to be smaller in 
chronically, treatment-resistant depressed patients than in currently depressed patients 
with recurrent depression. This conclusion is in line with a meta-analysis, which reported 
smaller effect sizes of psychotherapy for chronic depression compared to non-chronic 
depression (Cuijpers, Andersson, Donker, & van Straten, 2011). The current RCT is the 
first study focusing on chronic and treatment-resistant depressed patients, who are 
an important group of patients in clinical practice. Therefore, it is complex to compare 
the current study with previous literature on samples with either chronic or treatment-
resistant depressed patients. Our findings are partly in line with Michalak et al. (2015) 
who compared MBCT, TAU and CBASP in chronically depressed patients. They found 
that MBCT was only superior to TAU at one of the two treatment sites, and seemed to be 
inferior to CBASP in the total sample. We also found no significant effect of MBCT over 
TAU on depressive symptoms in our main analyses. These two results indicate that MBCT 
does not have a large effect on depressive symptoms in chronically depressed patients. 
However, our finding that MBCT was effective for completers of the MBCT is more in 
line with findings by Eisendraht et al. (2016) who concluded that MBCT was effective for 
pharmaco-resistant depressed patients in reducing depressive symptoms. With regard 
to the percentage of participants that dropped out of the MBCT, our result (24.5%) is 
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comparable with the percentages found by Michalak et al (2015) and Eisendrath et al. 
(2016), who report that respectively 28% and 22.9% of patients were not completing 
MBCT. This indicates that chronically or treatment-resistant depressed patients are 
prone to premature discontinuation of MBCT. 
The secondary hypotheses were that MBCT would influence rumination, quality of life, 
mindfulness skills, and self-compassion. We found significant effects of MBCT on all of 
these measures. This implies that MBCT might be used as a treatment for chronically, 
treatment-resistant depressed patients if the goal is primarily to increase positive mental 
health rather than to reduce depressive symptoms. It is important to realize that the 
study sample consisted of patients with very persistent depressive symptoms. Eighty 
percent of the sample suffered from major depressive episode for more than two years 
and the average duration was 5.30 years (SD=5.90). All patients were severly impaired in 
their functioning in daily life. Therefore, small improvements in rumination or quality of 
life might be clinical meaningful for these patients. It has previously been argued that 
the absence of mental illnesses and positive mental health are correlated but distinct 
constructs (Keyes, 2005). It therefore seems beneficial to not only focus on reducing 
depressive symptoms but also on improving positive mental health in patients with 
chronic, treatment-resistant depression.
 In sum, the results of the main analysis of the RCT did not confirm the hypothesis that 
MBCT would reduce depressive symptoms. However, MBCT did reduce depressive 
symptoms in patients who were able to complete the MBCT. In addition, MBCT might 
has the potential to increase positive mental health in chronically, treatment-resistant 
depressed patients. 
Moderation of treatment effect
In addition to the general question about the effectiveness of MBCT, we set out to 
investigate whether it is possible to identify specific groups of patients who benefit 
from MBCT. Knowledge about specific moderating variables would support the 
prediction of treatment response in individual patients. Previous research found that 
patients who experienced childhood trauma (Ma & Teasdale, 2004; Williams et al., 2014), 
a higher number of previous episodes (Teasdale et al., 2000), or more pronounced 
residual symptoms (Kuyken, Warren, Taylor, & et al., 2016) showed less relapse after 
MBCT. This indicates that individuals who are more vulnerable might benefit more from 
MBCT. In chronically depressed samples, the duration of the current episode might be 
as informative as the number of episodes; we therefore tested both as a moderator. 
However, in the current study, we did not find any moderating effect of childhood 
trauma, number of previous episodes or duration of depressive symptoms. Importantly, 
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in contrast to the previous studies, the current study did not focus on remitted depressed 
patients. Therefore, it might be the case that these variables moderate the effect of 
MBCT on chances of relapse, but not the effect of MBCT on symptom reduction. This 
hypothesis is in line with Eisendrath et al. (2016), who also found no moderating effect 
of childhood trauma on the effect of MBCT on reduction of depressive symptoms in 
pharmaco-resistant depressed patients. Furthermore, Geschwind et al. (2012) found no 
moderating effect of the number of episodes on residual depressive symptoms. 
Interestingly, we found that baseline levels of rumination moderated the effect of MBCT 
on depressive symptoms. High ruminators benefitted from the MBCT, whereas low 
ruminators showed no change in depressive symptoms. This finding is remarkable as it 
is in line with the theoretical underpinnings of MBCT. It is assumed that MBCT teaches 
participants to become aware of negative thoughts and to disengage from these 
thoughts (Segal, Williams, & Teasdale, 2012). Our results suggest that high ruminators 
learn to react in a less dysfunctional manner to negative thoughts, which in turn 
decreases their depressive symptoms. This statement is supported by our findings that 
MBCT had an effect on rumination assessed with a behavioral measure (chapter 5) and 
cognitive reactivity (chapter 4), which are further discussed in the following section.
Working mechanisms of MBCT
In terms of potential working mechanisms of MBCT, this dissertation mainly focused on 
dysfunctional cognitive processes. We found that MBCT affects cognitive reactivity, trait 
rumination (i.e. the general tendency to ruminate) and state rumination (i.e. rumination 
at a particular moment). In addition, we found preliminary evidence that the effect 
of MBCT on depressive symptoms is mediated by change in cognitive reactivity. This 
implies that MBCT weakens the automatic link between a slight deterioration in mood 
and dysfunctional attitudes. Furthermore, MBCT seems to decrease the amount of 
repetitive negative thoughts about causes and implications of depressive symptoms, 
which would otherwise typically reinforce other negative thoughts and feelings. In 
addition to changes in dysfunctional thought processes, the results of the RCT imply 
that MBCT increases mindfulness skills and self-compassion in chronically, treatment-
resistant depressed patients. These results are in line with the theoretical model of 
MBCT (Segal et al., 2012) and previous reviews about the working mechanisms of MBCT 
(Gu, Strauss, Bond, & Cavanagh, 2015; van der Velden et al., 2015). A following step 
would be to investigate further how exactly MBCT influences dysfunctional cognitive 
processes. According to the ‘impaired disengagement hypothesis’ (Koster et al. 2011, 
see figure 1, page 22), rumination is maintained by the disability to redirect attention 
away from negative stimuli. One hypothesis for future research is therefore that MBCT 
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increases attentional control and thereby reduces rumination in chronically, treatment-
resistant depressed patients. Previous studies have shown that training in mindfulness 
might affect attentional processes in healthy individuals or remitted depressed patients 
(Anderson, Lau, Segal, & Bishop, 2007; De Raedt et al., 2012; Verhoeven, Vrijsen, van 
Oostrom, Speckens, & Rinck, 2014). However, specific effects of different meditation 
techniques on attentional processes are not yet clear (Tang, Hölzel, & Posner, 2015). 
Assessing Mindfulness skills
Mindfulness is a multi-facet construct and it is a challenge to define and reliably assess 
mindfulness skills (Davidson & Kaszniak, 2015). The psychometric properties of the 
translated version of the CHIME are promising and show that the Dutch CHIME can be 
used in clinical research to assess mindfulness skills. It has been shown that the factor 
structure of the FFMQ (Baer et al., 2008; Bohlmeijer, ten Klooster, Fledderus, Veehof, 
& Baer, 2011) might depend on meditation experience (Gu et al., 2016). Therefore it 
is important that a Dutch mindfulness questionnaire with a stable factor structure is 
available that is comprehensible for meditation naïve and experienced meditators. 
The CHIME was based on all existing mindfulness questionnaires and therefore 
includes facets of mindfulness that are not included in the FFMQ, such as openness 
to experiences, awareness of thought’s relativity, and insightful understanding. The 
CHIME might therefore be especially useful in research focusing of the associations 
of specific mindfulness facets with psychiatric disorders and well-being. In addition, 
we developed a short form of the CHIME (CHIME-SF) which might be used in research 
settings that require short measurement instruments. The CHIME-SF makes it possible 
to use a comprehensive measure of mindfulness skills with a limited number of items. 
However, it is important to realize that the full CHIME covers the concept in more detail 
and should be used if time allows. Both the CHIME and the CHIME-SF were sensitive to 
change in clinical and non-clinical samples. However, the factor structure of the CHIME-
SF should be replicated in an unrelated sample.
Strengths, limitations and future directions
Strengths
One major strength of this dissertation is the fact that study described in chapter 3 is 
the first RCT to examine the effectiveness of MBCT in chronically, treatment-resistant 
depressed patients. Previous RCTs included patients either fulfilling criteria for chronic 
depression or criteria for treatment-resistance. Chronicity and treatment-resistance are 
often co-occurring, and there are limited treatment options for these patients available. 
This RCT is the first to provide insight in the effectiveness of MBCT for this vulnerable 
patient group. 
157
Summary and general discussion
7
A second strength is that the RCT was a pragmatic trial, embedded in clinical practice. 
Participants attended regular 8-session MBCT trainings, which were provided for 
remitted or currently depressed patients. Trainers used the standard MBCT training 
described by Segal, Williams and Teasdale (2012) which makes the current results 
comparable to previous studies using the same manual. This 8-session MBCT training 
is currently available in several mental health care institutions in the Netherlands. 
Thereby, the results are generalisable to clinical practice and allow conclusions on 
effectiveness rather than efficacy. The need for effectiveness studies in the field of 
mindfulness research was pointed out in an overview article by Dimidjian and Segal 
(2015). Therefore, the current research fills a gap in the current knowledge about MBCT.
Another strength of this dissertation is that we used RCT designs. An RCT is often seen 
as the “gold standard” for testing the effects of an intervention but it is often difficult 
to conduct in mental health care settings. Due to the participation of an university 
medical center (Radboud Centre for Mindfulness) and a mental health care institution 
(Pro Persona) it was possible to recruit a sufficient amount of participants. Furthermore, 
the majority of participants of the RCT described in chapter 2 and 3 were actively 
recruited from the mental health care institution rather than (self-) referred for MBCT. 
This recruitment strategy supports the conclusion that the results are generaliseable to 
a broad group of patients and are not only limited to patients with a special interest in 
MBCT. 
Finally, we not only focused on effectiveness but also on potential working mechanisms 
of MBCT, which is an important goal in the research field according to an overview article 
by Dimidijan and Segal (2015). To assess rumination as a potential working mechanism, 
not only self-report but also a behavioral measure was used. The BFT is an ‘on-line’ 
measure, assessing ruminative thoughts during task performance. The findings on the 
BFT described in chapter 5 support the findings on the self-report questionnaire (RRS) in 
chapter 3. Both show that MBCT reduces rumination. Behavioral measures decrease the 
influences of response bias or social desirability. Therefore finding the same results on 
a questionnaire and a behavioral measure increases the certainty that MBCT influences 
rumination.
Limitations and future directions
There are several limitations of this dissertation, which might give directions for future 
research. First, in both RCTs MBCT was added to TAU, which was compared to TAU only 
rather than to an active control condition. Therefore, participants in the MBCT conditions 
received more treatment sessions than the control condition and participants were not 
blind to the study hypotheses. Therefore, the results could partly be due to general 
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therapeutic effects such as attention by the trainer, hope or peer support. Ideally, the 
findings of the RCT should be replicated with a design including blind raters and an 
active control group matched on treatment intensity. Previous research found that 
MBCT might be as effective as other treatments for depression (Strauss, Cavanagh, 
Oliver, & Pettman, 2014). MBCT is typically provided as a group treatment, which can 
be provided with considerably lower costs than individual therapy (Vos, Corry, Haby, 
Carter, & Andrews, 2005). It therefore would be interesting to compare the effectiveness 
and cost-effectiveness of MBCT with other evidence-based treatments for chronic, 
treatment-resistant depression.
Future research focused on MBCT for chronically, treatment-resistant depressed 
patients should pay attention to the effect size that might be expected. Based on 
the current result the expected effect size on depressive symptoms in chronically, 
treatment-resistant depressed patients is smaller than in currently depressed patients 
and therefore a larger sample would be required to find a significant effect. In addition, 
we found that a relatively large percentage of participants were unable to complete 
the MBCT, therefore sample size calculations should include a realistic amount of MBCT 
drop-outs. However, one might argue that instead of focusing on the exact effect size of 
MBCT for this target group, it might be clinically more meaningful to further investigate 
potential moderators.
Furthermore, it is important to notice that we only investigated short-term effects of 
MBCT. Further research would be needed to test whether the effects on quality of life, 
rumination and depressive symptoms in MBCT completers are stable during a longer 
period of time. We are currently analyzing the available follow-up data of the current 
sample, which will give insights in the long-term effects of MBCT. However, as this 
analysis will be based on an uncontrolled design further studies including a controlled 
follow-up period are needed.
Future research should also focus on the definition of treatment-resistant depression. We 
included patients who previously did not respond to both antidepressant medication 
and psychological treatment based on treatment guidelines (NICE, 2009; Spijker et al., 
2013). In contrast, most of the previous research on treatment-resistance focused on 
biological treatments only, with a large variety in definitions (Berlim & Turecki, 2007). 
The comparison of the current findings with previous research was impeded by these 
different definitions. It is conceivable that psychological interventions, as for example 
MBCT, might have different effects for patients who did not respond to antidepressants 
(Eisendrath et al., 2016) versus patients who did not respond to a combination of 
antidepressants and evidence-based psychological treatments (chapter 3). The field 
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would benefit from a unified definition of treatment-resistance, which should also 
include the number of psychological treatments. A new staging method that not only 
includes biological treatment steps but also previous psychological treatment is the 
Dutch Measure of Treatment-resistance (DM-TRD , Peeters et al., 2016). Making use of 
staging methods such as the DM-TRD might further improve the integration of results 
of different studies. 
Secondly, another possible avenue for future research relates to improvements of the 
intervention itself. We found that a higher than expected amount of participants dropped 
out of MBCT. It therefore seems important to examine the reasons for non-completion 
and to explore strategies to support patients with chronic, treatment-resistant 
depression in completing MBCT. Examining barriers and facilitators in qualitative studies 
could give important indications which adjustments might be needed for this particular 
population. In addition, the length of the course and duration of meditation exercises 
could be further investigated. A recent study (Winnebeck, Fissler, Gärtner, Chadwick, 
& Barnhofer, 2017) tested an individual three-session MBCT training offering shorter 
meditations for chronic or recurrently depressed patients and found significant effects 
on depressive symptoms. However, in contrast to our RCT, no post-treatment scores of 
non-completers were collected, and the effect therefore might be more comparable 
with our per-protocol analysis. Furthermore the sample investigated in the study by 
Winnebeck et al (2017) was self-referred whereas we also actively recruited patients 
in a mental health care institution. In contrast to the beneficial effects of a three-
session MBCT training (Winnebeck et al., 2017), a meta-analysis of the effectiveness of 
psychotherapies for chronic depression (Cuijpers et al., 2010) concluded that at least 18 
sessions were needed to achieve optimal effects. Incorporating these findings might 
imply that more MBCT sessions with shorter meditations could be more effective than 
the standard MBCT for chronically, treatment-resistant depressed patients. Studies 
directly comparing different formats of MBCT would be needed to examine the optimal 
amount of MBCT sessions and meditation lengths for chronically, treatment-resistant 
depressed patients. 
Third, there are several limitations and directions for future research related to working 
mechanisms of MBCT. It is a major limitation that the studies in this dissertation do not 
include assessments of the outcomes and potential mediating variables during the 
MBCT or control condition. Therefore, the temporal order of changes in potential working 
mechanisms and depressive symptoms remains unclear. Evidence about the temporal 
order of changes is needed before a variable can be seen as a working mechanism 
of therapy (Kazdin, 2007). The current studies imply that MBCT affects rumination, 
cognitive reactivity, mindfulness skills and self-compassion, which is an important 
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first step for a better understanding of working mechanisms of MBCT. However, future 
research is needed to investigate whether these changes precede changes in depressive 
symptoms. In addition, it is important to realize that there might be important working 
mechanisms that were not included in this dissertation. Previous research found that 
MBCT has an effect on meta-awareness, anxiety symptoms, memory and attentional 
processing of emotional information (Gu et al., 2015; van der Velden et al., 2015). Future 
research should investigate whether MBCT influences these processes in chronically, 
treatment-resistant depressed patients and whether these processes mediate the effect 
on depressive symptoms. Because of the high comorbidity of depression and anxiety 
disorders (Sartorius, Üstün, Lecrubier, & Wittchen, 1996), particular attention should be 
paid to anxiety sensitivity. Furthermore, it would be interesting to investigate which 
working mechanisms are most important. To address this question, statistical models 
that include several potential mediators of MBCT would be needed, to test the individual 
effects of mediating variables. 
Furthermore, future research should strive to improve measurements of mindfulness 
skills. The CHIME largely resolves the problem that the semantic understanding of 
items is dependent on meditation experience. However, the CHIME is a retrospective 
self-report measure. Therefore scores on the CHIME could be influenced by recall and 
response biases. Furthermore, there might be a difference between peoples own 
judgment how mindful they are and the actual mindfulness of an individual. Therefore 
it might be interesting to combine self-report measures of mindfulness with second-
person perspectives (e.g. of a spouse) and experimental measures of attention and 
awareness (Davidson et al., 2016).
Finally, with regard to moderating variables, it is important to realize that the finding 
that baseline rumination moderates the effect of MBCT was exploratory and requires 
replication. However, the finding that MBCT works best for high-ruminators within the 
group of chronically, treatment-resistant depressed patients, fits well with the theoretical 
underpinnings of MBCT (Segal et al., 2012). As the effect of MBCT on depressive 
symptoms seems to be smaller in patients with chronic, treatment-resistant depression 
than in currently depressed patients, more knowledge of moderating variables seems 
to be especially important in this particular population. Thereby we would hopefully be 
able to make better predictions for whom MBCT is most effective.
By further investigating the interplay of different working mechanisms and moderating 
variables, we could gain a better understanding how MBCT works. In the long term, this 
could lead to improved or more individually tailored treatments.
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Clinical implications
There are several clinical implications that could derive from this dissertation. First, 
our results show that it is difficult for some chronically, treatment-resistant depressed 
patients to complete the MBCT. Barriers might be MBCT-specific (e.g. length of the 
sessions or meditations) or general (e.g. unrelated physical symptoms). Clinicians 
should be attentive to possible barriers and discuss difficulties with their patients. Close 
cooperation between the MBCT trainer and other involved clinicians would probably 
support patients in completing the course.
Secondly, -if replicated- the result that high ruminators benefitted most from MBCT 
could inform clinical decision making. If a patient did not respond to antidepressant 
medication and psychological treatment, clinicians could assess the level of rumination 
in this patient before deciding which therapy would be most suitable. Our results 
indicate that MBCT might be especially effective for high-ruminators. However, 
replication in an unrelated sample is needed before this result should be implemented 
in clinical practice.
Third, as we found effects of the MBCT on rumination, self-compassion and psychological 
quality of life, MBCT might be used for patients who wish to improve in these domains 
of their life. Our results show that MBCT teaches patients with chronic, treatment-
resistant depression to develop a more compassionate and accepting attitude towards 
negative thoughts and feelings. The experienced quality of life of a patient might 
thereby increase.
Mrs. S.
Mrs. S. started MBCT without any specific expectations. She attended 7 sessions and the day of silence. 
Her IDS score, which measures depression severity dropped from 45 (severe) to 32 (moderate). She 
reports that mindfulness practices have been difficult sometimes but that she learned to redirect her 
attention to her breathing. She described the overall change in symptoms like this: 
“Before I started MBCT there was a door and it was closed. Now, after the MBCT, there is still a door, but now it’s 
a bit open. I see everything a little more positively. If I feel down or depressed I try to do a body scan of sitting 
meditation and hope things will get better.”
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NEDERLANDSE SAMENVATTING
Depressie is een van de meest voorkomende psychiatrische aandoeningen en heeft veel 
gevolgen voor de persoon zelf, zijn of haar omgeving en de maatschappij. Elk jaar lijden 
ongeveer 30.3 miljoen mensen in Europa aan een depressie (Wittchen et al., 2011). 
Een depressie wordt gekenmerkt door een lang aanhoudende sombere stemming en het 
verlies van plezier. Daarnaast zijn gewichtstoename of gewichtsverlies, slaapproblemen, 
psychomotorische agitatie of vertraging, vermoeidheid, gevoelens van waardeloosheid 
of extreme schuldgevoelens, concentratieproblemen, geheugenklachten of 
gedachten aan de dood typische symptomen van een depressie. Een depressie wordt 
gediagnosticeerd als aan een aantal van deze criteria wordt voldaan volgens een 
psychiatrisch classificatiesysteem (DSM-V) en als de klachten lijden en beperkingen in 
het functioneren veroorzaken.
Gelukkig zijn er bewezen effectieve behandelingen voor een depressie. Patiënten 
kunnen behandeld worden met medicatie of psychologische therapie. Bij de meeste 
mensen gaat een depressie binnen een paar maanden weer over. Echter zijn er ook 
patiënten bij wie de depressie lang aanhoudt. Bij patiënten bij wie de depressie langer 
dan twee jaar duurt spreekt men van een chronische depressie. Dit is bij ongeveer 
20% van alle depressieve patiënten het geval. Gegevens van een groot onderzoek in 
Nederland lieten echter zien dat als depressieve klachten één jaar aanhouden, de kans 
op een chronische depressie al erg hoog is (Spijker et al., 2002). Daarnaast zijn er veel 
patiënten bij wie bestaande behandelingen niet voldoende helpen. Studies laten zien 
dat maar ongeveer de helft van de patiënten herstelt na een psychologische behandeling 
of een eerste behandeling met antidepressiva (DeRubeis et al., 2005) . Patiënten 
die niet reageren op de behandeling worden in de literatuur als ‘therapieresistent’ 
beschreven. Hierbij valt op dat vaak alleen het aantal behandelingen met medicatie 
wordt meegenomen in de definitie, terwijl richtlijnen ook psychologische behandeling 
adviseren (Spijker et al., 2013). Chronische en therapieresistente depressies veroorzaken 
niet alleen veel persoonlijk lijden, maar ook hoge kosten voor de maatschappij door 
kosten voor behandeling en uitval op het werk (Pincus, 2001). 
Een relatief nieuwe behandeling voor depressie is Mindfulness-Based Cognitive Therapy 
(MBCT). MBCT is gebaseerd op Mindfulness-Based Stress Reduction (MBSR). MBSR is 
een 8-weeks programma dat in de late jaren ’70 door Jon Kabat-Zinn is ontwikkeld voor 
mensen met chronische pijn en somatisch onverklaarbare lichamelijke klachten. Later 
werd op basis van MBSR de MBCT ontwikkeld (Segal, Williams, & Teasdale, 2012). MBCT 
combineert mindfulness meditatie technieken met cognitieve-gedrags therapie (CGT). 
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Mindfulness wordt gedefinieerd als het aandacht besteden aan de ervaring in het huidige 
moment met en accepterende, niet-oordelende houding (Kabat-Zinn, 1994, p. 4). Tijdens 
de MBCT leren deelnemers meditatie technieken zoals de bodyscan, zitmeditatie of de 
3-minuten ademruimte. Daarnaast bestaat het programma uit bewegingsoefeningen 
gebaseerd op Hatha-yoga en technieken uit de CGT. In tegenstelling tot CGT ligt het 
accent echter niet op het uitdagen of evalueren van gedachten, maar op het observeren 
en leren accepteren van gedachten en ervaringen. In plaats van de inhoud van 
gedachten te onderzoeken leren deelnemers het proces van denken waar te nemen. 
De nadruk ligt in de MBCT niet op praten over gedachten en ervaringen maar op het 
samen oefenen. Deelnemers kunnen tijdens de MBCT leren zich minder te identificeren 
met negatieve gedachten. Daarnaast speelt het ontwikkelen van een vriendelijke en 
compassievolle houding naar gevoelens en gedachten een belangrijke rol. 
MBCT werd ontwikkeld als terugvalpreventieprogramma voor mensen die eerder 
meerdere depressieve episoden hebben meegemaakt. Wetenschappelijke onderzoeken 
toonden aan dat MBCT inderdaad effectief is om een terugval te voorkomen. Een van de 
meest recente studies werd uitgevoerd door Kuyken en collega’s (2016). Hierbij hebben 
zij data van alle beschikbare studies samengevoegd, met in totaal 1258 deelnemers. 
Zij vonden dat deelnemers die de MBCT gevolgd hebben minder kans hadden op een 
terugval dan deelnemers die de ‘gebruikelijke behandeling’ ontvingen. Daarnaast lieten 
studies zien dat MBCT ook effectief is voor het verminderen van depressieve klachten bij 
mensen die op het moment van deelname lijden aan een depressie (Strauss, Cavanagh, 
Oliver, & Pettman, 2014). Een volgende vraag is of MBCT ook effectief zou kunnen zijn 
voor mensen met chronische of therapieresistente depressie. Een aantal kleine studies 
toonde aan dat depressieve klachten minder werden bij mensen met chronische of 
therapieresistente depressie (Barnhofer et al., 2009; Kenny & Williams, 2007). De resultaten 
van drie grotere, klinische studies waren echter minder eenduidig. Een onderzoek bij 
farmaco-resistente patiënten vergeleek MBCT met een actieve controlegroep en vond 
een significant effect van MBCT op depressieve klachten (Eisendrath et al., 2016). Ook 
een studie naar een verkorte versie van de MBCT (drie sessies) voor chronische depressie 
vond significante effecten op depressieve klachten (Winnebeck, Fissler, Gärtner, 
Chadwick, & Barnhofer, 2017). Deels tegenstrijdige resultaten werden gevonden in een 
onderzoek voor chronische depressie waarin MBCT met de gebruikelijke behandeling 
en Cognitive Behavioural Analysis System of Psychotherapy (CBASP) werd vergeleken 
(Michalak, Schultze, Heidenreich, & Schramm, 2015). CBASP is een behandeling die 
specifiek werd ontwikkeld voor chronische depressie waarin elementen uit CGT, IPT en 
psychodynamische therapie samengevoegd zijn. In dit onderzoek was MBCT alleen in 
één van de twee onderzoekscentra meer effectief dan de gebruikelijke behandeling. 
Tussen MBCT en CBASP werden geen significante verschillen gevonden, maar er was 
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een trend dat de CBASP meer effect had. Belangrijk is om op te merken dat bijna alle 
studies zich gericht hebben op chronische depressie óf therapieresistente depressie, 
terwijl deze in de klinische praktijk vaak samen optreden. Mensen die niet goed op 
behandeling reageren blijven doorgaans langer depressief. Het is dus nog niet duidelijk 
of MBCT effectief is voor mensen met een chronische, therapieresistente depressie.
Naast de vraag of MBCT werkt word er de laatste jaren ook steeds meer onderzoek 
gedaan naar de vraag hoe MBCT werkt. Welke factoren veranderen door de MBCT en 
maken dat klachten afnemen? Onderzoek naar de werkingsmechanismen van MBCT 
staat nog in de kinderschoenen. Volgens de onderliggende theorie zorgt MBCT voor 
een toename in mindfulness vaardigheden wat vervolgens een effect op klachten 
heeft. Eerder onderzoek toonde dan ook aan dat patiënten in remissie of met lichtere 
klachten na afloop van de MBCT meer mindfulness vaardigheden en meer zelfcompassie 
ontwikkeld hebben (van der Velden et al., 2015). Voor mensen met een chronische of 
therapieresistente depressie is dit minder eenduidig. Een studie vond bijvoorbeeld 
dat mensen met een farmaco-resistente depressie wel een afname in klachten lieten 
zien maar geen toename van mindfulness vaardigheden of zelfcompassie (Eisendrath 
et al., 2016). De laatste jaren ontstond er ook steeds meer discussie rondom de vraag 
hoe je mindfulness vaardigheden het beste kunt meten. Het bleek dat items van een 
van de meest gebruikte vragenlijsten (Five Facet Mindfulness Scale; FFMQ) anders 
werden geïnterpreteerd door mensen met meditatie ervaring dan mensen zonder 
meditatie ervaring. De precieze formulering van de items maakt dus uit. In 2014 
ontwikkelden een aantal onderzoekers op basis van alle bestaande vragenlijsten een 
nieuwe mindfulness vragenlijst (Bergomi, Tschacher, & Kupper, 2014). Deze vragenlijst 
(Comprehensive Inventory of Mindfulness Experiences; CHIME) vragenlijst was echter 
nog niet beschikbaar in het Nederlands. 
Naast het ontwikkelen van mindfulness vaardigheden en zelfcompassie wordt ervan 
uit gegaan dat MBCT automatische negatieve gedachtenpatronen beïnvloed. Ook in 
een gezonde periode voelt iedereen zich wel eens somber of neerslachtig. Meestal gaat 
deze stemming binnen een paar uur of dagen weer over. Bij sommige mensen kan een 
tijdelijke sombere stemming echter negatieve cognities uitlokken zoals “Ik kan niets” of 
“Het komt nooit goed met mij”. Hierdoor blijft de negatieve stemming langer bestaan 
en neemt de kans op een depressie toe. Hoe snel een licht negatieve stemming dit soort 
negatieve attitudes uitlokt wordt cognitieve reactiviteit genoemd. Als mensen na afloop 
van de MBCT minder cognitieve reactiviteit vertonen zou dit de kans op een terugval 
kleiner maken. Eerder onderzoek gaf aanwijzingen dat MBCT cognitieve reactiviteit 
beïnvloedt, maar er zijn nog geen gerandomiseerde studies met voormalig depressieve 
mensen uitgevoerd. Een proces dat sterk gerelateerd is aan cognitieve reactiviteit is 
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rumineren. Rumineren is gedefinieerd als het herhaaldelijk nadenken over de oorzaken 
en redenen van klachten zonder dat men tot oplossingsgerichte acties komt. Door 
MBCT zouden deelnemers kunnen leren zich eerder bewust te worden van ruminerende 
gedachten, en hoe zij actief de aandacht kunnen verleggen naar het huidige moment. 
Eerder onderzoek gaf aanwijzingen dat MBCT invloed heeft op rumineren. Echter voor 
chronische en therapieresistente depressie is dit verband nog niet duidelijk. Daarnaast 
werden tot op heden meestal vragenlijsten gebruikt om rumineren te meten. Het is 
bekend dat een depressie vaak gepaard gaat met vertekeningen in het geheugen, wat 
de antwoorden op een vragenlijst kan beïnvloeden. Daarom beval recent onderzoek 
(van der Velden et al., 2015) aan ook experimentele taken te gebruiken.
Het belangrijkste doel van dit proefschrift was om de effectiviteit van MBCT voor 
chronische, therapieresistente depressie te onderzoeken. Daarnaast werden cognitieve 
reactiviteit en rumineren als mogelijke werkingsmechanismen van MBCT onderzocht. 
Tenslotte hebben we de CHIME vragenlijst vertaald naar het Nederlands, de validiteit 
onderzocht en een verkorte versie ontwikkeld. Hieronder volgt een samenvatting van 
de bevindingen en conclusies uit dit proefschrift.
Effectiviteit van MBCT voor mensen met chronische, therapieresistente 
depressie
Om de effectiviteit van MBCT voor mensen met een chronische, therapieresistente 
depressie te onderzoeken hebben we een gerandomiseerde, gecontroleerde studie 
(RCT) opgezet. De opzet en uitkomsten hiervan worden beschreven in hoofdstuk 2 en 3.
Hoofdstuk 2 beschrijft de opzet en het protocol van de RCT. Tot de doelgroep 
behoorden mensen met matig tot ernstige huidige depressieve klachten die al langer 
dan 12 maanden duurden ondanks behandeling met medicatie en psychologische 
behandeling. De behandeling moest aan bepaalde kwaliteitscriteria voldoen: de 
behandeling met medicatie moest minimaal 4 weken geduurd hebben met een 
voldoende dosering, en de psychologische behandeling moest bestaan uit minimaal 
10 sessies CGT of interpersoonlijke therapie. Deelnemers werden geworven binnen 
de ambulante teams van Pro Persona in Nijmegen, Ede, Tiel, Arnhem en binnen 
het Radboud Centrum voor Mindfulness in het Radboudumc. Alle deelnemers 
ontvingen gedurende de hele studie de gebruikelijke behandeling. Willekeurig werd 
daarnaast de helft van de deelnemers toegewezen aan de MBCT. De andere helft werd 
toegewezen aan de controlegroep die alleen de gebruikelijke behandeling ontving. 
Ook de controlegroep mocht na afloop van de nameting de MBCT volgen. De MBCT 
werd gegeven door gekwalificeerde trainers volgens het standaard MBCT protocol. 
Deelnemers participeerden in MBCT groepen die gegeven werden voor patiënten 
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met terugkerende depressie. De behandeling vond plaats binnen de gewone klinische 
setting. De primaire uitkomstmaat waren depressieve klachten. Daarnaast werden 
veranderingen in rumineren, kwaliteit van leven, mindfulness vaardigheden en 
zelfcompassie gemeten. Ook werd onderzocht of er modererende variabelen waren, 
d.w.z. of bepaalde groepen meer of minder profiteerden van de MBCT.
Hoofdstuk 3 beschrijft de uitkomsten van de RCT. In totaal hebben 106 patiënten deel 
genomen aan de studie. Ten eerste viel op dat sommige deelnemers moeite hadden de 
MBCT af te ronden. Van de 49 deelnemers in de MBCT conditie hebben 12 (24.5%) de 
MBCT niet afgerond of zijn uiteindelijk helemaal niet gestart. Als we deze deelnemers 
meenemen in de analyses zien we geen significant effect van de MBCT op depressieve 
klachten. Wel waren er significante effecten van de MBCT op rumineren, kwaliteit van 
leven, mindfulness vaardigheden en zelfcompasssie. Als we alleen de mensen die de 
training af (konden) ronden vergelijken met de controlegroep zien we daarnaast ook een 
significant effect van MBCT op depressieve klachten. Verder zagen we dat deelnemers 
die vooraf aan de MBCT meer dan klinisch gemiddeld rumineren een grotere afname in 
depressieve klachten lieten zien dan deelnemers die weinig rumineren. Dit betekend 
dat de MBCT effectief was voor patiënten die in staat waren de MBCT af te ronden. 
Mogelijk is MBCT het meest effectief voor patiënten die veel rumineren. Het percentage 
patiënten wat de MBCT niet afronde was vergelijkbaar met eerdere studies (Eisendrath 
et al., 2016; Michalak et al., 2015). MBCT kan daarom nog niet voor alle patiënten met 
chronische, therapieresistente depressie aangeraden worden om de depressieve 
klachten te verminderen. Wel zagen we in alle analyses effecten op de kwaliteit van 
leven en rumineren. Als het vergroten van de kwaliteit van leven en leren minder te 
rumineren het hoofddoel van de behandeling is, dan zou MBCT kunnen helpen. Al zou 
dit met een nieuwe studie definitief bevestigd moeten worden. De bevinding dat de 
MBCT voornamelijk effectief was voor mensen die veel rumineren is erg interessant en 
verdient vervolgonderzoek.
Werkingsmechanismen: cognitieve reactiviteit & rumineren
Hoofdstuk 4 en 5 zijn beiden gericht op mogelijke werkingsmechanismen van MBCT. 
Hoofdstuk 4 gaat over cognitieve reactiviteit als mogelijk werkingsmechanisme van 
MBCT. Met data van een eerdere RCT hebben we onderzocht of MBCT effect heeft 
op cognitieve reactiviteit en of een afname in cognitieve reactiviteit depressieve 
klachten vermindert. Patiënten in remissie (n=115) werden op basis van toeval 
toegewezen aan de MBCT of de gebruikelijke behandeling. Deelnemers in de MBCT 
groep lieten na afloop van de training een significante afname in cognitieve reactiviteit 
zien. Ook was cognitieve reactiviteit een mediator. Dat wil zeggen dat de afname in 
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cognitieve reactiviteit deels de afname in depressieve klachten verklaarde. Dit is een 
eerste aanwijzing dat cognitieve reactiviteit een werkingsmechanisme is van MBCT. 
Voordat definitieve conclusies over de causale relaties getrokken worden dienen deze 
bevindingen echter bevestigd te worden met studies die ook metingen afnemen 
gedurende de MBCT training.
Hoofdstuk 5 beschrijft resultaten rondom rumineren als werkingsmechanisme van 
MBCT. Om rumineren te meten hebben we een nieuwe gedragsmaat gebruikt, de 
‘Breathing Focus Task’ (BFT). Gedurende de taak wordt de deelnemer gevraagd op 
zijn ademhaling te letten en opkomende gedachten (negatief/positief/neutraal) te 
rapporteren. Omdat deze taak nog nooit in een depressieve steekproef werd gebruikt 
hebben we de BFT eerst vergeleken tussen gezonde, nooit depressieve deelnemers 
(n=106) en patiënten met chronische, therapieresistente depressie (n=62). Hieruit 
bleek dat de patiënten significant meer negatieve maar niet meer positieve of neutrale 
gedachten rapporteerden. Het aantal negatieve gedachten correleerde met de 
eigen beoordeling van de deelnemers over hoe erg zij aan het rumineren waren. De 
patiëntengroep rapporteerde daarnaast ook somberder te zijn na de BFT. Dit effect 
is te verwachten, omdat we weten dat rumineren de stemming negatief beïnvloedt. 
Ten tweede hebben we de scores van de chronisch, therapieresistente depressieve 
deelnemers onderzocht in een RCT design. Dit onderzoek was onderdeel van de studie 
die beschreven is in hoofdstuk 3. Vergeleken met de controlegroep rapporteerde de 
MBCT groep minder ruminatie na afloop van de MBCT. Deze resultaten laten zien dat de 
BFT gebruikt kan worden in chronisch, therapieresistente depressieve patiënten en dat 
MBCT rumineren in deze groep vermindert. 
Meten van mindfulness vaardigheden
In hoofdstuk 6 beschrijven we de vertaling en psychometrische eigenschappen van 
een nieuwe mindfulness vragenlijst (CHIME). Aanleiding voor de ontwikkeling van 
een nieuwe vragenlijst was dat items van een veelgebruikte mindfulness vragenlijst 
door mensen met mediatie ervaring anders geïnterpreteerd werden dan door mensen 
zonder meditatie ervaring. Dit is een probleem als men de scores voor en na de MBCT 
wil vergelijken. Bij de CHIME lijkt dit probleem niet te bestaan. We hebben de CHIME 
vertaald van het Duits naar het Nederlands en de psychometrische eigenschappen 
onderzocht. Ook hebben we een verkorte versie van de vragenlijst ontwikkeld (CHIME-
SF). De psychometrische eigenschappen van zowel de CHIME (37 items) als de CHIME-SF 
(24 items) zijn acceptabel. Beide vragenlijsten kunnen gebruikt worden voor onderzoek 
naar mindfulness. De CHIME is met name geschikt voor studies naar specifieke 
mindfulness vaardigheden omdat de CHIME aspecten meet die niet voorkomen in 
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de FFMQ (open, niet-vermijdende houding; relativeren van gedachten; inzicht). De 
validiteit van de CHIME-SF dient echter nog bevestigd te worden in een onafhankelijke 
steekproef.
Sterke punten & aanbevelingen voor vervolgonderzoek
Zoals elk onderzoek hebben de hier gepresenteerde studies sterke en zwakke punten. 
Een sterk punt is dat we de effectiviteit van MBCT voor patiënten onderzocht hebben 
die chronisch depressief en therapieresistent waren. Dit is een belangrijke groep in de 
klinische praktijk in Nederland. Ondanks dat chroniciteit en therapieresistentie vaak 
samen voorkomen hebben eerdere studies zich gericht op één van deze aspecten. Ten 
tweede vond het onderzoek plaats binnen de klinische praktijk. Deelnemers volgden 
MBCT trainingen die beschikbaar zijn binnen de GGZ. Daardoor laten de resultaten 
conclusies toe over de effectiviteit van MBCT in de klinische praktijk. Daarnaast is het 
een sterk punt dat wij de effecten van MBCT konden onderzoeken in een RCT, wat als 
de ‘gouden standaard’ geldt. 
Een minder sterk punt van de RCT is het feit dat we MBCT vergeleken hebben met 
de gebruikelijke behandeling. Hierdoor heeft de MBCT groep meer behandelsessies 
gevolgd dan de controlegroep en kunnen we niet uitsluiten dat algemene effecten 
zoals hoop, aandacht door een trainer of lotgenotencontact het effect mede bepaald 
hebben. Daarnaast hebben we alleen de korte termijn effecten van MBCT onderzocht. 
Verder onderzoek zal moeten uitwijzen of de effecten stabiel zijn over een langere 
periode. Daarnaast is het belangrijk om vervolgonderzoek te doen naar het relatief grote 
percentage deelnemers dat de MBCT niet afrondde. Kwalitatief onderzoek zou verder in 
kaart kunnen brengen welke factoren deelname belemmeren of faciliteren. Eventueel 
zou op basis daarvan de MBCT aangepast kunnen worden voor deze doelgroep. 
Een duidelijke beperking van de studies naar mogelijke werkingsmechanismen is 
dat onze designs geen metingen gedurende de MBCT of controleperiode bevatten. 
Daardoor zijn geen harde uitspraken over de causale relaties tussen de potentiele 
werkingsmechanismen en klinische uitkomstmaten mogelijk. Daarnaast hebben we 
niet alle mogelijke werkingsmechanismen onderzocht. Er zijn waarschijnlijk andere 
variabelen- zoals aandachtsprocessen, geheugenprocessen, of angstsensitiviteit- die 
het effect mee bepalen. Vervolgonderzoek zou moeten uitwijzen wat de bijdrage van 
deze variabelen is, en of er interactie bestaat tussen verschillende variabelen.
Tenslotte is nog meer onderzoek nodig naar meetinstrumenten om mindfulness 
vaardigheden in kaart te brengen. De CHIME lijkt een verbetering te zijn ten opzichte 
van de bestaande vragenlijsten. Maar ook de CHIME is een zelfrapportagelijst en wordt 
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waarschijnlijk beïnvloed door vertekeningen in geheugenprocessen en de neiging 
sociaal wenselijke antwoorden te geven. Ook het combineren van zelfrapportage 
met de beoordeling door een naaste of de uitkomsten van experimentele tests zou 
interessant kunnen zijn.
Implicaties voor de klinische praktijk
De bevindingen uit dit proefschrift leiden tot een aantal aanbevelingen voor de 
klinische praktijk. Ten eerste laten de resultaten zien dat het voor sommige chronisch, 
therapieresistente depressieve patiënten goed mogelijk is de MBCT te volgen en zij na 
afloop minder depressieve klachten ervaren. Maar er zijn ook patiënten die de MBCT 
niet af konden ronden. Clinici zouden er goed aan doen attent te zijn op mogelijke 
problemen en deze met de patiënt bespreken. Ook een nauwe samenwerking tussen 
de MBCT trainer en andere clinici zou het proces van de patiënt mogelijk kunnen 
ondersteunen. 
Ten tweede zou het resultaat dat met name patiënten die veel rumineren profijt hadden 
van de MBCT gebruikt kunnen worden in de indicatiestelling voor MBCT. Voordat het 
opgenomen wordt in de klinische praktijk dient dit resultaat echter nog gerepliceerd 
te worden.
Onze resultaten laten zien dat MBCT een effect had op rumineren, kwaliteit van leven en 
zelfcompassie van patiënten met chronische, therapieresistente depressie. Als het doel 
van de behandeling is om patiënten te leren een meer compassievolle en vriendelijke 
houding tegenover negatieve gedachten en gevoelens te ontwikkelen zou MBCT 
ingezet kunnen worden voor deze doelgroep. Door MBCT zou de kwaliteit van leven 
toe kunnen nemen van deze ernstig aangedane patiëntengroep.
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DEUTSCHE ZUSAMMENFASSUNG
Depressive Störungen gehören zu den häufigsten psychischen Erkrankungen und 
führen bei Patienten zu erheblichen Beeinträchtigungen im privaten und beruflichen 
Leben. Jedes Jahr erkranken 30,3 Millionen Menschen in Europa an einer depressiven 
Störung (Wittchen et al., 2011). 
Symptome einer Depression sind eine anhaltende depressive Verstimmung, deutlich 
vermindertes Interesse, Appetitverlust oder gesteigerter Appetit mit entsprechender 
Gewichtsveränderung, Schlafstörungen, psychomotorische Agitation oder Hemmung, 
Müdigkeit oder Energieverlust, Gefühle von Wertlosigkeit oder unangemessene 
Schuldgefühle, Konzentrationsprobleme oder Entscheidungsprobleme, sowie 
wiederkehrende Gedanken an den Tod oder Suizid. 
Die Diagnose einer depressiven Episode erfolgt, wenn eine bestimmte Anzahl dieser 
Symptome über einen Zeitraum von mindestens zwei Wochen besteht und in klinisch 
bedeutsamer Weise Leiden verursacht. 
Depressive Episoden können sowohl psychotherapeutisch als auch mit Psychopharmaka 
behandelt werden. In den meisten Fällen verläuft eine Depression episodisch und 
lässt nach einigen Monaten nach. Bei ungefähr 20% aller Patienten halten depressive 
Episoden allerdings sehr lange an und entwickeln einen chronischen Verlauf. Im 
Allgemeinen spricht man von einer chronischen Depression ab einer Dauer von zwei 
Jahren. Epidemiologische Daten aus den Niederlanden konnten jedoch zeigen, dass 
bereits ab einer Dauer von einem Jahr die Wahrscheinlichkeit für einen chronischen 
Verlauf sehr hoch ist (Spijker et al., 2002). Des Weiteren gibt es Patienten, die nicht 
oder nur unzureichend auf antidepressive Medikation oder psychotherapeutische 
Behandlung ansprechen. Nur ungefähr 50% der Patienten erreichen nach einer 
ersten psychotherapeutischen oder medikamentösen Therapie mit Antidepressiva 
eine vollständige Remission (DeRubeis et al., 2005). Patienten, die auf mehrere 
Therapieversuche nicht oder nur eingeschränkt reagieren, werden als therapieresistent 
bezeichnet. Auffällig ist hierbei, dass die gängigen Definitionen von Therapieresistenz 
fast ausschließlich auf der Anzahl medikamentöser Behandlungsversuche basieren 
und der Anzahl psychotherapeutischer Therapien keine Beachtung schenken, obwohl 
die Psychotherapie ein wichtiges Element in Behandlungsleitlinien ist. Insbesondere 
chronische und therapieresistente depressive Episoden verursachen nicht nur 
starkes persönliches Leiden, sondern auch hohe gesellschaftliche Ausgaben durch 
Therapiekosten und Erwerbsunfähigkeiten (Pincus, 2001).
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Eine relativ neue Behandlungsmöglichkeit für depressive Störungen ist die 
Achtsamkeitsbasierte Kognitive Therapie (Mindfulness-based cognitive therapy, 
MBCT). MBCT basiert auf Mindfulness-based Stress Reduction (MBSR), eine 
Gruppenintervention, die Ende der 70er -Jahre von Jon Kabat-Zinn für Menschen 
mit chronischen Schmerzen oder somatoformen Störungen entwickelt wurde. Laut 
Kabat-Zinn bedeutet Achtsamkeit das bewusste Richten der Aufmerksamkeit auf den 
gegenwärtigen Moment mit einer akzeptierenden und nicht-wertenden Haltung 
(Kabat-Zinn, 1994). Während des 8-wöchigem MBCT Interventionsprogramms 
erlernen Teilnehmer Meditationsübungen wie den Body-Scan, Sitzmeditation und 
den Atemraum. Außerdem besteht das Programm aus Elementen der kognitiven 
Verhaltenstherapie und Yogaübungen. Die Erfahrungen der Teilnehmer werden mit 
dem Trainer und anderen Kursteilnehmern intensiv nachbesprochen. Insgesamt steht 
aber nicht der Austausch über depressive Symptome, sondern das Erleben eines 
Seins-Modus im Vordergrund. Fokus der Therapie ist das gemeinsame Erlernen von 
Achtsamkeitsübungen. Im Gegensatz zur kognitiven Verhaltenstherapie steht das 
Wahrnehmen von kognitiven Prozessen und nicht deren Veränderung im Vordergrund. 
Teilnehmer werden ermutigt, Gedanken als ein Produkt des menschlichen Geistes zu 
begreifen und sich nicht mit dem Inhalt negativer Gedanken zu identifizieren. Darüber 
hinaus spielt das Erlernen von selbstbezogenem Mitgefühl (Self-Compassion) eine 
wichtige Rolle während des Programms.
MBCT wurde ursprünglich als Rückfallprophylaxe für depressive Patienten entwickelt. 
Wissenschaftliche Studien belegten, dass MBCT die Rückfallwahrscheinlichkeit 
senken kann und zeigten darüber hinaus, dass durch MBCT ebenfalls eine 
Symptomverminderung bei akut depressiven Patienten erreicht werden kann. Es ist 
noch nicht deutlich, inwiefern diese Ergebnisse auch auf Patienten mit chronischer 
oder therapieresistenter Depression zutreffen. In einer randomisiert kontrollierte Studie 
mit depressiven Patienten, die vor Studienbeginn mit mindestens zwei verschiedenen 
Antidepressiva behandelt wurden, wurde eine signifikante Reduktion der depressiven 
Symptome gefunden (Eisendrath et al., 2016). In einer anderen Studie wurde ebenfalls 
ein signifikanter Effekt eines verkürztem MBCT Programms (drei Sitzungen) bei 
chronische depressiven Patienten berichtet (Winnebeck, Fissler, Gärtner, Chadwick, & 
Barnhofer, 2017). Zu teilweise widersprüchlichen Ergebnissen kam eine andere Studie 
mit chronisch depressiven Patienten, in der MBCT mit einer anderen Gruppentherapie 
für chronische Depression (Cognitive Behavioral Analysis System of Psychotherapy; 
CBASP) verglichen wurde. MBCT erzielte in nur einer der zwei Studienzentren bessere 
Ergebnisse als die Standardbehandlung mit individueller Psychotherapie (TAU). Es 
wurden keine signifikanten Unterschiede zwischen MBCT und CBASP gefunden, wobei 
ein Trend zu beobachten war, dass CBASP möglicherweise effektiver war.
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Insgesamt ist wichtig anzumerken, dass die vorliegenden Studien sich entweder 
auf chronisch oder therapieresistente Patienten richten, obwohl diese Formen der 
Depression in der klinischen Praxis häufig gemeinsam auftreten. Bei Patienten, die nicht 
gut auf Behandlungen ansprechen, entwickelt die depressive Episode häufig einen 
chronischen Verlauf.
Wissenschaftler beschäftigten sich in den letzten Jahren nicht nur mit der Frage, ob 
MBCT eine effektive Therapieform ist, sondern untersuchen vermehrt auch wie MBCT 
wirkt. Welche Prozesse werden genau durch MBCT beeinflusst und wie wirken sich 
diese Prozesse auf depressive Symptome aus? Die Forschung zu Wirkmechanismen 
von MBCT steckt noch in ihren Anfängen. Laut der Theorie, auf der MBCT beruht, 
müsste das bessere Beherrschen von Achtsamkeit Symptome positiv beeinflussen. 
Studien mit remittiert depressiven Patienten zeigten auch, dass Patienten nach der 
Teilnahme an MBCT mehr Achtsamkeit und Self-Compassion entwickelt hatten (van 
der Velden et al., 2015). Es ist noch nicht eindeutig belegt, ob dies bei Menschen mit 
chronischer oder therapieresistenter Depression ebenfalls der Fall ist. In einer Studie 
wurde beispielsweise gefunden, dass therapieresistente, depressive Patienten nach 
der Teilnahme an MBCT zwar weniger Symptome, jedoch nicht mehr Achtsamkeit 
oder Self-Compassion zeigten (Eisendrath et al., 2016). Des Weiteren wird seit einigen 
Jahren immer häufiger diskutiert, wie sich Achtsamkeit am besten messen lässt. Es 
zeigte sich, dass die Interpretation von bestimmten Fragen in einem der am häufigsten 
verwendeten Fragebögen zur Messung von Achtsamkeit (der Five Facet Mindfulness 
Scale; FFMQ) abhängig ist von der persönlichen Erfahrung mit Achtsamkeit. Menschen 
mit einer langen Achtsamkeitspraxis interpretierten die Fragen anders als Menschen 
ohne Erfahrungen mit Achtsamkeit. Daraufhin entwickelten Wissenschaftler in 2014 
einen neuen Fragenbogen zur Erfassung von Achtsamkeit (Comprehensive Inventory of 
Mindfulness Experiences; CHIME; Bergomi, Tschacher, & Kupper, 2014), wobei besonders 
auf die Formulierung der Items geachtet wurde. Von diesem Fragebogen war bisher 
noch keine validierte niederländische Version verfügbar.
Neben dem Erwerb von Achtsamkeit und Self-Compassion gehen Wissenschaftler 
davon aus, dass MBCT negative kognitive Prozesse, wie kognitive Reaktivität und 
depressive Rumination beeinflusst. Unter kognitiver Reaktivität wird eine starke 
Reaktion auf leichte Stimmungsschwankungen verstanden. Menschen mit einer 
(oder mehreren) Depression(en) in der Vorgeschichte können mit sehr negativen 
gedanklichen Schemata auf eine normale Stimmungsschwankung reagieren. Wenn 
eine relativ leichte Stimmungsschwankung schädliche Gedankenstrukturen wie z.B. 
„Ich bin nur etwas wert, wenn ich in allem was ich tue erfolgreich bin“ hervorruft, ist 
die Wahrscheinlichkeit, erneut depressiv zu erkranken erhöht. Wenn durch MBCT die 
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kognitive Reaktivität verringert werden kann, müsste demnach die Wahrscheinlichkeit 
an einer erneuten Depression zu erkranken verringert sein. Es wurden bis jetzt jedoch 
noch keine randomisiert-kontrollierten Studien mit remittiert depressiven Patienten 
durchgeführt.
Unter depressiver Rumination wird ein fortwährendes Grübeln über depressive 
Symptome und deren Ursprung verstanden. Patienten bleiben in Grübelgedanken 
hängen, ohne dass problemlösende Strategien entwickelt werden. Studien haben dies 
bereits bei remittierten Patienten untersucht, jedoch wurde noch nicht getestet, ob 
MBCT auch bei therapieresistenten Patienten ruminieren verringert. Bis zum heutigen 
Zeitpunkt wurden außerdem vor allem Fragebögen benutzt um Rumination zu messen. 
Es ist bekannt, dass Antworten auf Fragebögen durch die für eine Depression typische 
Tendenz negative Informationen besser zu behalten, verzerrt werden können, was eine 
experimentelle Messung von Rumination wünschenswert macht. 
Das wichtigste Ziel dieser Dissertation war die Effektivität von MBCT für chronische, 
therapieresistente depressive Patienten zu untersuchen. Außerdem wurden kognitive 
Reaktivität und Rumination als mögliche Wirkmechanismen untersucht. Des Weiteren 
haben wir den CHIME ins Niederländische übersetzt, dessen Validität getestet und eine 
Kurzversion dieses Fragebogens entwickelt. 
Effektivität von MBCT für Patienten mit chronischer, therapieresistenter 
Depression
Die Effektivität von MBCT für Patienten mit chronischer, therapieresistenter Depression 
wurde in einer randomisierten-kontrollierten Studie (randomised-controlled trial, RCT) 
untersucht. 
In Kapitel 2 wird das Design und Protokoll des RCT’s beschrieben. Zur Zielgruppe 
gehörten Patienten mit einer klinischen Depression, die mindestens seit 12 Monaten 
bestand, obwohl psychotherapeutische und medikamentöse Behandlungen 
stattgefunden hatten. Die frühere psychotherapeutische Behandlung musste dabei 
aus mindestens 10 Sitzungen Kognitiver Verhaltenstherapie oder Interpersoneller 
Therapie bestanden haben. Die antidepressive Medikation musste über vier Wochen in 
einer angemessenen Dosierung eingenommen worden sein. Alle Teilnehmer waren in 
Behandlung bei Pro Persona oder dem Radboudumc in Nijmegen in den Niederlanden. 
In den jeweiligen Studienzentren erhielten alle Teilnehmer ihre normale Therapie 
(treatment-as-usual, TAU). Zusätzlich wurde ungefähr die Hälfte der Teilnehmer per 
Losverfahren in die MBCT Gruppe eingeteilt. Diese Gruppe erhielt zusätzlich einen 
MBCT Kurs durch qualifizierte Trainer. Vor und nach dem MBCT oder TAU wurden 
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depressive Symptome, Rumination, Lebensqualität, Achtsamkeitsfertigkeiten und Self-
Compassion gemessen. Des Weiteren wurde getestet, ob Patienteneigenschaften (z.B. 
Geschlecht, Alter, Hang zur Rumination) den Effekt von MBCT mitbeeinflussen.
In Kapitel 3 werden die Ergebnisse des RCT’s beschrieben. Insgesamt haben 106 
Patienten an der Studie teilgenommen. Zuallererst fiel auf, dass 12 (24.5%) der 49 
Teilnehmer in der MBCT Gruppe den MBCT Kurs nicht abgeschlossen haben. Wenn 
diese Teilnehmer in die Analyse eingeschlossen wurden, wurde kein Effekt von 
MBCT auf depressive Symptome gefunden. Es lag allerdings ein Effekt von MBCT auf 
Rumination, Lebensqualität, Achtsamkeit und Self-Compassion vor. Wenn die MBCT-
Abbrecher nicht in de Analyse eingeschlossen wurden, zeigte sich zudem auch ein 
signifikanter Effekt auf depressive Symptome. Diese Ergebnisse zeigen, dass MBCT für 
Patienten mit chronischer, therapieresistenter Depression effektiv sein kann. Auf Grund 
der hohen Abbruchquote scheint MBCT jedoch nicht für alle Patienten mit chronischer, 
therapieresistenter Depression geeignet zu sein. Ein weiteres interessantes Ergebnis 
war, dass MBCT bei denjenigen Patienten den größten Effekt hatte, die zu Anfang der 
Studie einen überdurchschnittlich großen Hang zur Rumination zeigten. Falls dieses 
Ergebnis in neuen Studien repliziert werden sollte, könnte es sinnvoll sein, MBCT gezielt 
bei Patienten mit chronischer, therapieresistenter Depression einzusetzen, die viel 
rumineren.
Wirkmechanismen: kognitive Reaktivität & Rumination
Kapitel 4 widmet sich einer Studie über kognitive Reaktivität als möglichen 
Wirkmechanismus von MBCT. Mit Daten einer früheren Studie konnten wir untersuchen, 
ob MBCT kognitive Reaktivität beeinflusst und ob diese Abnahme in kognitiver 
Reaktivität eine Verringerung der depressiven Symptome herbeiführt. Remittiert 
depressive Patienten (n=115) wurden per Losverfahren in eine MBCT Gruppe oder TAU 
aufgenommen. Patienten berichteten nach dem MBCT Kurs nicht nur eine Abnahme in 
kognitiver Reaktivität, sondern diese Abnahme schien auch die Abnahme depressiver 
Symptomen zu bedingen. Zukünftige Studien sollten dies weiter untersuchen mit 
Studiendesigns, in denen auch Messungen während des MBCT Kurses stattfinden. 
In Kapitel 5 werden die Ergebnisse einer Studie zur Rumination als möglichem 
Wirkmechanismus von MBCT beschrieben. Um Rumination zu messen, wurde ein 
neuer experimenteller Test benutzt, der “Breathing Focus Task“ (BFT). Bei diesem Test 
werden Teilnehmer gebeten sich auf die eigene Atmung zu konzentrieren und dabei 
auftretende, störende Gedanken (negativ/positiv/neutral) zu berichten. Da der BFT 
bisher noch nicht bei klinisch depressiven Gruppen angewandt wurde, haben wir 
zuerst Testergebnisse von gesunden, nicht-depressiven Teilnehmern (n=106) mit denen 
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von Patienten mit chronischer, therapieresistenter Depression (n=62) verglichen. Die 
Ergebnisse zeigten, dass Patienten signifikant mehr negative -jedoch nicht mehr positive 
oder neutrale- Gedanken berichteten. Die Anzahl negativer Gedanken korrelierte 
zudem mit der Selbsteinschätzung von Teilnehmern über ihre aktuelle Rumination. Des 
Weiteren waren die Patienten trauriger nach dem BFT, was ein zu erwartender Effekt ist, 
da Rumination klassischerweise die Stimmung verschlechtert. In einem zweiten Schritt 
haben wir den BFT in einem RCT-design untersucht. Diese Studie war Teil der Studie, 
die in Kapitel 3 beschrieben ist. Nach der Therapie zeigte die MBCT Gruppe, verglichen 
mit der Kontrollgruppe, signifikant weniger negative Gedanken gemessen mit dem 
BFT. Diese Ergebnisse zeigen, dass der BFT auch bei Patienten mit einer chronischen, 
therapieresistenten Depression benutzt werden kann, und dass MBCT negative 
Gedanken und damit Ruminieren beeinflusst. 
Die Erfassung von Achtsamkeit
In Kapitel 6 wird die Übersetzung und Validierung eines neuen Fragenbogens (CHIME) 
zur Erfassung von Achtsamkeit beschrieben. Der CHIME wurde vom Deutschen ins 
Niederländische übersetzt und eine Kurzversion (CHIME-SF) wurde entwickelt. Die 
psychometrischen Eigenschaften des CHIME’s (37 Items) und des CHIME-SF (24 Items) 
können als akzeptabel beschrieben werden. Beide Skalen können benutzt werden um 
in wissenschaftlichen Studien Achtsamkeit zu messen. Der CHIME könnte vor allem 
nützlich sein für Studien zu bestimmten Dimensionen von Achtsamkeit, da im CHIME 
Unterskalen enthalten sind (Offene, nicht-vermeidende Haltung; Bewusstsein über 
Relativität von Gedanken und Überzeugungen; Einsichtsvolles Verstehen), die nicht in 
anderen Fragebögen, wie z.B. dem FFMQ, vorkommen. Die Faktorenstruktur des CHIME-
SF sollte in einer unabhängigen Stichprobe noch weiter validiert werden.
Stärken, Einschränkungen & weitere Forschung
Wie jede wissenschaftliche Arbeit haben die hier vorliegenden Studien Stärken, 
unterliegen jedoch auch Einschränkungen. Es ist eine Stärke der Arbeit, dass der Fokus auf 
Menschen mit chronischer, therapieresistenter Depression lag. Es gibt nur eingeschränkte 
Therapiemöglichkeiten für diese Zielgruppe. Des Weiteren fokussierten frühere Studien 
sich meistens entweder auf chronische oder therapieresistente Patienten, obwohl diese 
Eigenschaften in der klinischen Praxis häufig zusammen auftreten. Eine zweite Stärke 
der Arbeit ist es, dass die Forschung innerhalb der klinischen Praxis stattgefunden hat. 
Patienten nahmen an MBCT Kursen teil, die innerhalb der Therapiezentren verfügbar 
waren. Des Weiteren wurde die Effektivität von MBCT in einem RCT-Design untersucht, 
was als Goldstandard innerhalb der psychologischen Forschung gilt.
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Eine wichtige Einschränkung der vorliegenden Studien ist, dass wir MBCT mit der 
normalen Therapie (TAU) verglichen haben, die allen Teilnehmern offen stand. 
Dadurch erhielten die MBCT Teilnehmer mehr Therapiestunden und wir können 
nicht ausschließen, dass allgemeine Faktoren wie die Hoffnung auf Besserung, 
Aufmerksamkeit durch den Trainer, oder der Kontakt mit anderen Patienten den Effekt 
mit beeinflusst haben. Des Weiteren haben wir nur relativ kurzzeitige Effekte von MBCT 
untersucht. Weitere Untersuchungen sind nötig, um zu testen, ob die Effekte über einen 
längeren Zeitraum stabil bleiben. Auch die relativ hohe Abbruchquote sollte weiter 
untersucht werden. Mit qualitativen Studien könnte in Erfahrung gebracht werden, 
welche Faktoren die Teilnahem an einem MBCT Kurs erleichtern beziehungsweise 
erschweren. 
Eine Einschränkung der Untersuchungen zu möglichen Wirkmechanismen ist, dass die 
Studiendesigns keine Messungen wahrend des MBCT Kurses beinhalteten. Dadurch 
bleibt die zeitliche Entwicklung der Veränderungen undeutlich und es können keine 
Aussagen über kausale Zusammenhänge gemacht werden. Weiterhin ist zu beachten, 
dass nur wenige Wirkmechanismen untersucht wurden. Es ist wahrscheinlich, dass 
andere Faktoren, wie z.B. Aufmerksamkeitsprozesse, Gedächtnisprozesse oder 
Angstsensitivität beim Effekt von MBCT auf depressive Symptome ebenfalls eine Rolle 
spielen. 
Abschließend ist zu bemerken, dass weitere Studien zur Erfassung von Achtsamkeit 
wünschenswert sind. Der CHIME scheint verglichen mit anderen Fragebögen eine 
Verbesserung zu sein. Allerdings basiert auch der CHIME auf Selbstreflexion, und wird 
möglicherweise durch Verzerrungen im Gedächtnis oder durch sozial erwünschtes 
Antwortverhalten beeinflusst. Eine interessante Richtung für zukünftige Forschung 
könnte die Kombination von Fragebögen, Befragungen von nahen Verwandten und 
experimentellen Tests zur Erhebung von Achtsamkeit sein.
Implikationen für die klinische Praxis
Aus den Ergebnissen der vorliegenden Dissertation lassen sich mehrere Implikationen 
für die klinische Praxis ableiten. Als erstes ist aufzuführen, dass es für einige Patienten 
mit chronischer, therapieresistenter Depression möglich ist an einem standardmäßigen 
MBCT Kurs teilzunehmen, und der MBCT Kurs bei diesen Patienten zu einer Verringerung 
der depressiven Symptome führt. Es hat sich allerdings auch gezeigt, dass manche 
Patienten den MBCT Kurs vorzeitig abgebrochen haben. Therapeuten sollten daher bei 
dieser Zielgruppe besonders gut auf mögliche Hürden achten, und eventuelle Probleme 
mit dem Patienten besprechen. Auch eine enge Zusammenarbeit zwischen Therapeut 
und MBCT Trainer könnte den Prozess des Patienten möglicherweise unterstützen. 
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Zweitens könnte zukünftig das Ergebnis, dass vor allem Patienten, die überdurchschnittlich 
viel ruminieren, von dem MBCT profitierten, zur Indikationsstellung einer Behandlung 
mit MBCT genutzt werden. Bevor dies in der klinischen Praxis umgesetzt wird, sollte 
dieses Ergebnis jedoch erst in einer unabhängigen Stichprobe repliziert werden.
Die Ergebnisse zeigen, dass MBCT bei Patienten mit chronischer, therapieresistenter 
Depression einen Effekt auf depressive Rumination, Lebensqualität und Self-
Compassion hatte. Falls das Therapieziel darin besteht, eine freundlichere, offenere 
Haltung zu negativen Gedanken und Gefühlen zu entwickeln, kann MBCT bei dieser 
Zielgruppe angewendet werden. MBCT hat dadurch das Potenzial, die Lebensqualität 
von dieser ernsthaft erkrankten Patientengruppe zu verbessern. 
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